
<html lang="en"     class="pb-page"  data-request-id="18d2675c-37c6-4a3c-bc26-86a46392700f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00365;issue:issue:10.1021/jmcmar.2017.60.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B" /></meta><meta name="dc.Creator" content="David C.  McGowan" /></meta><meta name="dc.Creator" content="Florence  Herschke" /></meta><meta name="dc.Creator" content="Frederik  Pauwels" /></meta><meta name="dc.Creator" content="Bart  Stoops" /></meta><meta name="dc.Creator" content="Ilham  Smyej" /></meta><meta name="dc.Creator" content="Stefaan  Last" /></meta><meta name="dc.Creator" content="Serge  Pieters" /></meta><meta name="dc.Creator" content="Werner  Embrechts" /></meta><meta name="dc.Creator" content="Mourad Daoubi  Khamlichi" /></meta><meta name="dc.Creator" content="Tine  Thoné" /></meta><meta name="dc.Creator" content="Bertrand  Van Schoubroeck" /></meta><meta name="dc.Creator" content="Wendy  Mostmans" /></meta><meta name="dc.Creator" content="Debbie  Wuyts" /></meta><meta name="dc.Creator" content="Dorien  Verstappen" /></meta><meta name="dc.Creator" content="Annick  Scholliers" /></meta><meta name="dc.Creator" content="Dorien  De Pooter" /></meta><meta name="dc.Creator" content="Deborah  Dhuyvetter" /></meta><meta name="dc.Creator" content="Herman  Borghys" /></meta><meta name="dc.Creator" content="Marianne  Tuefferd" /></meta><meta name="dc.Creator" content="Eric  Arnoult" /></meta><meta name="dc.Creator" content="Jin  Hong" /></meta><meta name="dc.Creator" content="Gregory  Fanning" /></meta><meta name="dc.Creator" content="Jacques  Bollekens" /></meta><meta name="dc.Creator" content="Vijay  Urmaliya" /></meta><meta name="dc.Creator" content="Ard  Teisman" /></meta><meta name="dc.Creator" content="Helen  Horton" /></meta><meta name="dc.Creator" content="Tim H. M.  Jonckers" /></meta><meta name="dc.Creator" content="Pierre  Raboisson" /></meta><meta name="dc.Description" content="Pyrrolo[3,2-d]pyrimidines were identified as a new series of potent and selective TLR7 agonists. Compounds were optimized for their activity and selectivity over TLR8. This presents an advantage ov..." /></meta><meta name="Description" content="Pyrrolo[3,2-d]pyrimidines were identified as a new series of potent and selective TLR7 agonists. Compounds were optimized for their activity and selectivity over TLR8. This presents an advantage ov..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 14, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00365" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00365" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00365" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00365" /></link>
        
    
    

<title>Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00365" /></meta><meta property="og:title" content="Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0012.jpeg" /></meta><meta property="og:description" content="Pyrrolo[3,2-d]pyrimidines were identified as a new series of potent and selective TLR7 agonists. Compounds were optimized for their activity and selectivity over TLR8. This presents an advantage over recently described scaffolds that have residual TLR8 activity, which may be detrimental to the tolerability of the candidate drug. Oral administration of the lead compound 54 effectively induced a transient interferon stimulated gene (ISG) response in mice and cynomolgus monkeys. We aimed for a high first pass effect, limiting cytokine induction systemically, and demonstrated the potential for the immunotherapy of viral hepatitis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00365"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00365">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00365&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00365&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00365&amp;href=/doi/10.1021/acs.jmedchem.7b00365" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6137-6151</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00369" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00380" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification and Optimization of Pyrrolo[3,2-<i>d</i>]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++McGowan">David C. McGowan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-3759-6771" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Herschke">Florence Herschke</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederik++Pauwels">Frederik Pauwels</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bart++Stoops">Bart Stoops</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ilham++Smyej">Ilham Smyej</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefaan++Last">Stefaan Last</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Serge++Pieters">Serge Pieters</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Werner++Embrechts">Werner Embrechts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mourad+Daoubi++Khamlichi">Mourad Daoubi Khamlichi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tine++Thon%C3%A9">Tine Thoné</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bertrand++Van+Schoubroeck">Bertrand Van Schoubroeck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wendy++Mostmans">Wendy Mostmans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debbie++Wuyts">Debbie Wuyts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dorien++Verstappen">Dorien Verstappen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Annick++Scholliers">Annick Scholliers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dorien++De+Pooter">Dorien De Pooter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Dhuyvetter">Deborah Dhuyvetter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herman++Borghys">Herman Borghys</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marianne++Tuefferd">Marianne Tuefferd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Arnoult">Eric Arnoult</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Hong">Jin Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory++Fanning">Gregory Fanning</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacques++Bollekens">Jacques Bollekens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vijay++Urmaliya">Vijay Urmaliya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ard++Teisman">Ard Teisman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helen++Horton">Helen Horton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tim+H.+M.++Jonckers">Tim H. M. Jonckers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierre++Raboisson">Pierre Raboisson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Janssen Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Janssen Research & Development L.L.C., 1400 McKean Road, Spring House, Pennsylvania 19454, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Villapharma Research S.L., Parque Tecnológico de Fuente Álamo, Ctra. El Estrecho-Lobosillo, Km. 2.5-Av. Azul, 30320 Fuente Álamo de Murcia, Murcia, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Alios Biopharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>D.C.M.: phone, +32 6414 1019; e-mail, <a href="/cdn-cgi/l/email-protection#15717876727a62747b557c61663b7f7b7f3b767a78"><span class="__cf_email__" data-cfemail="80e4ede3e7eff7e1eec0e9f4f3aeeaeeeaaee3efed">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>F.H.: phone, +32 6414 1644; e-mail, <a href="/cdn-cgi/l/email-protection#d3b5bbb6a1a0b0bbb893baa7a0fdb9bdb9fdb0bcbe"><span class="__cf_email__" data-cfemail="90f6f8f5e2e3f3f8fbd0f9e4e3befafefabef3fffd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00365&amp;href=/doi/10.1021%2Facs.jmedchem.7b00365" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6137–6151</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 3, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 March 2017</li><li><span class="item_label"><b>Published</b> online</span>14 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00365" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00365</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6137%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDavid%2BC.%2BMcGowan%252C%2BFlorence%2BHerschke%252C%2BFrederik%2BPauwels%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D14%26contentID%3Dacs.jmedchem.7b00365%26title%3DIdentification%2Band%2BOptimization%2Bof%2BPyrrolo%255B3%252C2-d%255Dpyrimidine%2BToll-like%2BReceptor%2B7%2B%2528TLR7%2529%2BSelective%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BB%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6151%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00365"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2030</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00365" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. McGowan&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Herschke&quot;},{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;Pauwels&quot;},{&quot;first_name&quot;:&quot;Bart&quot;,&quot;last_name&quot;:&quot;Stoops&quot;},{&quot;first_name&quot;:&quot;Ilham&quot;,&quot;last_name&quot;:&quot;Smyej&quot;},{&quot;first_name&quot;:&quot;Stefaan&quot;,&quot;last_name&quot;:&quot;Last&quot;},{&quot;first_name&quot;:&quot;Serge&quot;,&quot;last_name&quot;:&quot;Pieters&quot;},{&quot;first_name&quot;:&quot;Werner&quot;,&quot;last_name&quot;:&quot;Embrechts&quot;},{&quot;first_name&quot;:&quot;Mourad&quot;,&quot;last_name&quot;:&quot;Daoubi Khamlichi&quot;},{&quot;first_name&quot;:&quot;Tine&quot;,&quot;last_name&quot;:&quot;Thoné&quot;},{&quot;first_name&quot;:&quot;Bertrand&quot;,&quot;last_name&quot;:&quot;Van Schoubroeck&quot;},{&quot;first_name&quot;:&quot;Wendy&quot;,&quot;last_name&quot;:&quot;Mostmans&quot;},{&quot;first_name&quot;:&quot;Debbie&quot;,&quot;last_name&quot;:&quot;Wuyts&quot;},{&quot;first_name&quot;:&quot;Dorien&quot;,&quot;last_name&quot;:&quot;Verstappen&quot;},{&quot;first_name&quot;:&quot;Annick&quot;,&quot;last_name&quot;:&quot;Scholliers&quot;},{&quot;first_name&quot;:&quot;Dorien&quot;,&quot;last_name&quot;:&quot;De Pooter&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Dhuyvetter&quot;},{&quot;first_name&quot;:&quot;Herman&quot;,&quot;last_name&quot;:&quot;Borghys&quot;},{&quot;first_name&quot;:&quot;Marianne&quot;,&quot;last_name&quot;:&quot;Tuefferd&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Arnoult&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;Fanning&quot;},{&quot;first_name&quot;:&quot;Jacques&quot;,&quot;last_name&quot;:&quot;Bollekens&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;Urmaliya&quot;},{&quot;first_name&quot;:&quot;Ard&quot;,&quot;last_name&quot;:&quot;Teisman&quot;},{&quot;first_name&quot;:&quot;Helen&quot;,&quot;last_name&quot;:&quot;Horton&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;H. M. Jonckers&quot;},{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;Raboisson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6137-6151&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00365&quot;},&quot;abstract&quot;:&quot;Pyrrolo[3,2-d]pyrimidines were identified as a new series of potent and selective TLR7 agonists. Compounds were optimized for their activity and selectivity over TLR8. This presents an advantage over recently described scaffolds that have residual TLR8 activity, which may be detrimental to the tolerability of the candidate drug. Oral administration of the lead compound 54 effectively induced a transient interferon stimulated gene (ISG) response in mice and cynomolgus monkeys. We aimed for a high first pass effect, limiting cytokine induction systemically, and demonstrated the potential for the immunotherapy of viral hepatitis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00365&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00365" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00365&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00365" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00365&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00365" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00365&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00365&amp;href=/doi/10.1021/acs.jmedchem.7b00365" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00365" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00365" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00365%26sid%3Dliteratum%253Aachs%26pmid%3D28671847%26genre%3Darticle%26aulast%3DMcGowan%26date%3D2017%26atitle%3DIdentification%2Band%2BOptimization%2Bof%2BPyrrolo%255B3%252C2-d%255Dpyrimidine%2BToll-like%2BReceptor%2B7%2B%2528TLR7%2529%2BSelective%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BB%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D14%26spage%3D6137%26epage%3D6151%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/jmcmar.2017.60.issue-14/20170727/jmcmar.2017.60.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pyrrolo[3,2-<i>d</i>]pyrimidines were identified as a new series of potent and selective TLR7 agonists. Compounds were optimized for their activity and selectivity over TLR8. This presents an advantage over recently described scaffolds that have residual TLR8 activity, which may be detrimental to the tolerability of the candidate drug. Oral administration of the lead compound <b>54</b> effectively induced a transient interferon stimulated gene (ISG) response in mice and cynomolgus monkeys. We aimed for a high first pass effect, limiting cytokine induction systemically, and demonstrated the potential for the immunotherapy of viral hepatitis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chronic hepatitis B affects over 350 million people worldwide, as it may eventually lead to cirrhosis or hepatocellular carcinoma (HCC), responsible for one million deaths every year.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Less than 1 in 10 patients achieves functional cure, defined as HBsAg loss and sustained HBV-DNA suppression with or without the appearance of HBsAb (seroconversion), with the approved treatments, nucleosides/nucleotides, and interferon-α (IFNα).<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> Low cure rates are due to high viral antigen loads, inability of the host immune system to control HBV, and the immunosuppressive environment of the liver.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">IFNα therapy, unlike nucleosides/nucleotides, has the potential to control all three issues when directly exposed to hepatocytes and liver nonparenchymal cells. IFNα treatment of HBV-infected hepatocytes, which induces the expression of interferon-stimulated genes (ISG),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> decreases both HBsAg and HBeAg levels.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> IFNα also induces the maturation of myeloid dendritic cells toward a Th1 immune response, which is key to controlling HBV.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The major reason for the limited clinical use is the intramuscular route of administration, leading to local and systemic exposure of exogenous recombinant IFNα responsible for both injection site and systemic side effects.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Conversely, orally administered agents inducing endogenous IFNα, like TLR7 agonists, could be more potent and better tolerated.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Toll-like receptors (TLRs) play an important role in human innate immunity by recognizing pathogen associated molecular patterns (PAMPs) present in a variety of viruses and microorganisms.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> TLR7 recognizes foreign genetic material in the form of single-stranded viral RNA. The receptor is localized in the endosome of plasmacytoid dendritic cells (pDC) and B lymphocytes.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Detection of foreign nucleic acid in pDCs leads to an antiviral immune response, resulting in an abundant production of endogenous IFNα and leading to the transcription of interferon stimulated genes (ISGs).<a onclick="showRef(event, 'ref8 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref8 ref15 ref16">(8, 15, 16)</a> In B cells, activation of TLR7 induces B cell maturation and secretion of antibodies which could promote HBsAg seroconversion.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> TLR8 shares a similar protein structure, is also involved in the detection of viral RNA, but differs in that it is found to be expressed on myeloid dendritic cells and monocytes rather than on pDC and B cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> TLR8 agonism may have the advantages of a strong Th1 response but may suffer drawbacks such as the induction of proinflammatory cytokines.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This manuscript focuses on the effort toward an oral, small-molecule TLR7 selective agonist with a high first pass effect that would limit IFNα levels in the plasma, resulting in a presystemic immune modifying response that could be beneficial toward the treatment of chronic HBV.</div><div class="NLM_p">There are several TLR7 agonist series described to date; some examples are shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. Imiquimod (<b>1</b>) is a marketed medication to treat actinic keratosis and basal cell carcinoma.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A second example of TLR7 selective agonist from the literature is <b>2</b>, of the 8-hydroxyadenine series, described as a potent IFN inducer in both mice and monkeys.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>The pteridone series of agonists, represented by GS-9620 (<b>3</b>), was examined in clinical trials to treat HBV.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A cynomolgus monkey study performed with <b>3</b> has demonstrated that an oral dose of 2 mg/kg resulted in a <i>C</i><sub>max</sub> that was 2-fold lower than that achieved following iv infusion of 0.1 mg/kg <b>3</b>. However, mean IFNα plasma levels induced following oral dosing were greater than 60-fold higher than that produced by iv infusion.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>Drug candidates having a rapid elimination after oral administration would potentially improve the overall tolerability and limit the risk for tachyphylaxis, and this was indeed one objective in this program. Another objective was to maximize the selectivity of the TLR7 agonist series over TLR8, to limit the induction of pro-inflammatory cytokines (e.g., TNFα). Indeed, <b>3</b> has been reported to be 30-fold selective for human TLR7 vs TLR8.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Described TLR 7 agonists and novel pyrrolo[3,2-<i>d</i>]pyrimidine (<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A structural observation of known TLR 7 agonists from <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> reveals several common aspects. They all contain, at minimum, a bicyclic core scaffold, with an aryl group pendant, or fused as in imiquimod. Contained in the core structure is a minimal pattern of a nitrogen hydrogen bond acceptor and an adjacent, unsubstituted NH<sub>2</sub> hydrogen bond donor. A third common aspect is the hydrophobic tail, typically four carbon atoms, connected by an oxygen or nitrogen atom and positioned three to four bonds away from the aryl group. If indeed there is a recognition element of the TLR7 protein toward RNA bases, then perhaps new scaffolds would best imitate the shape and electrostatics of adenine and guanine. The design of pyrrolo[3,2-<i>d</i>]pyrimidine (<b>9</b>) started from the concept to use the core pyrimidine scaffold of previously described TLR agonists,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a>keeping the hydrogen bond donor and acceptor pattern of the pyrimidine and adding a fused ring so that the pendent benzyl group was placed proximal to the alkyl chain. Among the many permutations attempted in our laboratory, we would like to focus this manuscript on the success of the TLR7 selective pyrrolo[3,2-<i>d</i>]pyrimidine series starting from the initial compound synthesized (<b>9</b>). Indeed, this novel structure holds all three of the desired design attributes. The butyl chain and pendent benzyl group project ipsilaterally from the bicyclic aromatic scaffold containing a similar donor–acceptor pattern as the described agonists in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>.</div><div class="NLM_p last">We employed two in vitro assays to assess the activity of compounds during the SAR exploration. In the first in vitro assay, the ability of compounds to agonize human TLR7 and TLR8 was assessed in a cell-based reporter assay using HEK293 cells transiently transfected with a wild-type TLR7 or TLR8 expression vector and a NFκB-luc reporter construct. To confirm the activity, compounds were tested in the second in vitro assay, using IFN-mediated anti-HCV activity in the replicon system upon incubation with conditioned media from human peripheral blood mononuclear cells (hPBMCs). In this assay, activation of human TLR7 on pDCs results in the production of IFN. Promising derivatives were evaluated in rat pharmacokinetic studies and a mouse pharmacokinetic–pharmacodynamic model. The selected lead candidate was tested in the mouse hydrodynamic injection (HDI) model and finally in cynomolgus monkey.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Medicinal Chemistry Strategy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our strategy was to systematically investigate the structure–activity relationship of this novel series of pyrrolo[3,2-<i>d</i>]pyrimidines, which was divided into three subseries. The initial subseries, represented by analogues <b>9</b>–<b>27</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), where the <i>n</i>-butylamine was conserved and the phenyl ring is replaced by aliphatic and heterocyclic substituents, was designed to optimize activity and selectivity toward TLR7. The second subseries (compounds <b>28</b>–<b>45</b>) allowed the exploration of alternatives to the aliphatic amine. Finally, in the third subseries (compounds <b>46</b>–<b>59</b>), to afford selective TLR7 agonists with limited off-target activity, the nitrogen atom of <b>42</b> was replaced with an oxygen that afforded the lead compound <b>54</b> for further evaluation. In the context of this project and in contrast to a traditional medicinal chemistry program, rapidly metabolized compounds were desired, thus limiting compound exposure and systemic cytokine activation. Furthermore, it has been demonstrated that a robust antiviral response can be achieved in non-human primates with less than daily dosing of a TLR7 agonist.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Despite the expected low compound plasma concentrations, an effort was made to remove off-target activity including, for example, the potential to inhibit the hERG potassium ion channel.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Activity Relationship of Benzyl Group Replacements<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0006.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0007.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All compounds had a CC<sub>50</sub> > 24 μM in the HEK 293 cytotoxicity assay (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">LEC; least effective concentration values were averaged when determined in two or more independent experiments. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div></div><div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of this series of pyrrolo[3,2-<i>d</i>]pyrimidines is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and began with 2,4-dichloropyrrolo[3,2-<i>d</i>]pyrimidine (<b>4</b>). Alkylation with benzyl bromide in DMF afforded <i>N</i>-benzyl analogue <b>5</b> in 50% yield. Displacement of the first chlorine atom with <i>n</i>-butylamine in 1,4-dioxane afforded <b>6</b> in a modest 67% yield. On the side, the 2-chlorine was converted to a hydroxyl group by heating in aqueous acetic acid to afford <b>7</b>. Finally, nucleophilic aromatic substitution at the 2-chlorine with sodium azide in a mixture of NMP/water afforded the 2-azido intermediate <b>8</b>, followed by a Staudinger reduction that provided the initial agonist <b>9</b> after purification via silica gel column chromatography.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Representative Synthetic Route of Pyrrolo[3,2-<i>d</i>]pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 50% isolated yield; (b) <i>n</i>-butylamine, 1,4-dioxane, 100 °C, 67% yield; (c) HOAc, aq HCl, 100 °C, 24 h, 40%; (d) NaN<sub>3</sub>, NMP/H<sub>2</sub>O 9/1, microwave 170 °C, 5 h, 86%; (e) PPh<sub>3</sub>, 1,4-dioxane:H<sub>2</sub>O 9:1, 120 °C, 16 h, 76%.</p></p></figure><div class="NLM_p">For later analogues, the synthesis was ameliorated to a more scalable route, avoiding the hazardous use of azides and high temperature microwave reaction.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> depicts an example of the synthetic pathway starting with the condensation between ethyl 3-amino-1<i>H</i>-pyrrole-2-carboxylate and 1,3-bis(methoxycarbonyl)-2-methyl-2-thiopseudourea, analogous to methods described in the literature.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The resulting 4-hydroxypyrrolo[3,2-<i>d</i>]pyrimidyl carbamate (<b>10</b>) was converted to the 4-chloropyrrolo[3,2-<i>d</i>]pyrimidinyl carbamate (<b>11</b>) via phosphorus oxychloride in 46% yield. Alkylation of the pyrrole nitrogen under standard Mitsunobu conditions proceeded in moderate yield (65%) to afford <b>12</b>. This was followed by base mediated deprotection of the 2-amino carbamate (<b>13</b>) and finally displacement of the chlorine by an amine nucleophile in a polar solvent that provided <b>37</b> or by an oxygen nucleophile, as in the third subseries, facilitated by NaH (e.g., <b>55)</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Alternative Synthesis of Pyrrolo[3,2-<i>d</i>]pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,3-bis(methoxycarbonyl)-2-methyl-2-thiopseudourea, HOAc, NaOCH<sub>3</sub>, CH<sub>3</sub>OH, rt, 16 h, 87%; (b) POCl<sub>3</sub>, DIPEA, ACN, 70 °C, 1 h, 46%; (c) 2-pyridylmethanol, PPh<sub>3</sub>, DIAD, THF, rt, 30 min, 65%; (d) NaOH, 1,4-dioxane, 60 °C, 5 h, 75%; (e) 5-methyl-2-oxazolemethanamine, DMSO, 110 °C, 16 h, 15%; (f) (5-methyloxazol-2-yl)methanol), NaH, THF, 0–50 °C, 30 min, 22%. See patent applications WO2014056953 and WO2014207082.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure–Activity Relationship</h3><div class="NLM_p">Changes in the 2-amino group led to inactivity (e.g., <b>7</b> and <b>8</b> were >25 μM [hTLR7, 8]) and so further modifications were not pursued. The first example, having an unsubstituted phenyl ring and an <i>n</i>-butyl carbon chain (<b>9</b>), showed exceptional TLR7 activity but unsatisfactory selectivity over the hERG receptor (IC<sub>50</sub> = 2.1 μM). When the phenyl group was more distal to the scaffold (e.g., <b>14</b>, <b>15</b>), TLR7 potency resulted in the same range as <b>9</b>; however undesired TLR8 activity was observed. Replacement of the phenyl group of <b>9</b> with an amide led to lower activity (<b>16</b>) but improved with the isobutene replacement (<b>17</b>). The thiophene analogue <b>18</b> had TLR7 selectivity superior to <b>9</b> in contrast to the 2-thiazole congener <b>19</b> with a selectivity ratio of only 12. The imidazo[1,2-<i>a</i>]pyridine fragment (<b>20</b>) and the three pyridine analogs <b>21</b>–<b>23</b> demonstrated that TLR7 activity was gained when the nitrogen of the heterocycle was adjacent to the methylene group. This substitution pattern showed that the pyridine ring could be modified (<b>24</b>–<b>26</b>) and still retain TLR7 selectivity with the exception of the 2-pyridyl-6-methoxy analogue (<b>27</b>) that exhibited outstanding potency on TLR7 but carried undesired TLR8 activity. Indeed, <b>21</b> displayed remarkable activity and selectivity and lower CYP450 inhibition than the phenyl (<b>9</b>) or thiophene (<b>18</b>) congeners (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>) and would be held constant for exploration in the following subseries. In addition, extensive possibilities exist to access substituted pyridines, facilitating future SAR exploration.</div><div class="NLM_p">The subsequent subseries of analogues would focus on systematic changes of the amine group. Variation of the amine while holding the unsubstituted pyridyl group constant is described in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Differences in activity were seen when the butyl chain was replaced by other aliphatic or heteroaromatic groups; all were selective for TLR7 over TLR8. An ether variation on the butyl chain of <b>21</b> displayed a loss of activity (<b>28</b>). The same held true for alkyl ethers <b>29</b> and <b>30</b>. A modest decline in activity for amino alcohol <b>31</b> was observed when compared to <b>21</b> but highlighted that a polar group was well tolerated. Heterocyclic substituents presented a range of activity depending on the ring size and position of the heteroatoms. The bis-pyridyl analogues (<b>32</b>, <b>33</b>) did not show an increase in potency over the butyl chain, and furthermore the racemic α-methyl group of <b>33</b> did not display a favorable increase in activity, and so further modifications were not pursued. In contrast, thiazole and 1,3,4-oxadiazole (<b>34</b>, <b>35</b>) ring modifications were deleterious to activity, suggesting that the electrostatic properties of the ring are important in addition to the regiochemisty of the heterocycle. The oxazoles displayed higher potency when the methyl group was placed next to the oxygen (<b>37</b>), as opposed to neighboring the nitrogen atom (<b>38</b>). Both oxazoles showed binding to the serotonin receptors (e.g., IC<sub>50</sub>(5HT2a) = 0.65 and 2.3 μM, respectively). The methylisoxazole <b>42</b> was an equipotent TLR7 agonist and had less inhibition of the 5HT2a receptor (IC<sub>50</sub> = 6.2 μM). The cyclopropyl congener (<b>43</b>) was also an effective agonist but displayed more potent hERG inhibition than <b>42</b> (hERG IC<sub>50</sub> = 0.2 vs 1.2 μM, respectively). Finally, if the N–O bond in the isoxazole was reversed (<b>45</b>), then potency was lost.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationship of Amine Substitution<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0008.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0009.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All compounds were >25 μM LEC [hTLR8] and showed CC<sub>50</sub> > 24 μM in the HEK 293 cytotoxicity assay described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">LEC; least effective concentration values were averaged when determined in two or more independent experiments. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">Compound <b>42</b> had achieved the potency and selectivity that was desired and was identified to have no appreciable receptor kinase activity, and no CYP inhibition across several isozymes (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>). However, <b>42</b> remained a strong hERG binder (IC<sub>50</sub> = 1.2 μM).</div><div class="NLM_p">The strategy to identify the best lead candidate was 2-fold: First, the preferred 5-methylisoxazole moiety was held constant allowing the examination of the effect of substituted pyridines, which could influence hERG receptor binding as suggested in the literature.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>Second, it has been described that introduction of an oxygen atom into an aliphatic chain can reduce the propensity of hERG binding.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Thus, we explored pyridine ring variations and converted the amine connection of the heterocycle (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, R<sub>5</sub>) to an ether (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, X = O).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Modifications to the Heterocyclic Rings<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0010.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0011.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">All compounds were >25 μM LEC [hTLR8] and showed CC<sub>50</sub> > 24 μM in the HEK293 cytotoxicity assay described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>. n.d., not done.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">LEC values were averaged when determined in two or more independent experiments.</p></div></div><div></div></div><div class="NLM_p">Variations in the pyridine substitution (compounds <b>46</b>–<b>53</b>) afforded several potent agonists, especially when substituted by electron rich moieties (<b>46</b>, <b>47</b>). It is described in the literature that within a given series of compounds there can be a correlation between hERG binding and a measurement of lipophilicity such as cLogP.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> However, within this chemical series, there was a weak correlation between cLogP and hERG IC<sub>50</sub>. On the contrary, the best progress in avoiding hERG inhibition came with the discrete structural modification of <b>42</b> to the corresponding ether <b>54</b>, despite the two compounds having nearly the same cLogP of 1.1. This modification led to an improved cardiovascular safety profile with a minor loss in TLR7 potency. Further heterocyclic ether variants (oxazole <b>55</b>, thiazole <b>56</b>, oxadiazole <b>57</b>) also bore relatively no hERG inhibition and had intriguing differences in potency that may be rationalized by their difference in charge distribution.</div><div class="NLM_p">The electrostatic potential alignment of analogs <b>54</b>–<b>57</b> showed that the most potent compounds share a similar electrostatic profile (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>). There are two positions on the ring on either side of the methylene group that are key. One α position (south side, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) can be electronegatively charged, while the other (north side) must be electropositively charged (thiazole) or neutral as the potency decreases when this side of the molecule becomes strongly electronegative, as in oxadiazole derivative <b>57</b>. The electrostatic profile of the best substituent could be used as a signature for further exploration of this series. Finally, substituted pyridines <b>58</b> and <b>59</b> once again displayed that potency could be regained by the addition of electron donating methoxy groups on the pyridine ring but unfortunately afforded decreased selectivity over the hERG antitarget.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Left: Electrostatic potential comparison, based on AM1-BCC charges, between isoxazole (<b>54</b>), oxazole (<b>55</b>), thiazole (<b>56</b>), and oxadiazole (<b>57</b>). Right: Predicted binding mode by docking (Glide XP) for compound <b>54</b> in a monkeyTLR7 structure (one TLR7 monomer in cyan and the other in green). See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding mode of <b>54</b>, obtained by docking into monkey TLR7 (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>), illustrated in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, corresponds to the expected binding mode and is comparable to the binding mode described for Resiquimod.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Strong, direct dual hydrogen bonds between the 2-amino group of <b>54</b>, the acidic side chain of Asp555, and the backbone of Thr586 (Carbonyl) were observed. An additional H-bond between the 3-position of the pyrimidine and the backbone of Thr586 (amino) contributes to the stabilization of the compound in the binding site. The scaffold is further stabilized by a π-stacking interaction with Phe408 on one side and by CH−π interactions with Leu557 on the other side.</div><div class="NLM_p">The methylisoxazole is deeply buried in the hydrophobic pocket formed by residues Phe349, Phe351, Val381, and Ile585, stabilized by a π-stacking interaction with Phe351, and has good surface complementarities. In addition, the pyridine ring of <b>54</b> has a CH−π interaction with the Cα of Gln354.</div><div class="NLM_p">In comparison, the binding mode of <b>54</b> is less favorable in hTLR8 for two main reasons (illustrated in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Figure S1</a>): (1) Leu557 is replaced by Asp545 in hTLR8. The scaffold no longer has a CH−π interaction. Instead, Asp545 is making nonfavorable electrostatic interactions with the compound. (2) Thr586 is replaced by Thr574 in hTLR8. The side chain of Thr574 adopts a different orientation, providing less room to accommodate <b>54</b>. The Thr574 side chain is making only one H-bond with the 2-amino group instead of two with its backbone in monkey TLR7. In addition, the Phe351 (TLR7) is replaced by Tyr358 in TLR8 and does not allot enough room to accommodate the methylisoxazole in the hydrophobic pocket. The combination of both a less stable interaction of the scaffold and the methylisoxazole predicts that <b>54</b> would be less potent on hTLR8.</div><div class="NLM_p">Agonist <b>54</b> was found to be selective for TLR7 over TLR8 in the same cellular reporter assay using HEK293 cells transiently transfected with mouse, rat, or cynomolgus TLR7 or TLR8 expression vector and NFκB-luciferase reporter construct (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>). In addition, no direct activation of NFκB was observed. After repetition at higher concentration, <b>54</b> was found to be very selective over TLR8 (>100 μM LEC human TLR8) (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activity of <b>54</b> across Species in Vitro<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">transient transfection of HEK293 cells with</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">average LEC (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR7 + NFκB-luc</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">cynomolgus monkey</td><td class="colsep0 rowsep0" align="left">0.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR8 + NFκB-luc</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">cynomolgus monkey</td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NFκB-luc</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a> for <i>n</i> and confidence interval.</p></div></div></div><div class="NLM_p">The permeability of <b>54</b> was measured in a MDCK-MDR1 cellular assay at 5 μM. <b>54</b> displayed decent permeability with a <i>P</i><sub>app</sub> (A → B, in the presence of GF120918) of 41 × 10<sup>6</sup> cm s<sup>–1</sup> and an efflux ratio of 18, indicating that the compound is a P-gp substrate. <b>54</b> demonstrated low inhibition across five CYP450 isozymes (IC<sub>50</sub> > 10 μM; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>) and was also not a time dependent inhibitor of CYP450 3A4. <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> lists the in vitro metabolic stability of <b>54</b> in liver microsomes and whole-cell hepatocytes across species. Intrinsic clearance (CL<sub>int</sub>) in liver microsomes was moderate in mouse, dog, and human and high in rat and monkey. The intrinsic clearance in hepatocytes evaluated the potential for non-CYP mediated metabolism and was low to moderate in mouse, dog, and human and high in monkey and rat. Plasma protein binding across species remained relatively low and ranged from 54% to 63% bound. <b>54</b> had limited inhibition of the hERG potassium ion channel <sup>3</sup>H-dofetilide binding in vitro (IC<sub>50</sub> > 50 μM), which correlated with a relatively low functional hERG inhibition in the QPatch planar patch clamp assay (32% inhibition at 3 μM).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> To evaluate whether this effect, albeit low, or other undetected compound characteristics could lead to undesired electrophysiology effects in vivo, <b>54</b> was subjected to a cardiovascular safety pharmacology study in anesthetized female guinea pigs. In this model, electrophysiological changes were measured after administration of <b>54</b> by iv infusion in pentobarbital anesthetized animals (cumulatively dosed up to 4.9 mg/kg iv). From this study, no major cardioelectrophysiological effects were observed up to maximal total plasma exposures of 9700 ng/mL (at the end of the infusion). There was no tendency for the formation of micronuclei in vitro in the presence and absence of rat S9 fraction and no potential for mutagenicity revealed by the AMES II test. In further support of the lead compound, cytokine induction was measured after compound stimulation of whole blood of healthy volunteers ex vivo and included IFNα, IFNγ, IL-12p40, and IL-12p70.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Metabolic Stability and Plasma Protein Binding of <b>54</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> microsomes ((μL/min)/mg)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> hepatocytes ((μL/min)/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center" char=".">plasma protein binding (% bound)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">>346</td><td class="colsep0 rowsep0" align="char" char=".">>277</td><td class="colsep0 rowsep0" align="char" char=".">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cynomolgus monkey</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values were rounded to the nearest whole number.</p></div></div></div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Pharmacokinetics</h3><div class="NLM_p last">Among preclinical species, the in vitro metabolism in rat hepatocytes was exceptionally high, and the in vivo clearance was predicted to be above rat liver blood flow. A pharmacokinetic study in healthy male Sprague-Dawley rats investigated the exposure of <b>54</b> in systemic circulation following intravenous administration at 2.5 mg/kg and in the portal vein, liver, and systemic circulation following oral administration of 10 mg/kg. The iv clearance correlated well with the in vitro clearance and exceeded rat liver blood flow, resulting in a very short terminal half-life. The maximum concentration in the portal vein was equal to 314 ng/mL and occurred 1 h postdose. The concentration measurements in the liver and systemic circulation were below quantifiable limits. Oral administration in dogs (1 mg/kg) resulted in fast absorption (<i>T</i><sub>max</sub> at 0.5 h, first sampled time point). The <i>C</i><sub>max</sub> was 125 ng/mL and the systemic concentration dropped below 10 ng/mL, 4 h after administration. The systemic concentration in dog was higher than in rat which is in line with the in vitro stability in microsomes and hepatocytes.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetic and Pharmacodynamic Studies in Mice and Cynomolgus Monkeys</h3><div class="NLM_p">A mouse in vivo model was used to demonstrate the initial proof of concept to induce endogenous IFNα. Single oral administration of 0.3, 1, 3, and 10 mg/kg doses of <b>54</b> was given to healthy, female, fasted C57Bl/6 mice. Concentrations of compound and mouse-IFN via ELISA were measured from the plasma and compared to vehicle. The results are shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. <b>54</b> was found to be rapidly cleared in conjunction with our target profile. Both <i>C</i><sub>max</sub> and AUC increased less than dose proportionally between 0.3 and 3 mg/kg and more than dose-proportionally between 3 and 10 mg/kg. <i>T</i><sub>max</sub> occurred between 0.5 and 1 h, and a liver to plasma ratio of 2 was measured. Levels of IFNα peaked between 1 and 2 h after administration in both plasma and liver. Increase in IFNα was dose-proportional in plasma but sigmoidal in the liver, suggesting a possible saturation of endogenous IFNα production especially in the liver (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). ISG (interferon-stimulated gene) expression was measured in parallel by RT-qPCR. Interestingly, all three <i>Isg15</i>, <i>Oas1b</i>, and <i>Mx1</i> were upregulated to a higher level in the liver than in the plasma, while IFNα, <i>Cxcl10</i>, and the target <i>Tlr7</i> were upregulated similarly in blood and liver (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). These data reveal that <b>54</b> can induce an antiviral ISG response without inducing an IFNα response at a low dose. One potential drawback of the TLR7 selective agonist <b>2</b> is the significant plasma concentrations observed at 8 h in mice after an oral dose of 1 mg/kg,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in contrast to <b>54</b> that was below quantifiable limits at the same dose and time point. Therefore, compound <b>54</b> has rapid clearance after oral administration in mice, limiting compound exposure and systemic cytokine activation, resulting in an improved potential tolerability profile.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mean Maximum Levels in the Plasma and Liver and ISG Upregulation, Induced by <b>54</b> after Oral Dosing in C57Bl/6 Mice<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">dose (mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">0.3</th><th class="colsep0 rowsep0" align="center">1</th><th class="colsep0 rowsep0" align="center">3</th><th class="colsep0 rowsep0" align="center">10</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> plasma (ng/mL)</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">72.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> liver (ng/g)</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">23.0</td><td class="colsep0 rowsep0" align="left">152.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IFNα<sub>max</sub> plasma (pg/mL)</td><td class="colsep0 rowsep0" align="left">105</td><td class="colsep0 rowsep0" align="left">205</td><td class="colsep0 rowsep0" align="left">560</td><td class="colsep0 rowsep0" align="left">1365</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IFNα<sub>max</sub> liver (pg/g)</td><td class="colsep0 rowsep0" align="left">BQL</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">470</td><td class="colsep0 rowsep0" align="left">580</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Oas1b</i><sub>max</sub> plasma<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.85</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">2.45</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Oas1b</i><sub>max</sub> liver<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Isg15</i><sub>max</sub> plasma<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.35</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1.95</td><td class="colsep0 rowsep0" align="left">1.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Isg15</i><sub>max</sub> liver<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Mx1</i><sub>max</sub> plasma<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Mx1</i><sub>max</sub> liver<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">315</td><td class="colsep0 rowsep0" align="left">745</td><td class="colsep0 rowsep0" align="left">775</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Tlr7</i><sub>max</sub> plasma<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">4.05</td><td class="colsep0 rowsep0" align="left">4.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Tlr7</i><sub>max</sub> liver<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3.15</td><td class="colsep0 rowsep0" align="left">2.45</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">3.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Groups of nine mice were dosed with 0.3, 1, 3, or 10 mg/kg of <b>54</b>. At 0.5 h, blood was drawn to quantify compound. At 1, 2, or 4 h, three mice of each group were sacrificed and blood was drawn to measure plasma and liver compound levels (by LC–MS), IFNα (by ELISA) and ISG expression levels (by RT-qPCR). Values were rounded to the nearest whole number. BQL, below quantifiable limit.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Fold-change relative to vehicle.</p></div></div></div><div class="NLM_p">The potential of <b>54</b> to inhibit HBV replication in vivo was tested in the hydrodynamic injection (HDI) HBV mouse model. This model allows an initial assessment of the anti-HBV activity, as mice develop an acute infection that is cleared within 2 weeks.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><b>54</b> was administered orally to C57Bl/6 male mice 1 day after HDI for 5 consecutive days at 0.3, 1, 2.5, and 5 mg/kg q.d. and was found to be well tolerated (no clinical observations were noted). The dose was chosen based on the robust ISG upregulation observed in healthy C57Bl/6 mice (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). <b>54</b> induced a 2.7 log decrease in serum HBV viral load from 0.3 mg/kg, and a maximum 3.1 log decrease was observed for doses between 1 and 5 mg/kg (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Also, 1 day after the last dose, mice were sacrificed to evaluate liver HBV viral load (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). A small but statistically significant (one-way ANOVA with Dunnett’s multiple comparison) decrease was observed at all doses and was maximal for the 5 mg/kg dose (0.63 log decrease). In contrast, a similar decrease in viral load, in either the serum or the liver, required a higher dose of <b>3</b> (20 mg/kg).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Efficacy of <b>54</b> in the HDI-HBV mouse model. Left: Serum HBV viral load over time (mean ± SD). Right: Liver HBV viral load at end of dosing (qPCR, mean ± SD). Seven groups of eight male C57Bl/6 mice, 4–6 weeks old, were administered 20 μg of pAAV2-HBV1.3mer genotype D plasmid by hydrodynamic injection. One day later, groups 1–7 received compound <b>54</b> orally at 0, 0.3, 1, 2.5, and 5 mg/kg q.d., respectively, for 5 days. HPbCD20% at acidic pH was used as vehicle. At different time points, blood was sampled to measure serum HBV viral load by qPCR. One day after the last dose, mice were euthanized to measure liver HBV viral load by qPCR. LLOQ indicates lower limit of quantification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Healthy cynomolgus monkeys were chosen as the next preclinical pharmacokinetic–pharmacodynamic model, as they are the closest available model to human immunology (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Oral doses of 1, 3, and 10 mg/kg of <b>54</b> were well tolerated (no clinical observations and no relevant change in body weight, body temperature observed). Maximum mean plasma concentration occurred at 0.25–2 h postdose and increased dose-proportionally, despite the large variability observed. The low oral bioavailability (<i>F</i> < 1%) can potentially be attributed to a high first pass effect, assuming that absorption was similar to that generated in the rat hepatic portal vein pharmacokinetic study. According to the mode of action, a transient and dose-dependent decrease in lymphocyte counts and increase in neutrophil counts were observed from 1 mg/kg.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> Cytokines were measured in plasma by Luminex or ELISA. IFNα production was detected in all animals starting from the 3 mg/kg dose and showed a more than dose-proportional profile of maximum response, despite high interindividual variability. Interestingly, an ISG response was induced starting from 1 mg/kg: <i>Isg15</i>, <i>Oas1b</i>, <i>Oasl</i>, <i>Mx1</i>, <i>Cxcl11</i>, <i>Ifit44l</i> where upregulation (measured by microarray) was detected from 1 mg/kg and peaked at 4–8 h postdose. A second wave of gene induction was observed at 72 h postdose, including ISG <i>Cxcl10</i>, as well as monocyte-induced <i>Ccl18</i>. Monocyte activation was also suggested by the production of MCP1 (from 1 mg/kg) and IL-1Ra (from 3 mg/kg). General proinflammatory cytokines IL-6 and G-CSF were measurable from 10 mg/kg, while anti-inflammatory cytokine IL-10 was induced from 3 mg/kg. This is encouraging in regard to the safety of compound <b>54</b>. Overall, these results demonstrate that <b>54</b> is more than simply an interferon inducer and warrant further evaluation for HBV indications.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mean Plasma Pharmacokinetic and Pharmacodynamic Parameters of <b>54</b> in Cynomolgus Monkey after Administration by Oral Gavage<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">dose (mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">1</th><th class="colsep0 rowsep0" align="center">3</th><th class="colsep0 rowsep0" align="center">10</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">4.12</td><td class="colsep0 rowsep0" align="left">11.2</td><td class="colsep0 rowsep0" align="left">23.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">1–2</td><td class="colsep0 rowsep0" align="left">0.5–2</td><td class="colsep0 rowsep0" align="left">0.5–2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–last</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">26.7</td><td class="colsep0 rowsep0" align="left">57.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IFNα max<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">BQL</td><td class="colsep0 rowsep0" align="left">120 (3/5)</td><td class="colsep0 rowsep0" align="left">2980 (5/5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCP1 max<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">325 (2/5)</td><td class="colsep0 rowsep0" align="left">1560 5/5)</td><td class="colsep0 rowsep0" align="left">8295 (5/5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IL-1Ra max<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">75 (5/5)</td><td class="colsep0 rowsep0" align="left">1820 (5/5)</td><td class="colsep0 rowsep0" align="left">10575 (5/5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IL-6 max<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">20 (4/5)</td><td class="colsep0 rowsep0" align="left">10 (3/5)</td><td class="colsep0 rowsep0" align="left">525 (5/5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">G-CSF max<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">90 (3/5)</td><td class="colsep0 rowsep0" align="left">75 (2/5)</td><td class="colsep0 rowsep0" align="left">120 (4/5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IL-10 max<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">20 (3/5)</td><td class="colsep0 rowsep0" align="left">45 (3/5)</td><td class="colsep0 rowsep0" align="left">125 (5/5)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">pg/mL, frequency; BQL, below quantification limit; NA, not applicable. Five cynomolgus monkeys were administered 1, 3, or 10 mg/kg of <b>54</b> by oral gavage. At 0 (predose), 0.25, 0.5, 1, 2, 4, 8, 24, 48, and 72 h postdose, blood was sampled to measure compound concentrations in plasma, cytokine levels (by ELISA or Luminex), and gene expression (by microarray). Doses were administered in different animals but staggered by 3 days for acute toxicity evaluation.</p></div></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this manuscript, the research on a novel class of TLR7 selective agonists for immunotherapy of hepatitis B was described. This new series of pyrrolo[3,2-<i>d</i>]pyrimidines was designed by taking key elements of chemical series previously described in the literature and combining them into a new structure. We found <b>54</b> to be potent and selective over other TLRs in preclinical species. Oral administration of <b>54</b> was well tolerated in vivo, displayed a high first pass effect, and induced an interferon stimulated gene response in both mice and cynomolgus monkeys. This ISG response was of higher magnitude in the liver, the site of viral infection, than in the periphery in mice. In the HDI-HBV mouse model, <b>54</b> reduced viral load in the serum and in the liver. In cynomolgus monkey, <b>54</b> did not induce IFNα systemically after a low (1 mg/kg) oral dose but induced an upregulation of ISGs. In summary, we have identified a series of novel and potent TLR7 agonists and presented data that indicate the potential for the immunotherapy of viral hepatitis.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Intrinsic Clearance (CL<sub>int</sub>) of <b>54</b></h3><div class="NLM_p last">CL<sub>int</sub> was determined in mouse, rat, dog, cynomolgus monkey, and human liver microsomes. Incubations were performed at 37 °C at a compound concentration of 1 μM and a microsomal protein concentration of 0.5 mg/mL. Samples were removed at intervals of up to 60 min and analyzed for the concentration of compound to determine its intrinsic clearance rate. <b>54</b> was incubated in mouse, rat, dog, cynomolgus monkey, and human hepatocytes (10<sup>6</sup> cells/mL) at 1 μM for 0, 10, 20, 40, 60, and 120 min. Samples were removed at intervals of up to 120 min and analyzed for the concentration of compound to determine its intrinsic clearance rate.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Plasma Protein Binding</h3><div class="NLM_p last">The free fraction in mouse, rat, dog, cyno, and human plasma was determined by rapid equilibrium dialysis (RED device, Thermo Fisher Scientific, Geel, Belgium). The RED device consists of a 48-well plate containing disposable inserts bisected by a semipermeable membrane creating two chambers. A 300 μL aliquot of plasma containing test compound at 5 μM was placed on one side and 500 μL of phosphate buffered saline (PBS) on the other. The plate was sealed and incubated at 37 °C for 4.5 h. Samples were removed from both the plasma and buffer compartment and analyzed for test compound using a specific LC–MS/MS method to estimate free and bound concentrations.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Permeability and Efflux</h3><div class="NLM_p">The in vitro permeability and potential to be transported by P-glycoprotein (P-gp) was determined using an MDCK cell line transfected with human MDR1 (P-glycoprotein). 5 μM <b>54</b> was added to the apical (A) or basolateral (B) side of a confluent monolayer of MDCK-MDR1 cells. Apparent permeability in the A → B direction in absence (<i>P</i><sub>app</sub>(A→B) = 5.5 × 10<sup>–6</sup> cm/s) and presence (<i>P</i><sub>app</sub>(A→B) = 41 × 10<sup>–6</sup> cm/s) of GF120918 (P-gp inhibitor) and in the B → A direction in absence of GF120918 (<i>P</i><sub>app</sub>(A→B) = 23 × 10<sup>–6</sup> cm/s) was measured by monitoring the appearance of the test compound on the opposite side of the membrane using a specific LC–MS/MS method. The efflux ratios ((B → A, GF120918)/(A → B, GF120918)) were calculated to determine whether the test compound was a P-gp substrate.</div><div class="NLM_p last">All in vivo studies were performed in AAALAC-accredited sites, and ethical approval by the corresponding ethical committee was obtained.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p last">Reagents and solvents were purchased from commercial sources and used without purification. All final products were >95% pure. NMR spectra were recorded on a Bruker Avance 400 spectrometer, operating at 400 MHz for <sup>1</sup>H NMR and 101 MHz for <sup>13</sup>C NMR, or a Bruker 360 spectrometer, operating at 360 MHz for <sup>1</sup>H NMR and 91 MHz for <sup>13</sup>C NMR. Chemical shifts and multiplicity data are given according to the ACS NMR guidelines. High resolution mass spectrometry was performed on a Waters Acquity IClass UPLC-DAD and Xevo G2-S QTOF. The samples were run on a Waters BEH C18 (1.7 μm, 2.1 mm × 50 mm, at 50 °C) column with a flow rate of 1 mL/min, using reverse phase chromatography with a gradient from 95% A to 5% A in 4.6 min and holding for 0.4 min (A, 95% CH<sub>3</sub>COONH<sub>4</sub> 6.5 mM + 5% CH<sub>3</sub>CN; B, CH<sub>3</sub>CN).</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5-Benzyl-2,4-dichloro-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (<b>5</b>)</h3><div class="NLM_p last">Into a 50 mL vial were placed 2,4-dichloro-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (1 g, 5.32 mmol), DMF (10 mL), DIPEA (2.75 mL, 16 mmol), and benzyl bromide (0.7 mL, 5.85 mmol). The vial was sealed and shaken for 16 h at rt. The reaction mixture was filtered through silica, and the solvent of the filtrate was removed under reduced pressure. The crude was used without further purification in the next step.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-Benzyl-<i>N</i>-butyl-2-chloro-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-4-amine (<b>6</b>)</h3><div class="NLM_p last">Into a 50 mL round-bottom flask equipped with a magnetic stir bar were placed 5-benzyl-2,4-dichloro-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (1.4 g, 5.03 mmol), <i>n</i>-butylamine (0.59 mL, 6.04 mmol), and 1,4-dioxane (5 mL). The flask was equipped with a reflux condenser and allowed to heat with stirring at 100 °C for 16 h. After cooling to rt, the solvents were removed under reduced pressure. The crude was purified via silica gel column chromatography using a heptane to EtOAc gradient. The best fractions were pooled and the solvents were removed under reduced pressure to afford the title compound.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-Benzyl-4-(butylamino)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-ol (<b>7</b>)</h3><div class="NLM_p last">A suspension of <b>6</b> (70 mg, 0.22 mmol) in acetic acid (1 mL) and conc HCl (0.2 mL) was heated in a sealed tube at 100 °C for 24 h. The solvent was removed under reduced pressure, and the crude was purified via silica gel column chromatography using a gradient of CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH (95:5). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.33 (s, 1H), 7.16–7.35 (m, 4H), 6.98 (d, <i>J</i> = 6.74 Hz, 2H), 6.19 (t, <i>J</i> = 5.43 Hz, 1H), 5.85 (d, <i>J</i> = 2.75 Hz, 1H), 5.52 (s, 2H), 3.22–3.30 (m, 2H), 1.23–1.37 (m, 2H), 0.91–1.06 (m, 2H), 0.73–0.80 (m, 3H).</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Azido-5-benzyl-<i>N</i>-butyl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-4-amine Hydrochloride (<b>8</b>)</h3><div class="NLM_p last">Into a glass vial equipped with a magnetic stir bar were placed 5-benzyl-<i>N</i>-butyl-2-chloro-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-4-amine (1 g, 3.18 mmol), NaN<sub>3</sub> (0.62 g, 9.53 mmol), and NMP/water (9:1, 4 mL). The glass vial was sealed, and the mixture was heated with stirring to 170 °C for 5 h. After cooling to rt, the mixture was diluted with EtOAc (20 mL) and washed with water (5 × 15 mL). The organic layer was dried over magnesium sulfate, the solids were removed via filtration, and the solvents of the filtrate were removed under reduced pressure. The crude was purified via silica gel column chromatography using a heptane to EtOAc gradient. The best fractions were combined and the solvents were removed under reduced pressure. The product was suspended in 0.5 mL of dioxane, and to it was added 1 equiv of 4 N HCl in dioxane at 0 °C. The mixture was stirred for 16 h at room temperature and then the solvent was removed under reduced pressure to afford the title compound. LC–MS (M + H) <i>m</i>/<i>z</i> = 322. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.32–7.42 (m, 3H), 7.18–7.22 (m, 2H), 6.99–7.08 (m, 2H), 6.90 (d, <i>J</i> = 3.16 Hz, 1H), 5.51 (s, 2H), 4.95 (br s, 1H), 3.37 (dt, <i>J</i> = 5.22, 6.94 Hz, 2H), 1.13–1.26 (m, 2H), 0.98 (qd, <i>J</i> = 7.31, 14.90 Hz, 2H), 0.69–0.78 (m, 3H).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-Benzyl-<i>N</i><sup>4</sup>-butyl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>9</b>)</h3><div class="NLM_p last">Into a glass vial equipped with a magnetic stir bar were placed 2-azido-5-benzyl-<i>N</i>-butyl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-4-amine (100 mg, 0.311 mmol), 1,4-dioxane (4 mL), water (1 mL), and triphenylphosphine (245 mg, 0.93 mmol). The vial was sealed and the mixture heated with stirring to 120 °C for 16 h. After cooling to rt, the solvents were removed under reduced pressure. The crude was purified via silica gel column chromatography using a CH<sub>2</sub>Cl<sub>2</sub> to 10% CH<sub>3</sub>OH in CH<sub>2</sub>Cl<sub>2</sub> gradient. The best fractions were pooled and the solvents were removed under reduced pressure to afford the title compound. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.25–7.33 (m, 3H), 7.19–7.25 (m, 1H), 6.95–7.01 (m, 2H), 5.98 (d, <i>J</i> = 2.86 Hz, 1H), 5.73 (t, <i>J</i> = 5.50 Hz, 1H), 5.49 (s, 2H), 5.23 (s, 2H), 3.25–3.32 (m, 2H), 1.28–1.39 (m, 2H), 1.04 (qd, <i>J</i> = 7.39, 15.02 Hz, 2H), 0.73–0.82 (m, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.8, 151.7, 150.8, 139.4, 133.2, 129.0, 127.8, 126.5, 110.4, 99.7, 52.0, 39.8, 31.5, 19.8, 14.2. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 296.1878 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>21</sub>N<sub>5</sub>, 295.1797).</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl (4-Hydroxy-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)carbamate (<b>10</b>)</h3><div class="NLM_p last">Amino-2-ethoxycarbonylpyrrole hydrochloride (25.8 g, 135.7 mmol) was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and sat. aq NaHCO<sub>3</sub>, the organic layer was dried over MgSO<sub>4</sub>, the solids were removed by filtration, and the filtrate was evaporated to dryness. The residue was dissolved in CH<sub>3</sub>OH (500 mL) along with 1,3-bis(methoxycarbonyl)-2-methyl-2-thiopseudourea (32.1 g, 156 mmol) and acetic acid (39 mL, 619 mmol) and stirred at rt for 1 h. A precipitate appeared, and stirring was continued overnight. NaOCH<sub>3</sub> (73.1 g, 1353 mmol) was added. An exotherm was observed, and the reaction mixture was stirred overnight. The reaction mixture was brought to pH 5 via addition of acetic acid and the precipitate was isolated by filtration, triturated with water (2 × 350 mL), CH<sub>3</sub>CN (350 mL), and diisopropyl ether (350 mL).</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Methyl (4-Chloro-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)carbamate (<b>11</b>)</h3><div class="NLM_p last">Methyl <i>N</i>-(4-hydroxy-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)carbamate (25 g, 120 mmol) was dispensed into acetonitrile (350 mL) in a 500 mL multineck flask at rt. POCl<sub>3</sub> (22.1 mL, 238.2 mmol) was added, and the reaction mixture was heated to 70 °C while stirring by an overhead, mechanical stirrer at 300 rpm. <i>N</i>,<i>N</i>-Diisopropylethylamine (41.4 mL, 240.2 mmol) was added dropwise by a syringe pump at a flow rate of 0.2 mL/min. The reaction mixture was cooled to rt and poured into a stirred solution of sodium acetate (78.8 g, 961 mmol) in water (500 mL) at 45 °C. The organic solvents were removed under reduced pressure, and the remaining liquid was stirred and cooled in an ice bath. The formed solid was isolated by filtration, washed with CH<sub>3</sub>CN, and triturated with diisopropyl ether to afford the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 12.27 (br s, 1H), 10.22 (s, 1H), 7.92 (t, <i>J</i> = 2.97 Hz, 1H), 6.57 (dd, <i>J</i> = 1.76, 3.08 Hz, 1H), 3.66 (s, 3H).</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Methyl (4-Chloro-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)carbamate (<b>12</b>)</h3><div class="NLM_p last">To a suspension of methyl (4-chloro-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)carbamate (5 g, 22 mmol), 2-pyridinemethanol (2.6 mL, 26.5 mmol), and polystyrene-bound triphenylphosphine (18.4 g, 55.2 mmol) in anhydrous THF (153 mL) was added DIAD (6.9 mL, 33 mmol) at rt, and the reaction mixture was stirred for 30 min, then was concentrated under reduced pressure. The product was purified via silica gel column chromatography using a gradient of CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH 100:0 to 90:10. The product fractions were collected and concentrated under reduced pressure. The product was recrystallized in CH<sub>3</sub>CN, isolated by filtration, and dried under vacuum to afford the title compound as a white solid.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-Chloro-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>13</b>)</h3><div class="NLM_p last">Methyl (4-chloro-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)carbamate (4.5 g, 14.2 mmol) was dissolved in 1,4-dioxane (68 mL) in a 100 mL round-bottom flask, and NaOH (1 N aq, 34 mL) was added. The mixture was heated at 60 °C for 5 h. The mixture was cooled and concentrated under reduced pressure. The crude was treated with water and the precipitate was isolated by filtration and dried to afford the title compound. The product was used without further purification in the next step.</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i><sup>4</sup>-Butyl-5-(2-phenoxyethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.20–7.28 (m, 3H), 6.92 (t, <i>J</i> = 7.50 Hz, 1H), 6.82 (dd, <i>J</i> = 0.73, 8.78 Hz, 2H), 6.32 (t, <i>J</i> = 5.31 Hz, 1H), 5.94 (d, <i>J</i> = 2.93 Hz, 1H), 5.36 (br s, 2H), 4.62 (t, <i>J</i> = 5.31 Hz, 2H), 4.16 (t, <i>J</i> = 5.12 Hz, 2H), 3.39–3.49 (m, 2H), 1.58 (quin, <i>J</i> = 7.32 Hz, 2H), 1.35 (qd, <i>J</i> = 7.38, 14.82 Hz, 2H), 0.89 (t, <i>J</i> = 7.32 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.7, 156.6, 149.3, 148.9, 131.2, 128.3, 119.7, 113.1, 108.9, 97.6, 66.7, 46.5, 38.4, 30.1, 18.6, 12.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 326.1980 (calcd for C<sub>18</sub>H<sub>23</sub>N<sub>5</sub>O [M + H]<sup>+</sup>, 326.1980).</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i><sup>4</sup>-Butyl-5-(3-phenylpropyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.22–7.30 (m, 2H), 7.08–7.22 (m, 4H), 6.34 (br t, <i>J</i> = 5.50 Hz, 1H), 5.94 (d, <i>J</i> = 3.08 Hz, 1H), 5.59 (br s, 2H), 4.29 (t, <i>J</i> = 7.04 Hz, 2H), 3.38–3.51 (m, 2H), 2.39–2.55 (m, 2H), 1.82–1.99 (m, 2H), 1.49–1.64 (m, 2H), 1.34 (qd, <i>J</i> = 7.40, 14.99 Hz, 2H), 0.90 (t, <i>J</i> = 7.37 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.6, 151.1, 148.8, 141.6, 132.8, 128.8, 128.5, 126.3, 109.9, 98.3, 48.7, 40.1, 33.8, 32.3, 31.8, 20.2, 14.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 324.2189 (calcd for C<sub>19</sub>H<sub>25</sub>N<sub>5</sub> [M + H]<sup>+</sup>, 324.2188).</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(2-Amino-4-(butylamino)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-5-yl)-<i>N</i>-methylacetamide (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (br d, <i>J</i> = 4.40 Hz, 1H), 7.11 (d, <i>J</i> = 3.08 Hz, 1H), 6.93 (t, <i>J</i> = 5.17 Hz, 1H), 5.94 (d, <i>J</i> = 2.86 Hz, 1H), 5.38 (br s, 2H), 4.74 (s, 2H), 3.31–3.45 (m, 2H), 2.64 (d, <i>J</i> = 4.62 Hz, 3H), 1.49–1.64 (m, 2H), 1.29–1.44 (m, 2H), 0.92 (t, <i>J</i> = 7.37 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.4, 158.5, 151.4, 150.1, 132.7, 111.4, 99.5, 51.9, 31.6, 26.1, 20.2, 14.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 277.1779 (calcd for C<sub>13</sub>H<sub>20</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 277.1777).</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i><sup>4</sup>-Butyl-5-(3-methylbut-2-en-1-yl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.14 (d, <i>J</i> = 2.93 Hz, 1H), 5.98 (t, <i>J</i> = 5.49 Hz, 1H), 5.89 (d, <i>J</i> = 2.93 Hz, 1H), 5.41 (br s, 2H), 5.21 (ddd, <i>J</i> = 1.46, 5.21, 6.50 Hz, 1H), 4.83 (br d, <i>J</i> = 6.59 Hz, 2H), 3.34–3.47 (m, 2H), 1.73 (s, 3H), 1.69 (s, 3H), 1.48–1.61 (m, 2H), 1.34 (qd, <i>J</i> = 7.35, 14.91 Hz, 2H), 0.87–0.96 (m, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.5, 149.4, 148.5, 134.0, 130.2, 120.2, 108.7, 97.1, 45.4, 38.3, 30.0, 24.0, 18.4, 16.6, 12.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 274.2034 (calcd for C<sub>15</sub>H<sub>23</sub>N<sub>5</sub> [M + H]<sup>+</sup>, 274.2031)</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i><sup>4</sup>-Butyl-5-(thiophen-3-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine Hydrochloride (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.68 (br s, 1H), 7.55–7.67 (m, 2H), 7.50 (dd, <i>J</i> = 2.86, 4.84 Hz, 1H), 7.37 (br s, 2H), 7.25 (br s, 1H), 6.82 (d, <i>J</i> = 4.84 Hz, 1H), 6.22 (d, <i>J</i> = 2.86 Hz, 1H), 5.70 (s, 2H), 3.48 (q, <i>J</i> = 6.53 Hz, 2H), 1.44 (quin, <i>J</i> = 7.15 Hz, 2H), 1.11 (qd, <i>J</i> = 7.29, 14.88 Hz, 2H), 0.75–0.90 (m, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.1, 151.9, 138.8, 136.7, 134.8, 127.7, 126.7, 122.8, 108.5, 95.4, 48.0, 40.4, 31.1, 19.7, 14.2. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 302.1442 (calcd for C<sub>15</sub>H<sub>19</sub>N<sub>5</sub>S [M + H]<sup>+</sup>, 302.1439).</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i><sup>4</sup>-Butyl-5-(thiazol-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.77 (d, <i>J</i> = 3.29 Hz, 1H), 7.67 (d, <i>J</i> = 3.29 Hz, 1H), 7.36 (d, <i>J</i> = 2.93 Hz, 1H), 6.50 (t, <i>J</i> = 5.31 Hz, 1H), 5.99 (d, <i>J</i> = 3.29 Hz, 1H), 5.80 (s, 2H), 5.33 (s, 2H), 3.28–3.40 (m, 2H), 1.49 (quin, <i>J</i> = 7.23 Hz, 2H), 1.24 (qd, <i>J</i> = 7.49, 14.87 Hz, 2H), 0.86 (t, <i>J</i> = 7.32 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.6, 157.2, 150.0, 149.2, 141.0, 130.9, 120.2, 108.8, 98.9, 47.7, 38.3, 29.8, 18.3, 12.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 303.1393 (calcd for C<sub>14</sub>H<sub>18</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, 303.1392)</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i><sup>4</sup>-Butyl-5-(imidazo[1,2-<i>a</i>]pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49–8.60 (m, 1H), 7.83–7.92 (m, 2H), 7.50 (dd, <i>J</i> = 0.66, 9.02 Hz, 1H), 7.39 (d, <i>J</i> = 2.86 Hz, 1H), 7.29 (ddd, <i>J</i> = 1.10, 6.71, 9.13 Hz, 1H), 6.92 (dt, <i>J</i> = 1.10, 6.71 Hz, 1H), 5.97 (d, <i>J</i> = 2.86 Hz, 1H), 5.69 (br s, 2H), 5.49 (s, 2H), 3.41–3.50 (m, 2H), 1.60 (quin, <i>J</i> = 7.26 Hz, 2H), 1.31 (qd, <i>J</i> = 7.40, 14.99 Hz, 2H), 0.86 (t, <i>J</i> = 7.37 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.3, 151.6, 144.5, 143.2, 132.6, 127.8, 126.2, 116.7, 113.0, 111.4, 110.7, 98.4, 46.5, 40.5, 31.4, 20.2, 14.2. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 336.1941 (calcd for C<sub>18</sub>H<sub>21</sub>N<sub>7</sub> [M + H]<sup>+</sup>, 336.1937).</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i><sup>4</sup>-Butyl-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (d, <i>J</i> = 4.76 Hz, 1H), 8.07 (br t, <i>J</i> = 5.12 Hz, 1H), 7.85 (dt, <i>J</i> = 1.46, 7.68 Hz, 1H), 7.57 (d, <i>J</i> = 2.93 Hz, 1H), 7.38 (dd, <i>J</i> = 5.12, 7.32 Hz, 1H), 7.34 (d, <i>J</i> = 7.68 Hz, 1H), 6.56 (br s, 2H), 6.11 (d, <i>J</i> = 2.93 Hz, 1H), 5.57 (s, 2H), 3.40–3.51 (m, 2H), 1.54 (quin, <i>J</i> = 7.23 Hz, 2H), 1.15–1.31 (m, 2H), 0.87 (t, <i>J</i> = 7.32 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.8, 156.2, 149.6, 148.7, 147.5, 136.7, 130.8, 122.1, 121.7, 121.1, 109.1, 97.9, 52.2, 29.8, 18.4, 12.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 297.1833 (calcd for C<sub>16</sub>H<sub>20</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 297.1828).</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i><sup>4</sup>-Butyl-5-(pyridin-3-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (dd, <i>J</i> = 1.46, 4.76 Hz, 1H), 8.25 (d, <i>J</i> = 1.83 Hz, 1H), 7.49 (d, <i>J</i> = 2.93 Hz, 1H), 7.27–7.36 (m, 1H), 7.22–7.27 (m, 1H), 6.75 (t, <i>J</i> = 5.27 Hz, 1H), 6.21 (br s, 2H), 6.12 (d, <i>J</i> = 2.93 Hz, 1H), 5.65 (s, 2H), 3.33–3.40 (m, 2H), 1.28–1.42 (m, 2H), 0.91–1.06 (m, 2H), 0.71–0.80 (m, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.8, 150.2, 147.5, 149.8, 146.4, 132.8, 132.6, 132.5, 122.5, 107.9, 96.8, 48.0, 39.3, 29.8, 18.1, 12.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 297.1833 (calcd for C<sub>16</sub>H<sub>20</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 297.1828).</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i><sup>4</sup>-Butyl-5-(pyridin-4-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 5.16 Hz, 2H), 7.39 (d, <i>J</i> = 3.08 Hz, 1H), 6.83 (d, <i>J</i> = 5.94 Hz, 2H), 6.19 (br s, 1H), 6.08 (d, <i>J</i> = 2.86 Hz, 1H), 5.66–5.75 (m, 2H), 5.60 (s, 2H), 3.17 (br. s., 2H), 1.32 (td, <i>J</i> = 7.54, 14.86 Hz, 2H), 0.97 (sxt, <i>J</i> = 7.39 Hz, 2H), 0.69–0.79 (m, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.7, 151.1, 150.2, 148.3, 133.8, 121.3, 110.0, 99.3, 50.9, 40.9, 31.4, 19.7, 14.1. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 297.1835 (calcd for C<sub>16</sub>H<sub>20</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 297.1828).</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i><sup>4</sup>-Butyl-5-((6-methylpyridin-2-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.59–7.83 (m, 2H), 7.46 (br d, <i>J</i> = 2.20 Hz, 1H), 7.23 (br d, <i>J</i> = 7.48 Hz, 1H), 7.07 (br d, <i>J</i> = 7.48 Hz, 1H), 6.02 (br d, <i>J</i> = 2.42 Hz, 1H), 5.81 (br s, 2H), 5.44 (s, 2H), 3.44 (br d, <i>J</i> = 5.50 Hz, 2H), 2.49 (s, 3H), 1.47–1.69 (m, 2H), 1.17–1.39 (m, 2H), 0.89 (br t, <i>J</i> = 7.26 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.8, 157.2, 156.9, 151.6, 147.2, 138.8, 132.8, 123.2, 120.0, 110.4, 98.7, 53.8, 31.6, 24.2, 20.1, 14.2. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 311.1988 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>22</sub>N<sub>6</sub>: 310.1906). ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 311.1988 (calcd for C<sub>17</sub>H<sub>22</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 311.1984).</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i><sup>4</sup>-Butyl-5-(quinolin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>25</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39 (d, <i>J</i> = 8.42 Hz, 1H), 7.95–8.02 (m, 2H), 7.83 (ddd, <i>J</i> = 1.46, 6.95, 8.42 Hz, 1H), 7.63 (t, <i>J</i> = 7.39 Hz, 1H), 7.56 (d, <i>J</i> = 3.20 Hz, 1H), 7.26 (d, <i>J</i> = 8.42 Hz, 1H), 7.02 (t, <i>J</i> = 5.31 Hz, 1H), 6.05 (d, <i>J</i> = 2.93 Hz, 1H), 5.70 (s, 2H), 5.53 (br s, 2H), 3.32–3.45 (m, 2H), 1.38–1.48 (m, 2H), 1.11 (qd, <i>J</i> = 7.46, 14.96 Hz, 2H), 0.71 (t, <i>J</i> = 7.32 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.1, 156.5, 149.4, 148.0, 145.2, 136.8, 131.1, 129.0, 126.9, 126.8, 125.9, 125.6, 118.6, 108.9, 97.8, 53.0, 38.3, 29.9, 18.3, 12.4. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 347.1983 (calcd for C<sub>20</sub>H<sub>22</sub>N<sub>6</sub> [M + H]<sup>+</sup>, 347.1984).</div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i><sup>4</sup>-Butyl-5-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>26</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (s, 1H), 7.86 (t, <i>J</i> = 4.95 Hz, 1H), 7.30 (d, <i>J</i> = 3.08 Hz, 1H), 5.92 (d, <i>J</i> = 2.86 Hz, 1H), 5.44 (s, 2H), 5.23 (s, 2H), 3.71 (s, 3H), 3.39 (dt, <i>J</i> = 5.28, 6.93 Hz, 2H), 2.32 (s, 3H), 2.21 (s, 3H), 1.53–1.69 (m, 2H), 1.37 (qd, <i>J</i> = 7.38, 14.83 Hz, 2H), 0.93 (t, <i>J</i> = 7.37 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.8, 158.6, 155.3, 151.2, 150.6, 148.7, 132.6, 126.8, 126.0, 111.3, 99.3, 60.3, 52.1, 40.3, 31.5, 20.3, 14.3, 13.4, 11.1. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 355.2244 (calcd for C<sub>19</sub>H<sub>26</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 355.2246).</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i><sup>4</sup>-Butyl-5-((3-methoxypyridin-2-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10 (dd, <i>J</i> = 1.46, 4.76 Hz, 1H), 7.61 (t, <i>J</i> = 4.94 Hz, 1H), 7.54 (dd, <i>J</i> = 1.10, 8.42 Hz, 1H), 7.42 (dd, <i>J</i> = 4.76, 8.42 Hz, 1H), 7.21 (d, <i>J</i> = 2.93 Hz, 1H), 5.90 (d, <i>J</i> = 2.93 Hz, 1H), 5.38 (s, 2H), 5.24 (s, 2H), 3.90 (s, 3H), 3.42 (dt, <i>J</i> = 5.12, 6.95 Hz, 2H), 1.59–1.68 (m, 2H), 1.41 (qd, <i>J</i> = 7.30, 15.05 Hz, 2H), 0.91–0.97 (m, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.9, 152.7, 149.3, 148.9, 144.4, 138.4, 131.2, 123.9, 118.4, 109.3, 97.5, 54.6, 47.6, 38.7, 29.8, 18.6, 12.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 327.1934 (calcd for C<sub>17</sub>H<sub>22</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 327.1933).</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i><sup>4</sup>-(2-Methoxyethyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (dd, <i>J</i> = 0.73, 4.03 Hz, 1H), 7.82 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.43 (t, <i>J</i> = 5.31 Hz, 1H), 7.40 (d, <i>J</i> = 3.29 Hz, 1H), 7.35 (dd, <i>J</i> = 5.12, 7.32 Hz, 1H), 7.29 (d, <i>J</i> = 8.05 Hz, 1H), 5.96 (d, <i>J</i> = 2.93 Hz, 1H), 5.44 (s, 2H), 5.39 (br s, 2H), 3.56 (q, <i>J</i> = 5.37 Hz, 2H), 3.41–3.52 (m, 2H), 3.24 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.9, 156.0, 149.5, 147.7, 149.2, 136.8, 130.9, 122.1, 121.2, 109.2, 98.0, 69.5, 56.8, 52.2, 38.5. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 299.1624 (calcd for C<sub>15</sub>H<sub>18</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 299.1620).</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i><sup>4</sup>-(3-Methoxypropyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>29</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (d, <i>J</i> = 4.76 Hz, 1H), 7.81 (dt, <i>J</i> = 1.46, 7.68 Hz, 1H), 7.38 (d, <i>J</i> = 3.26 Hz, 1H), 7.32–7.37 (m, 1H), 7.15 (d, <i>J</i> = 7.87 Hz, 1H), 7.05 (t, <i>J</i> = 5.14 Hz, 1H), 5.97 (d, <i>J</i> = 2.93 Hz, 1H), 5.48 (s, 2H), 5.30 (s, 2H), 3.39–3.43 (m, 2H), 3.31 (t, <i>J</i> = 6.40 Hz, 2H), 3.19 (s, 3H), 1.78 (quin, <i>J</i> = 6.59 Hz, 2H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.1, 156.4, 149.6, 149.5, 147.6, 136.7, 130.9, 122.0, 121.0, 109.2, 98.2, 68.7, 56.7, 52.2, 36.2, 27.8. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 313.1780 (calcd for C<sub>16</sub>H<sub>20</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 313.1777).</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i><sup>4</sup>-(2-Ethoxyethyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>30</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (d, <i>J</i> = 5.12 Hz, 1H), 7.81 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.39 (d, <i>J</i> = 2.93 Hz, 1H), 7.34 (dt, <i>J</i> = 5.12, 7.14 Hz, 2H), 7.25 (d, <i>J</i> = 7.68 Hz, 1H), 5.96 (d, <i>J</i> = 2.93 Hz, 1H), 5.44 (s, 2H), 5.33 (s, 2H), 3.52–3.58 (m, 2H), 3.47–3.52 (m, 2H), 3.42 (q, <i>J</i> = 7.07 Hz, 2H), 1.07 (t, <i>J</i> = 6.95 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.1, 156.2, 149.6, 149.5, 147.7, 136.8, 130.9, 122.1, 121.2, 109.3, 98.2, 67.4, 64.3, 52.2, 46.8, 14.0. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 313.1781 (calcd for C<sub>16</sub>H<sub>20</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 313.1777).</div></div><div id="sec6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-((2-Amino-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-4-yl)amino)butan-2-ol (<b>31</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (d, <i>J</i> = 4.76 Hz, 1H), 7.81 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.39 (d, <i>J</i> = 2.93 Hz, 1H), 7.34 (dd, <i>J</i> = 4.94, 6.77 Hz, 1H), 7.18–7.27 (m, 2H), 5.96 (d, <i>J</i> = 2.93 Hz, 1H), 5.47 (s, 2H), 5.30 (s, 2H), 4.84 (br s, 1H), 3.54 (quin, <i>J</i> = 5.85 Hz, 1H), 3.41–3.50 (m, 1H), 3.24–3.34 (m, 1H), 1.21–1.43 (m, 2H), 0.86 (t, <i>J</i> = 7.32 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.9, 156.1, 149.6, 149.5, 147.7, 147.7, 136.6, 130.9, 121.9, 121.0, 98.1, 69.4, 52.1, 44.9, 26.2, 8.8. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 313.1699 (calcd for C<sub>16</sub>H<sub>20</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 313.1777).</div></div><div id="sec6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i><sup>4</sup>-((5-Methylpyridin-2-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>32</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (d, <i>J</i> = 4.89 Hz, 1H), 8.32 (s, 1H), 7.79 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.65 (t, <i>J</i> = 5.67 Hz, 1H), 7.38–7.47 (m, 2H), 7.32 (dd, <i>J</i> = 4.94, 6.77 Hz, 1H), 7.12 (d, <i>J</i> = 8.05 Hz, 1H), 6.95 (d, <i>J</i> = 8.05 Hz, 1H), 6.00 (d, <i>J</i> = 2.93 Hz, 1H), 5.55 (s, 2H), 5.31 (s, 2H), 4.68 (d, <i>J</i> = 5.49 Hz, 2H), 2.25 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.2, 156.5, 155.4, 150.1, 149.3, 147.8, 142.5, 136.7, 135.7, 131.4, 129.6, 122.0, 120.8, 119.3, 109.4, 98.4, 52.3, 43.7, 16.5. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 346.1785 (calcd for C<sub>19</sub>H<sub>19</sub>N<sub>7</sub> [M + H]<sup>+</sup>, 346.1780).</div></div><div id="sec6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i><sup>4</sup>-(1-(Pyridin-2-yl)ethyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>33</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46–8.51 (m, 2H), 7.84 (t, <i>J</i> = 7.56 Hz, 1H), 7.80 (d, <i>J</i> = 7.41 Hz, 1H), 7.66 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.45 (d, <i>J</i> = 2.93 Hz, 1H), 7.25–7.38 (m, 3H), 7.21 (dd, <i>J</i> = 5.12, 7.32 Hz, 1H), 5.96 (d, <i>J</i> = 2.93 Hz, 1H), 5.47–5.58 (m, 2H), 5.42 (t, <i>J</i> = 6.95 Hz, 1H), 5.24 (s, 2H), 1.52 (d, <i>J</i> = 6.95 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.9, 156.8, 155.9, 148.4, 147.4, 141.0, 136.7, 136.6, 135.2, 124.8, 122.0, 121.0, 119.7, 119.1, 115.0, 97.9, 52.2, 48.7, 20.2. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 346.1780 (calcd for C<sub>19</sub>H<sub>19</sub>N<sub>7</sub> [M + H]<sup>+</sup>, 346.1780).</div></div><div id="sec6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i><sup>4</sup>-((2-Methylthiazol-4-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>34</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (d, <i>J</i> = 4.87 Hz, 1H), 7.75–7.85 (m, 2H), 7.41 (d, <i>J</i> = 2.93 Hz, 1H), 7.33 (dd, <i>J</i> = 4.94, 7.50 Hz, 1H), 7.23 (d, <i>J</i> = 7.32 Hz, 1H), 7.01 (s, 1H), 5.98 (d, <i>J</i> = 2.20 Hz, 1H), 5.49 (s, 2H), 5.36 (s, 2H), 4.67 (d, <i>J</i> = 5.49 Hz, 2H), 2.63 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.9, 157.1, 156.3, 153.4, 150.0, 149.2, 147.7, 136.9, 131.2, 122.1, 121.3, 113.1, 109.4, 98.3, 52.2, 17.7. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 352.1353 (calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>S [M + H]<sup>+</sup>, 352.1344).</div></div><div id="sec6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i><sup>4</sup>-((5-Methyl-1,3,4-oxadiazol-2-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>35</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45 (d, <i>J</i> = 4.76 Hz, 1H), 8.05 (t, <i>J</i> = 5.67 Hz, 1H), 7.80 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.44 (d, <i>J</i> = 2.93 Hz, 1H), 7.34 (dd, <i>J</i> = 5.12, 6.95 Hz, 1H), 7.23 (d, <i>J</i> = 8.05 Hz, 1H), 5.99 (d, <i>J</i> = 2.93 Hz, 1H), 5.49 (s, 2H), 5.37 (s, 2H), 4.85 (d, <i>J</i> = 5.85 Hz, 2H), 2.43 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.5, 162.3, 156.7, 156.0, 150.3, 148.5, 147.5, 136.7, 131.6, 122.0, 121.1, 109.2, 98.2, 52.0, 33.3, 9.2. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 337.1525 (calcd for C<sub>16</sub>H<sub>16</sub>N<sub>8</sub>O [M + H]<sup>+</sup>, 337.1525).</div></div><div id="sec6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i><sup>4</sup>-(Oxazol-2-ylmethyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>36</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 4.89 Hz, 1H), 8.08 (t, <i>J</i> = 5.67 Hz, 1H), 8.00 (s, 1H), 7.81 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.43 (d, <i>J</i> = 2.93 Hz, 1H), 7.28–7.36 (m, 2H), 7.14 (s, 1H), 5.98 (d, <i>J</i> = 2.93 Hz, 1H), 5.47 (s, 2H), 5.35 (s, 2H), 4.79 (d, <i>J</i> = 5.49 Hz, 2H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.8, 156.8, 155.9, 150.1, 148.8, 147.5, 138.3, 136.7, 131.4, 125.7, 122.0, 121.3, 109.3, 98.2, 52.0, 35.7. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 322.1426 (calcd for C<sub>16</sub>H<sub>15</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 322.1416).</div></div><div id="sec6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i><sup>4</sup>-((5-Methyloxazol-2-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>37</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 3.66 Hz, 1H), 8.01 (t, <i>J</i> = 5.67 Hz, 1H), 7.81 (t, <i>J</i> = 7.43 Hz, 1H), 7.43 (d, <i>J</i> = 2.93 Hz, 1H), 7.25–7.36 (m, 2H), 6.74 (s, 1H), 5.98 (d, <i>J</i> = 2.93 Hz, 1H), 5.47 (s, 2H), 5.34 (s, 2H), 4.72 (d, <i>J</i> = 5.49 Hz, 2H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.1, 158.5, 157.6, 151.7, 150.5, 149.2, 148.9, 138.4, 133.0, 123.7, 123.0, 111.0, 99.9, 53.7, 37.4, 11.0. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 336.1575 (calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 336.1572).</div></div><div id="sec6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i><sup>4</sup>-((4-Methyloxazol-2-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>38</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (d, <i>J</i> = 4.76 Hz, 1H), 8.03 (t, <i>J</i> = 5.49 Hz, 1H), 7.80 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.67 (d, <i>J</i> = 1.46 Hz, 1H), 7.43 (d, <i>J</i> = 2.93 Hz, 1H), 7.27–7.36 (m, 2H), 5.98 (d, <i>J</i> = 2.93 Hz, 1H), 5.47 (s, 2H), 5.35 (s, 2H), 4.73 (d, <i>J</i> = 5.49 Hz, 2H), 2.05 (d, <i>J</i> = 1.10 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.0, 158.5, 157.6, 151.8, 150.5, 149.2, 138.4, 136.1, 135.2, 133.1, 123.6, 123.0, 111.0, 99.9, 53.8, 37.4, 11.7. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 336.1573 (calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 336.1572).</div></div><div id="sec6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-(Pyridin-2-ylmethyl)-<i>N</i><sup>4</sup>-(thiazol-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>39</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (d, <i>J</i> = 4.76 Hz, 1H), 8.12 (t, <i>J</i> = 5.85 Hz, 1H), 7.78 (t, <i>J</i> = 7.73 Hz, 1H), 7.71 (d, <i>J</i> = 3.21 Hz, 1H), 7.52 (d, <i>J</i> = 3.29 Hz, 1H), 7.43 (d, <i>J</i> = 3.29 Hz, 1H), 7.31 (dd, <i>J</i> = 4.94, 6.77 Hz, 1H), 7.14 (d, <i>J</i> = 7.68 Hz, 1H), 6.01 (d, <i>J</i> = 2.93 Hz, 1H), 5.53 (s, 2H), 5.41 (s, 2H), 4.94 (d, <i>J</i> = 5.49 Hz, 2H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.7, 156.9, 156.3, 150.4, 147.7, 148.7, 141.0, 136.7, 131.8, 122.0, 120.9, 118.6, 109.3, 98.4, 52.1, 40.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 338.1191 (calcd for C<sub>16</sub>H<sub>15</sub>N<sub>7</sub>S [M + H]<sup>+</sup>, 338.1188).</div></div><div id="sec6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i><sup>4</sup>-((5-Methylthiazol-2-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>40</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.09 (br s, 1H), 9.40 (br s, 1H), 8.65 (br d, <i>J</i> = 5.12 Hz, 1H), 8.10 (t, <i>J</i> = 7.32 Hz, 1H), 7.55–7.79 (m, 4H), 7.47 (s, 1H), 7.32 (d, <i>J</i> = 7.68 Hz, 1H), 6.34 (d, <i>J</i> = 2.56 Hz, 2H), 4.95 (br d, <i>J</i> = 4.39 Hz, 2H), 2.36 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.6, 153.1, 151.4, 150.2, 145.0, 140.5, 137.3, 135.7, 134.3, 133.2, 123.3, 122.0, 107.6, 94.7, 50.1, 40.3, 10.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 352.1348 (calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>S [M + H]<sup>+</sup>, 352.1344).</div></div><div id="sec6_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i><sup>4</sup>-(Isoxazol-3-ylmethyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>41</b>)</h3><div class="NLM_p last"><b>13</b> (175 mg, 0.67 mmol), isoxazol-3-ylmethylamine hydrochloride (136 mg, 1.0 mmol), and DIPEA (173 mg, 1.3 mmol) were dissolved in NMP (2.4 mL) in a 7 mL glass vial. The mixture was stirred at 100 °C for 2 h and then cooled to rt and concentrated in vacuo. It was purified by prep HPLC (stationary phase, RP Vydac Denali C18, 10 μm, 200 g, 5 cm; mobile phase, 0.25% NH<sub>4</sub>OAc solution in water, CH<sub>3</sub>OH), and the desired fractions were collected and concentrated in vacuo. The product was triturated in CH<sub>3</sub>CN, isolated by filtration, and dried under vacuum to afford the title compound as a white solid. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (d, <i>J</i> = 1.46 Hz, 1H), 8.41 (d, <i>J</i> = 4.91 Hz, 1H), 7.90 (t, <i>J</i> = 5.50 Hz, 1H), 7.79 (t, <i>J</i> = 7.55 Hz, 1H), 7.41 (d, <i>J</i> = 2.93 Hz, 1H), 7.31 (dd, <i>J</i> = 4.94, 7.50 Hz, 1H), 7.19 (d, <i>J</i> = 7.68 Hz, 1H), 6.38 (d, <i>J</i> = 1.46 Hz, 1H), 5.99 (d, <i>J</i> = 2.93 Hz, 1H), 5.48 (s, 2H), 5.41 (s, 2H), 4.70 (d, <i>J</i> = 5.85 Hz, 2H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.7, 158.4, 157.0, 156.3, 150.2, 149.1, 147.6, 136.8, 131.5, 122.1, 121.2, 109.4, 103.4, 98.4, 52.2, 34.1. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 322.1422 (calcd for C<sub>16</sub>H<sub>15</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 322.1416).</div></div><div id="sec6_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i><sup>4</sup>-((5-Methylisoxazol-3-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>42</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (br d, <i>J</i> = 4.39 Hz, 1H), 8.17 (br s, 1H), 7.80 (br t, <i>J</i> = 7.14 Hz, 1H), 7.48 (d, <i>J</i> = 2.56 Hz, 1H), 7.28–7.38 (m, 1H), 7.21 (br d, <i>J</i> = 7.68 Hz, 1H), 6.06 (d, <i>J</i> = 2.56 Hz, 1H), 5.96 (s, 1H), 5.89 (br s, 2H), 5.52 (s, 2H), 4.65 (br d, <i>J</i> = 4.76 Hz, 2H), 2.33 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 161.4, 155.9, 155.7, 149.4, 147.6, 146.8, 136.8, 132.0, 122.1, 121.2, 109.0, 100.3, 97.4, 52.0, 34.2, 10.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 336.1575 (calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 336.1572).</div></div><div id="sec6_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i><sup>4</sup>-((5-Cyclopropylisoxazol-3-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>43</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 4.76 Hz, 1H), 7.74–7.82 (m, 2H), 7.41 (d, <i>J</i> = 2.85 Hz, 1H), 7.33 (t, <i>J</i> = 5.99 Hz, 1H), 7.15 (d, <i>J</i> = 7.68 Hz, 1H), 5.99 (d, <i>J</i> = 2.93 Hz, 1H), 5.89 (s, 1H), 5.49 (s, 2H), 5.41 (s, 2H), 4.59 (d, <i>J</i> = 5.85 Hz, 2H), 2.00–2.12 (m, 1H), 0.96–1.06 (m, 2H), 0.75–0.84 (m, 2H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.7, 161.5, 156.8, 156.1, 150.0, 148.8, 147.4, 147.4, 136.6, 131.3, 121.8, 120.9, 109.1, 98.2, 97.3, 51.9, 33.9, 6.8, 6.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 362.1729 (calcd for C<sub>19</sub>H<sub>19</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 362.1729).</div></div><div id="sec6_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i><sup>4</sup>-((5-Isopropylisoxazol-3-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>44</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.38–8.42 (m, 1H), 7.73–7.82 (m, 2H), 7.42 (d, <i>J</i> = 3.20 Hz, 1H), 7.31 (t, <i>J</i> = 5.90 Hz, 1H), 7.14 (d, <i>J</i> = 8.05 Hz, 1H), 5.99 (d, <i>J</i> = 2.93 Hz, 1H), 5.93 (s, 1H), 5.50 (s, 2H), 5.42 (s, 2H), 4.63 (d, <i>J</i> = 5.49 Hz, 2H), 3.01 (spt, <i>J</i> = 6.95 Hz, 1H), 1.18 (d, <i>J</i> = 6.95 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 178.2, 163.0, 158.6, 157.9, 151.8, 150.6, 149.1, 138.3, 133.1, 123.6, 122.6, 110.9, 100.0, 99.3, 53.7, 35.7, 26.9, 21.1. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 364.1891 (calcd for C<sub>19</sub>H<sub>21</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 364.1886).</div></div><div id="sec6_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i><sup>4</sup>-((3-Methylisoxazol-5-yl)methyl)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>45</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (d, <i>J</i> = 5.01 Hz, 1H), 7.89 (t, <i>J</i> = 5.67 Hz, 1H), 7.80 (t, <i>J</i> = 7.71 Hz, 1H), 7.42 (d, <i>J</i> = 3.11 Hz, 1H), 7.34 (t, <i>J</i> = 6.19 Hz, 1H), 7.19 (d, <i>J</i> = 7.92 Hz, 1H), 6.00 (d, <i>J</i> = 3.08 Hz, 1H), 5.95 (s, 1H), 5.50 (s, 2H), 5.37 (s, 2H), 4.71 (d, <i>J</i> = 5.50 Hz, 2H), 2.16 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.4, 159.8, 158.5, 157.9, 151.9, 149.3, 150.3, 138.4, 133.2, 123.7, 122.7, 111.0, 103.0, 100.0, 53.7, 36.1, 11.4. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 336.1577 (calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 336.1572).</div></div><div id="sec6_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-((5,6-Dimethoxypyridin-2-yl)methyl)-<i>N</i><sup>4</sup>-((5-methylisoxazol-3-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>46</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.35 (d, <i>J</i> = 2.93 Hz, 1H), 7.20 (d, <i>J</i> = 7.68 Hz, 1H), 6.87 (t, <i>J</i> = 5.85 Hz, 1H), 6.54 (d, <i>J</i> = 8.05 Hz, 1H), 5.99 (d, <i>J</i> = 2.93 Hz, 1H), 5.86 (s, 1H), 5.39 (s, 2H), 5.35 (s, 2H), 4.61 (d, <i>J</i> = 5.85 Hz, 2H), 3.71 (d, <i>J</i> = 2.93 Hz, 6H), 2.31 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.6, 161.6, 156.7, 151.9, 150.1, 148.5, 143.4, 141.7, 131.6, 117.5, 113.0, 109.0, 100.0, 98.0, 54.2, 51.5, 51.2, 34.0, 10.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 396.1787 (calcd for C<sub>19</sub>H<sub>21</sub>N<sub>7</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 396.1784).</div></div><div id="sec6_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 5-((6-Methoxypyridin-2-yl)methyl)-<i>N</i><sup>4</sup>-((5-methylisoxazol-3-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>47</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.58–7.65 (m, <i>J</i> = 8.10 Hz, 1H), 7.36 (d, <i>J</i> = 2.86 Hz, 1H), 6.90 (t, <i>J</i> = 5.83 Hz, 1H), 6.69 (d, <i>J</i> = 8.36 Hz, 1H), 6.50 (d, <i>J</i> = 7.26 Hz, 1H), 5.99–6.03 (m, 1H), 5.83 (s, 1H), 5.44 (s, 2H), 5.36 (s, 2H), 4.59 (d, <i>J</i> = 5.72 Hz, 2H), 3.71 (s, 3H), 2.31 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.7, 162.1, 161.8, 157.0, 154.5, 150.4, 148.8, 139.1, 132.0, 112.8, 109.4, 108.2, 100.2, 98.5, 51.9, 51.9, 34.2, 10.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 366.1678 (calcd for C<sub>18</sub>H<sub>19</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 366.1678).</div></div><div id="sec6_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 5-((5-Fluoropyridin-2-yl)methyl)-<i>N</i><sup>4</sup>-((5-methylisoxazol-3-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>48</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (d, <i>J</i> = 2.93 Hz, 1H), 7.70 (dt, <i>J</i> = 2.93, 8.78 Hz, 1H), 7.39 (d, <i>J</i> = 2.93 Hz, 1H), 7.31 (t, <i>J</i> = 5.67 Hz, 1H), 7.09 (dd, <i>J</i> = 4.57, 8.60 Hz, 1H), 6.00 (d, <i>J</i> = 2.93 Hz, 1H), 5.88 (s, 1H), 5.52 (s, 2H), 5.41 (s, 2H), 4.59 (d, <i>J</i> = 5.85 Hz, 2H), 2.32 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.6, 161.6, 156.9, 155.7, 152.7, 150.2, 148.6, 135.6, 131.5, 123.3, 121.9, 108.9, 100.1, 98.3, 51.2, 33.8, 10.4. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 354.1480 (calcd for C<sub>17</sub>H<sub>16</sub>FN<sub>7</sub>O [M + H]<sup>+</sup>, 354.1478).</div></div><div id="sec6_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 5-((3-Fluoropyridin-2-yl)methyl)-<i>N</i><sup>4</sup>-((5-methylisoxazol-3-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>49</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.22 (d, <i>J</i> = 4.76 Hz, 1H), 7.78 (t, <i>J</i> = 9.25 Hz, 1H), 7.63 (t, <i>J</i> = 5.58 Hz, 1H), 7.47 (td, <i>J</i> = 4.35, 8.51 Hz, 1H), 7.26 (d, <i>J</i> = 3.23 Hz, 1H), 6.06 (s, 1H), 5.97 (d, <i>J</i> = 2.93 Hz, 1H), 5.58 (d, <i>J</i> = 1.83 Hz, 2H), 5.39 (s, 2H), 4.63 (d, <i>J</i> = 5.49 Hz, 2H), 2.34 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.8, 161.7, 156.9, 150.0, 148.9, 143.8, 143.5, 131.6, 124.5, 123.3, 123.2, 109.6, 100.5, 98.4, 46.7, 34.1, 10.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 354.1479 (calcd for C<sub>17</sub>H<sub>16</sub>FN<sub>7</sub>O [M + H]<sup>+</sup>, 354.1478).</div></div><div id="sec6_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i><sup>4</sup>-((5-Methylisoxazol-3-yl)methyl)-5-((5-(trifluoromethyl)pyridin-2-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>50</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.85 (s, 1H), 8.17 (dd, <i>J</i> = 2.20, 8.42 Hz, 1H), 7.41 (d, <i>J</i> = 2.93 Hz, 1H), 7.10 (t, <i>J</i> = 5.67 Hz, 1H), 7.02 (d, <i>J</i> = 8.25 Hz, 1H), 6.05 (d, <i>J</i> = 2.93 Hz, 1H), 5.74 (s, 1H), 5.69 (s, 2H), 5.43 (s, 2H), 4.56 (d, <i>J</i> = 5.49 Hz, 2H), 2.28 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.5, 161.6, 161.2, 157.0, 150.5, 148.6, 144.4, 144.4, 133.8, 133.7, 131.9, 120.0, 109.0, 99.9, 98.7, 51.7, 33.7, 10.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 404.1450 (calcd for C<sub>18</sub>H<sub>16</sub>F<sub>3</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 404.1446).</div></div><div id="sec6_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i><sup>4</sup>-((5-Methylisoxazol-3-yl)methyl)-5-((4-(trifluoromethyl)pyridin-2-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>51</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (d, <i>J</i> = 5.12 Hz, 1H), 7.72 (d, <i>J</i> = 5.12 Hz, 1H), 7.30–7.45 (m, 3H), 6.03 (d, <i>J</i> = 3.29 Hz, 1H), 5.83 (s, 1H), 5.65 (s, 2H), 5.43 (s, 2H), 4.60 (d, <i>J</i> = 5.85 Hz, 2H), 2.31 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.5, 161.6, 158.2, 156.9, 150.3, 149.4, 148.6, 131.7, 117.3, 117.3, 115.9, 115.8, 109.0, 99.9, 98.6, 51.5, 33.8, 10.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 404.1451 (calcd for C<sub>18</sub>H<sub>16</sub>F<sub>3</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 404.1446).</div></div><div id="sec6_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 5-((3-Chloropyridin-2-yl)methyl)-<i>N</i><sup>4</sup>-((5-methylisoxazol-3-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>52</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (d, <i>J</i> = 4.76 Hz, 1H), 8.00 (d, <i>J</i> = 8.05 Hz, 1H), 7.71 (br t, <i>J</i> = 5.49 Hz, 1H), 7.42 (dd, <i>J</i> = 4.57, 8.23 Hz, 1H), 7.30 (d, <i>J</i> = 2.93 Hz, 1H), 6.03 (s, 1H), 5.94–6.00 (m, 1H), 5.62 (s, 2H), 5.44 (s, 2H), 4.62 (d, <i>J</i> = 5.49 Hz, 2H), 2.34 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.6, 161.6, 156.7, 152.0, 149.6, 148.7, 146.0, 136.9, 131.7, 128.7, 123.7, 109.7, 100.3, 98.0, 49.4, 33.9, 10.4. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 370.1183 (calcd for C<sub>17</sub>H<sub>16</sub>ClN<sub>7</sub>O [M + H]<sup>+</sup>, 370.1183).</div></div><div id="sec6_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 5-((4-Chloropyridin-2-yl)methyl)-<i>N</i><sup>4</sup>-((5-methylisoxazol-3-yl)methyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>53</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 5.50 Hz, 1H), 7.48 (dd, <i>J</i> = 1.87, 5.39 Hz, 1H), 7.36–7.45 (m, 2H), 7.17–7.23 (m, 1H), 6.01 (d, <i>J</i> = 3.08 Hz, 1H), 5.89 (s, 1H), 5.52 (br s, 2H), 5.38 (br s, 2H), 4.60 (d, <i>J</i> = 5.72 Hz, 2H), 2.33 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.7, 161.6, 158.3, 157.0, 150.3, 149.2, 148.7, 142.8, 131.6, 121.9, 120.6, 109.0, 100.1, 98.5, 51.4, 33.9, 10.5. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 370.1183 (calcd for C<sub>17</sub>H<sub>16</sub>ClN<sub>7</sub>O [M + H]<sup>+</sup>, 370.1183).</div></div><div id="sec6_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 4-((5-Methylisoxazol-3-yl)methoxy)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>54</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (qd, <i>J</i> = 0.96, 4.80 Hz, 1H), 7.65 (dt, <i>J</i> = 1.83, 7.68 Hz, 1H), 7.53 (d, <i>J</i> = 2.93 Hz, 1H), 7.24 (ddd, <i>J</i> = 1.10, 4.76, 7.68 Hz, 1H), 6.71 (d, <i>J</i> = 8.05 Hz, 1H), 6.14 (d, <i>J</i> = 2.93 Hz, 1H), 5.92 (s, 2H), 5.85 (d, <i>J</i> = 1.10 Hz, 1H), 5.47 (s, 2H), 5.37 (s, 2H), 2.35 (d, <i>J</i> = 0.73 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.4, 158.9, 156.7, 156.7, 153.8, 152.3, 147.8, 135.8, 133.3, 121.1, 119.0, 108.3, 100.0, 98.2, 56.6, 52.2, 10.5. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 337.1416 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>16</sub>N<sub>6</sub>O<sub>2</sub>: 337.1413).</div></div><div id="sec6_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4-((5-Methyloxazol-2-yl)methoxy)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>55</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (br d, <i>J</i> = 4.39 Hz, 1H), 7.62 (t, <i>J</i> = 7.83 Hz, 1H), 7.51–7.54 (m, 1H), 7.18–7.25 (m, 1H), 6.82 (s, 1H), 6.74 (d, <i>J</i> = 7.68 Hz, 1H), 6.13 (d, <i>J</i> = 2.20 Hz, 1H), 5.89 (s, 2H), 5.43 (s, 2H), 5.39 (s, 2H), 2.24 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.7, 156.5, 156.5, 156.4, 153.7, 152.4, 148.5, 147.8, 135.6, 133.5, 121.9, 121.2, 119.2, 98.2, 56.8, 52.3, 9.4. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 337.1413 (calcd for C<sub>17</sub>H<sub>16</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 337.1413).</div></div><div id="sec6_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-((5-Methylthiazol-2-yl)methoxy)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>56</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 4.76 Hz, 1H), 7.63 (dt, <i>J</i> = 1.46, 7.68 Hz, 1H), 7.52 (d, <i>J</i> = 2.93 Hz, 1H), 7.43 (d, <i>J</i> = 1.10 Hz, 1H), 7.22 (dd, <i>J</i> = 4.94, 7.14 Hz, 1H), 6.71 (d, <i>J</i> = 7.68 Hz, 1H), 6.15 (d, <i>J</i> = 3.29 Hz, 1H), 5.92 (s, 2H), 5.58 (s, 2H), 5.49 (s, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.7, 158.3, 158.3, 155.2, 154.2, 149.5, 140.5, 137.4, 135.1, 135.5, 122.8, 120.8, 110.1, 100.0, 63.5, 53.9, 11.8. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 353.1183 [M + H]<sup>+</sup> (calcd for C<sub>17</sub>H<sub>16</sub>N<sub>6</sub>OS: 353.1184).</div></div><div id="sec6_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 4-((5-Methyl-1,2,4-oxadiazol-3-yl)methoxy)-5-(pyridin-2-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>57</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.43 (br d, <i>J</i> = 4.03 Hz, 1H), 7.64 (br t, <i>J</i> = 7.68 Hz, 1H), 7.53 (d, <i>J</i> = 2.93 Hz, 1H), 7.16–7.28 (m, 1H), 6.84 (d, <i>J</i> = 7.68 Hz, 1H), 6.13 (d, <i>J</i> = 2.93 Hz, 1H), 5.89 (s, 2H), 5.51 (br s, 2H), 5.46 (br s, 2H), 2.54–2.61 (m, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 176.0, 165.1, 156.5, 156.3, 153.5, 152.3, 147.6, 135.5, 133.3, 121.0, 119.3, 108.2, 98.1, 55.6, 52.1, 10.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 338.1364 (calcd for C<sub>16</sub>H<sub>15</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 338.1365).</div></div><div id="sec6_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 5-((3-Methoxypyridin-2-yl)methyl)-4-((5-methyloxazol-2-yl)methoxy)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>58</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87 (dd, <i>J</i> = 1.10, 4.39 Hz, 1H), 7.37 (d, <i>J</i> = 2.93 Hz, 1H), 7.33 (dd, <i>J</i> = 1.10, 8.42 Hz, 1H), 7.21 (dd, <i>J</i> = 4.76, 8.05 Hz, 1H), 6.80 (d, <i>J</i> = 1.10 Hz, 1H), 6.07 (d, <i>J</i> = 2.93 Hz, 1H), 5.80 (s, 2H), 5.45 (s, 2H), 5.32 (s, 2H), 3.77 (s, 3H), 2.22 (d, <i>J</i> = 1.10 Hz, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.4, 156.3, 153.7, 152.0, 150.9, 148.4, 144.7, 138.8, 133.6, 122.0, 121.8, 116.2, 108.9, 97.5, 56.6, 54.2, 47.2, 9.3. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 367.1520 (calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 367.1518).</div></div><div id="sec6_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 5-((3-Methoxypyridin-2-yl)methyl)-4-((5-methylisoxazol-3-yl)methoxy)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>59</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89 (d, <i>J</i> = 4.39 Hz, 1H), 7.32–7.43 (m, 2H), 7.24 (dd, <i>J</i> = 4.76, 8.05 Hz, 1H), 6.06 (d, <i>J</i> = 2.56 Hz, 1H), 5.82 (br s, 2H), 5.77 (br s, 1H), 5.47 (s, 2H), 5.30 (s, 2H), 3.79 (s, 3H), 2.35 (s, 3H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.4, 159.0, 156.4, 153.8, 152.0, 151.0, 144.8, 138.9, 133.5, 122.1, 116.3, 109.0, 99.9, 97.6, 56.5, 54.2, 47.3, 10.6. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: 367.1519 (calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 367.1518).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00365">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00365" class="ext-link">10.1021/acs.jmedchem.7b00365</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental details, docking methods, biological assay details, and NMR spectra of <b>54</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_001.csv">jm7b00365_si_001.csv (2.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf">jm7b00365_si_002.pdf (395.07 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00365" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. McGowan</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3759-6771" title="Orcid link">http://orcid.org/0000-0002-3759-6771</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fc98919f9b938b9d92bc95888fd2969296d29f9391"><span class="__cf_email__" data-cfemail="47232a242028302629072e3334692d292d6924282a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Herschke</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f7919f928584949f9cb79e8384d99d999dd994989a"><span class="__cf_email__" data-cfemail="096f616c7b7a6a616249607d7a27636763276a6664">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik Pauwels</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bart Stoops</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ilham Smyej</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefaan Last</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Serge Pieters</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Werner Embrechts</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mourad Daoubi Khamlichi</span> - <span class="hlFld-Affiliation affiliation">Villapharma
Research S.L., Parque
Tecnológico de Fuente Álamo, Ctra. El Estrecho-Lobosillo,
Km. 2.5-Av. Azul, 30320 Fuente Álamo de Murcia, Murcia, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tine Thoné</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bertrand Van Schoubroeck</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wendy Mostmans</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debbie Wuyts</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dorien Verstappen</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annick Scholliers</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dorien De Pooter</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Dhuyvetter</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herman Borghys</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marianne Tuefferd</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Arnoult</span> - <span class="hlFld-Affiliation affiliation">Janssen
Research & Development L.L.C., 1400 McKean Road, Spring
House, Pennsylvania 19454, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Hong</span> - <span class="hlFld-Affiliation affiliation">Alios
Biopharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory Fanning</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacques Bollekens</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay Urmaliya</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ard Teisman</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helen Horton</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim H. M. Jonckers</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre Raboisson</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica, N. V. Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">Authors will release the atomic coordinates and experimental data upon article publication.</p></div></li></ul></div><div class="ack" id="ACK-d7e6004-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Thanks are extended to Eddy De Wilde, Kristien Raeymaekers, Michel Carpentier, Alex De Groot, Hilde Verheyen, and Alberto Fontana for analysis and purification, and Monicah Otieno for bioanalysis.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> Abbreviations Used</h2><tr><td class="NLM_term">HBV</td><td class="NLM_def"><p class="first last">hepatitis B virus</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κB</p></td></tr><tr><td class="NLM_term">pDC</td><td class="NLM_def"><p class="first last">plasmacytoid dentritic cell</p></td></tr><tr><td class="NLM_term">ISG</td><td class="NLM_def"><p class="first last">interferon stimulated gene</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Dienstag, J. L.</span><span> </span><span class="NLM_article-title">Hepatitis B virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1486</span><span class="NLM_x">–</span> <span class="NLM_lpage">1500</span><span class="refDoi"> DOI: 10.1056/NEJMra0801644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1056%2FNEJMra0801644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=18832247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2008&pages=1486-1500&author=J.+L.+Dienstag&title=Hepatitis+B+virus+infection&doi=10.1056%2FNEJMra0801644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis B virus infection</span></div><div class="casAuthors">Dienstag, Jules L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1486-1500</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with refs. on drug therapy of chronic hepatitis B, its co-infection with HIV viral infection, mono- and combination therapy and overcoming antiviral resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5ybm-V9V7urVg90H21EOLACvtfcHk0lh4thEx1-1pEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7bL&md5=e4ca2dbdb0fa268fa483eb7b77cf4643</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0801644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0801644%26sid%3Dliteratum%253Aachs%26aulast%3DDienstag%26aufirst%3DJ.%2BL.%26atitle%3DHepatitis%2520B%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D359%26spage%3D1486%26epage%3D1500%26doi%3D10.1056%2FNEJMra0801644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span> <span class="citation_source-book">Guidelines for the Prevention, Care, and Treatment of Persons with Chronic Hepatitis B Infection</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Guidelines+for+the+Prevention%2C+Care%2C+and+Treatment+of+Persons+with+Chronic+Hepatitis+B+Infection%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGuidelines%2520for%2520the%2520Prevention%252C%2520Care%252C%2520and%2520Treatment%2520of%2520Persons%2520with%2520Chronic%2520Hepatitis%2520B%2520Infection%26pub%3DWorld%2520Health%2520Organization%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Chang, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Man, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeHertogh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apelian, D.</span><span> </span><span class="NLM_article-title">A Comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1056/NEJMoa051285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1056%2FNEJMoa051285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=16525137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFWms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=1001-1010&author=T.-T.+Changauthor=R.+G.+Gishauthor=R.+de+Manauthor=A.+Gadanoauthor=J.+Sollanoauthor=Y.-C.+Chaoauthor=A.+Lokauthor=K.-H.+Hanauthor=Z.+Goodmanauthor=J.+Zhuauthor=A.+Crossauthor=D.+DeHertoghauthor=R.+Wilberauthor=R.+Colonnoauthor=D.+Apelian&title=A+Comparison+of+entecavir+and+lamivudine+for+HBeAg-positive+chronic+hepatitis+B&doi=10.1056%2FNEJMoa051285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B</span></div><div class="casAuthors">Chang, Ting-Tsung; Gish, Robert G.; de Man, Robert; Gadano, Adrian; Sollano, Jose; Chao, You-Chen; Lok, Anna S.; Han, Kwang-Hyub; Goodman, Zachary; Zhu, Jin; Cross, Anne; DeHertogh, Deborah; Wilber, Richard; Colonno, Richard; Apelian, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1001-1010</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Entecavir is a potent and selective guanosine analog with significant activity against hepatitis B virus (HBV).  METHODS: In this phase 3, double-blind trial, we randomly assigned 715 patients with hepatitis B e antigen (HBeAg)-pos. chronic hepatitis B who had not previously received a nucleoside analog to receive either 0.5 mg of entecavir or 100 mg of lamivudine once daily for a min. of 52 wk.  The primary efficacy end point was histol. improvement (a decrease by at least two points in the Knodell necroinflammatory score, without worsening of fibrosis) at week 48.  Secondary end points included a redn. in the serum HBV DNA level, HBeAg loss and seroconversion, and normalization of the alanine aminotransferase level.  RESULTS: Histol. improvement after 48 wk occurred in 226 of 314 patients in the entecavir group (72 %) and 195 of 314 patients in the lamivudine group (62 %, P = 0.009).  More patients in the entecavir group than in the lamivudine group had undetectable serum HBV DNA levels according to a polymerase-chain-reaction assay (67 % vs. 36 %, P < 0.001) and normalization of alanine amino-transferase levels (68 % vs. 60 %, P = 0.02).  The mean redn. in serum HBV DNA from baseline to week 48 was greater with entecavir than with lamivudine (6.9 vs. 5.4 log [on a base-10 scale] copies per mL, P < 0.001).  HBeAg seroconversion occurred in 21 % of entecavir-treated patients and 18 % of those treated with lamivudine (P = 0.33).  No viral resistance to entecavir was detected.  Safety was similar in the two groups.  CONCLUSIONS: Among patients with HBeAg-pos. chronic hepatitis B, the rates of histol., virol., and biochem. improvement are significantly higher with entecavir than with lamivudine.  The safety profile of the two agents is similar, and there is no evidence of viral resistance to entecavir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0BpM3kEiocbVg90H21EOLACvtfcHk0lgLPZd34eq_sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFWms7Y%253D&md5=4294c677544040ede9823bfdf8d53f8f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051285%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DT.-T.%26aulast%3DGish%26aufirst%3DR.%2BG.%26aulast%3Dde%2BMan%26aufirst%3DR.%26aulast%3DGadano%26aufirst%3DA.%26aulast%3DSollano%26aufirst%3DJ.%26aulast%3DChao%26aufirst%3DY.-C.%26aulast%3DLok%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DK.-H.%26aulast%3DGoodman%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DCross%26aufirst%3DA.%26aulast%3DDeHertogh%26aufirst%3DD.%26aulast%3DWilber%26aufirst%3DR.%26aulast%3DColonno%26aufirst%3DR.%26aulast%3DApelian%26aufirst%3DD.%26atitle%3DA%2520Comparison%2520of%2520entecavir%2520and%2520lamivudine%2520for%2520HBeAg-positive%2520chronic%2520hepatitis%2520B%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D1001%26epage%3D1010%26doi%3D10.1056%2FNEJMoa051285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Perrillo, R.</span><span> </span><span class="NLM_article-title">Benefits and risks of interferon therapy for hepatitis B</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">S103</span><span class="NLM_x">–</span> <span class="NLM_lpage">S111</span><span class="refDoi"> DOI: 10.1002/hep.22956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.22956" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=S103-S111&author=R.+Perrillo&title=Benefits+and+risks+of+interferon+therapy+for+hepatitis+B&doi=10.1002%2Fhep.22956"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fhep.22956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22956%26sid%3Dliteratum%253Aachs%26aulast%3DPerrillo%26aufirst%3DR.%26atitle%3DBenefits%2520and%2520risks%2520of%2520interferon%2520therapy%2520for%2520hepatitis%2520B%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3DS103%26epage%3DS111%26doi%3D10.1002%2Fhep.22956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Terrault, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonas, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murad, M. H.</span><span> </span><span class="NLM_article-title">AASLD guidelines for treatment of chronic hepatitis B</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1002/hep.28156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.28156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=26566064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BC28vhslGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=261-283&author=N.+A.+Terraultauthor=N.+H.+Bzowejauthor=K.-M.+Changauthor=J.+P.+Hwangauthor=M.+M.+Jonasauthor=M.+H.+Murad&title=AASLD+guidelines+for+treatment+of+chronic+hepatitis+B&doi=10.1002%2Fhep.28156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AASLD guidelines for treatment of chronic hepatitis B</span></div><div class="casAuthors">Terrault Norah A; Bzowej Natalie H; Chang Kyong-Mi; Hwang Jessica P; Jonas Maureen M; Murad M Hassan</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Baltimore, Md.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">261-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo5dAGIpJclHthwrmtH4OBfW6udTcc2eYYiOhzLZmtUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vhslGjsQ%253D%253D&md5=5790f93ea0f12638fc24a20608b7d11a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fhep.28156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.28156%26sid%3Dliteratum%253Aachs%26aulast%3DTerrault%26aufirst%3DN.%2BA.%26aulast%3DBzowej%26aufirst%3DN.%2BH.%26aulast%3DChang%26aufirst%3DK.-M.%26aulast%3DHwang%26aufirst%3DJ.%2BP.%26aulast%3DJonas%26aufirst%3DM.%2BM.%26aulast%3DMurad%26aufirst%3DM.%2BH.%26atitle%3DAASLD%2520guidelines%2520for%2520treatment%2520of%2520chronic%2520hepatitis%2520B%26jtitle%3DHepatology%26date%3D2016%26volume%3D63%26spage%3D261%26epage%3D283%26doi%3D10.1002%2Fhep.28156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Protzer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, P. A.</span><span> </span><span class="NLM_article-title">Living in the liver: hepatic infections</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/nri3169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2Fnri3169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=22362353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC38XislynsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=201-213&author=U.+Protzerauthor=M.+K.+Mainiauthor=P.+A.+Knolle&title=Living+in+the+liver%3A+hepatic+infections&doi=10.1038%2Fnri3169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Living in the liver: hepatic infections</span></div><div class="casAuthors">Protzer, Ulrike; Maini, Mala K.; Knolle, Percy A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-213</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The liver has vital metabolic and clearance functions that involve the uptake of nutrients, waste products and pathogens from the blood.  In addn., its unique immunoregulatory functions mediated by local expression of co-inhibitory receptors and immunosuppressive mediators help to prevent inadvertent organ damage.  However, these tolerogenic properties render the liver an attractive target site for pathogens.  Although most pathogens that reach the liver via the blood are eliminated or controlled by local innate and adaptive immune responses, some pathogens (such as hepatitis viruses) can escape immune control and persist in hepatocytes, causing substantial morbidity and mortality worldwide.  Here, we review our current knowledge of the mechanisms of liver targeting by pathogens and describe the interplay between pathogens and host factors that promote pathogen elimination and maintain organ integrity or that allow pathogen persistence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYKgwrpjMpx7Vg90H21EOLACvtfcHk0lhQmVcfU8J_mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XislynsL0%253D&md5=d4a033645cb461f84550ea4c292aaaaa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnri3169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3169%26sid%3Dliteratum%253Aachs%26aulast%3DProtzer%26aufirst%3DU.%26aulast%3DMaini%26aufirst%3DM.%2BK.%26aulast%3DKnolle%26aufirst%3DP.%2BA.%26atitle%3DLiving%2520in%2520the%2520liver%253A%2520hepatic%2520infections%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2012%26volume%3D12%26spage%3D201%26epage%3D213%26doi%3D10.1038%2Fnri3169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chan, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinot-Peignoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piratvisuth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillmann, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locarnini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span> </span><span class="NLM_article-title">Hepatitis B surface antigen quantification: why and how to use it in 2011 - A core group report</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span><span class="refDoi"> DOI: 10.1016/j.jhep.2011.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.jhep.2011.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=21718667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BC3MbitFShsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=1121-1131&author=H.+L.+Chanauthor=A.+Thompsonauthor=M.+Martinot-Peignouxauthor=T.+Piratvisuthauthor=M.+Cornbergauthor=M.+R.+Brunettoauthor=H.+L.+Tillmannauthor=J.+H.+Kaoauthor=J.+D.+Jiaauthor=H.+Wedemeyerauthor=S.+Locarniniauthor=H.+L.+Janssenauthor=P.+Marcellin&title=Hepatitis+B+surface+antigen+quantification%3A+why+and+how+to+use+it+in+2011+-+A+core+group+report&doi=10.1016%2Fj.jhep.2011.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report</span></div><div class="casAuthors">Chan Henry Lik-Yuen; Thompson Alex; Martinot-Peignoux Michelle; Piratvisuth Teerha; Cornberg Markus; Brunetto Maurizia Rossana; Tillmann Hans L; Kao Jia-Horng; Jia Ji-Dong; Wedemeyer Heiner; Locarnini Stephen; Janssen Harry L A; Marcellin Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1121-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Quantitative HBsAg had been suggested to be helpful in management of HBV, but assays were cumbersome.  The recent availability of commercial quantitative assays has restarted the interest in quantitative serum hepatitis B surface antigen (HBsAg) as a biomarker for prognosis and treatment response in chronic hepatitis B.  HBsAg level reflects the transcriptional activity of cccDNA rather than the absolute amount of cccDNA copies.  Serum HBsAg level tends to be higher in hepatitis B e antigen (HBeAg)-positive than HBeAg-negative patients.  Among patients with a low HBV DNA (<2000IU/ml), HBsAg <1000IU/ml in genotype D HBV infection and HBsAg <100IU/ml in genotype B/C HBV infection is associated with inactive carrier state in HBeAg-negative patients.  The HBsAg reduction by nucleos(t)ide analogues (NA) is not as pronounced as by interferon treatment.  On peginterferon treatment, sustained responders tend to show greater HBsAg decline than the non-responders.  The optimal on-treatment HBsAg cutoff to predict response needs further evaluation in HBeAg-positive patients, but an absence of HBsAg decline together with a <2 log reduction in HBV DNA at week 12 can serve as stopping rule in HBeAg-negative patients with genotype D HBV infection.  A rapid serum HBsAg decline during NA therapy may identify patients who will clear HBsAg in the long-term.  There are early reports among Asian patients that an HBsAg level of <100IU/ml might predict lower risk of relapse after stopping NA treatment.  In clinical practice, serum HBsAg level should be used together with, but not as a substitute for, HBV DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4Ym-TR-Q2esRAV4D_Ins_fW6udTcc2eZ40U-29U8anrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbitFShsg%253D%253D&md5=025b70ddfc809716d6d24c534ae3b334</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2011.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DH.%2BL.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DMartinot-Peignoux%26aufirst%3DM.%26aulast%3DPiratvisuth%26aufirst%3DT.%26aulast%3DCornberg%26aufirst%3DM.%26aulast%3DBrunetto%26aufirst%3DM.%2BR.%26aulast%3DTillmann%26aufirst%3DH.%2BL.%26aulast%3DKao%26aufirst%3DJ.%2BH.%26aulast%3DJia%26aufirst%3DJ.%2BD.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DLocarnini%26aufirst%3DS.%26aulast%3DJanssen%26aufirst%3DH.%2BL.%26aulast%3DMarcellin%26aufirst%3DP.%26atitle%3DHepatitis%2520B%2520surface%2520antigen%2520quantification%253A%2520why%2520and%2520how%2520to%2520use%2520it%2520in%25202011%2520-%2520A%2520core%2520group%2520report%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D55%26spage%3D1121%26epage%3D1131%26doi%3D10.1016%2Fj.jhep.2011.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Schoggins, J. W.</span><span> </span><span class="NLM_article-title">Interferon-stimulated genes: roles in viral pathogenesis</span> <span class="citation_source-journal">Curr. Opin. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/j.coviro.2014.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.coviro.2014.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=24713352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVarsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=40-46&author=J.+W.+Schoggins&title=Interferon-stimulated+genes%3A+roles+in+viral+pathogenesis&doi=10.1016%2Fj.coviro.2014.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-stimulated genes: roles in viral pathogenesis</span></div><div class="casAuthors">Schoggins, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-46</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Interferon-stimulated genes (ISGs) are crit. for controlling virus infections.  As new antiviral ISGs continue to be identified and characterized, their roles in viral pathogenesis are also being explored in more detail.  Our current understanding of how ISGs impact viral pathogenesis comes largely from studies in knockout mice, with isolated examples from human clin. data.  This review outlines recent developments on the contributions of various ISGs to viral disease outcomes in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwZqeFB6vxL7Vg90H21EOLACvtfcHk0livP6F9BzmZWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVarsLnI&md5=b551c90c2a205ad79260310617a552c8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DSchoggins%26aufirst%3DJ.%2BW.%26atitle%3DInterferon-stimulated%2520genes%253A%2520roles%2520in%2520viral%2520pathogenesis%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2014%26volume%3D6%26spage%3D40%26epage%3D46%26doi%3D10.1016%2Fj.coviro.2014.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Yokosuka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imazeki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, J.</span><span> </span><span class="NLM_article-title">Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span><span class="refDoi"> DOI: 10.1002/hep.1840050505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.1840050505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1985&pages=728-734&author=O.+Yokosukaauthor=M.+Omataauthor=F.+Imazekiauthor=K.+Okudaauthor=J.+Summers&title=Changes+of+hepatitis+B+virus+DNA+in+liver+and+serum+caused+by+recombinant+leukocyte+interferon+treatment%3A+analysis+of+intrahepatic+replicative+hepatitis+B+virus+DNA&doi=10.1002%2Fhep.1840050505"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fhep.1840050505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.1840050505%26sid%3Dliteratum%253Aachs%26aulast%3DYokosuka%26aufirst%3DO.%26aulast%3DOmata%26aufirst%3DM.%26aulast%3DImazeki%26aufirst%3DF.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DSummers%26aufirst%3DJ.%26atitle%3DChanges%2520of%2520hepatitis%2520B%2520virus%2520DNA%2520in%2520liver%2520and%2520serum%2520caused%2520by%2520recombinant%2520leukocyte%2520interferon%2520treatment%253A%2520analysis%2520of%2520intrahepatic%2520replicative%2520hepatitis%2520B%2520virus%2520DNA%26jtitle%3DHepatology%26date%3D1985%26volume%3D5%26spage%3D728%26epage%3D734%26doi%3D10.1002%2Fhep.1840050505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Santini, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapenta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pucchio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardelli, F.</span><span> </span><span class="NLM_article-title">Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">1777</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span><span class="refDoi"> DOI: 10.1084/jem.191.10.1777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1084%2Fjem.191.10.1777" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=1777-1788&author=S.+M.+Santiniauthor=C.+Lapentaauthor=M.+Logozziauthor=S.+Parlatoauthor=M.+Spadaauthor=T.+Di+Pucchioauthor=F.+Belardelli&title=Type+I+interferon+as+a+powerful+adjuvant+for+monocyte-derived+dendritic+cell+development+and+activity+in+vitro+and+in+Hu-PBL-SCID+mice&doi=10.1084%2Fjem.191.10.1777"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1084%2Fjem.191.10.1777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.191.10.1777%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DS.%2BM.%26aulast%3DLapenta%26aufirst%3DC.%26aulast%3DLogozzi%26aufirst%3DM.%26aulast%3DParlato%26aufirst%3DS.%26aulast%3DSpada%26aufirst%3DM.%26aulast%3DDi%2BPucchio%26aufirst%3DT.%26aulast%3DBelardelli%26aufirst%3DF.%26atitle%3DType%2520I%2520interferon%2520as%2520a%2520powerful%2520adjuvant%2520for%2520monocyte-derived%2520dendritic%2520cell%2520development%2520and%2520activity%2520in%2520vitro%2520and%2520in%2520Hu-PBL-SCID%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D1777%26epage%3D1788%26doi%3D10.1084%2Fjem.191.10.1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Roethle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadden, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrvatin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graupe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duatschek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R. L.</span><span> </span><span class="NLM_article-title">Identification and optimization of pteridinone toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7324</span><span class="NLM_x">–</span> <span class="NLM_lpage">7333</span><span class="refDoi"> DOI: 10.1021/jm400815m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400815m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7324-7333&author=P.+A.+Roethleauthor=R.+M.+McFaddenauthor=H.+Yangauthor=P.+Hrvatinauthor=H.+Huiauthor=M.+Graupeauthor=B.+Gallagherauthor=J.+Chaoauthor=J.+Hesselgesserauthor=P.+Duatschekauthor=J.+Zhengauthor=B.+Luauthor=D.+B.+Tumasauthor=J.+Perryauthor=R.+L.+Halcomb&title=Identification+and+optimization+of+pteridinone+toll-like+receptor+7+%28TLR7%29+agonists+for+the+oral+treatment+of+viral+hepatitis&doi=10.1021%2Fjm400815m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis</span></div><div class="casAuthors">Roethle, Paul A.; McFadden, Ryan M.; Yang, Hong; Hrvatin, Paul; Hui, Hon; Graupe, Michael; Gallagher, Brian; Chao, Jessica; Hesselgesser, Joseph; Duatschek, Paul; Zheng, Jim; Lu, Bing; Tumas, Daniel B.; Perry, Jason; Halcomb, Randall L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7324-7333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pteridinone-based Toll-like receptor 7 (TLR7) agonists were identified as potent and selective alternatives to the previously reported adenine-based agonists, leading to the discovery of GS-9620 (I).  Analogs were optimized for the immunomodulatory activity and selectivity vs. other TLRs, based on differential induction of key cytokines including interferon α (IFN-α) and tumor necrosis factor α (TNF-α).  In addn., physicochem. properties were adjusted to achieve desirable in vivo pharmacokinetic and pharmacodynamic properties.  GS-9620 is currently in clin. evaluation for the treatment of chronic hepatitis B (HBV) infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2wrWq68pK7Vg90H21EOLACvtfcHk0lhlwWlHSEkwbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjtbfL&md5=753aa20b0d0f9b16eb3a1d205fbe0a30</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm400815m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400815m%26sid%3Dliteratum%253Aachs%26aulast%3DRoethle%26aufirst%3DP.%2BA.%26aulast%3DMcFadden%26aufirst%3DR.%2BM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHrvatin%26aufirst%3DP.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DGallagher%26aufirst%3DB.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DDuatschek%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DHalcomb%26aufirst%3DR.%2BL.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520pteridinone%2520toll-like%2520receptor%25207%2520%2528TLR7%2529%2520agonists%2520for%2520the%2520oral%2520treatment%2520of%2520viral%2520hepatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7324%26epage%3D7333%26doi%3D10.1021%2Fjm400815m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmi, H.</span><span> </span><span class="NLM_article-title">Recognition of pathogen-associated molecular patterns by TLR family</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/S0165-2478(02)00228-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2FS0165-2478%2802%2900228-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=12527213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2003&pages=85-95&author=S.+Akiraauthor=H.+Hemmi&title=Recognition+of+pathogen-associated+molecular+patterns+by+TLR+family&doi=10.1016%2FS0165-2478%2802%2900228-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recognition of pathogen-associated molecular patterns by TLR family</span></div><div class="casAuthors">Akira, Shizuo; Hemmi, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are type I transmembrane proteins involved in innate immunity by recognizing microbial conserved structures.  Recent studies have shown that TLR3 recognizes dsRNA, a viral product, whereas TLR9 recognizes unmethylated CpG motifs frequently found in the genome of bacteria and viruses, but not vertebrates.  TLR7 recognizes small synthetic immune modifiers including imiquimod, R-848, loxoribine, and bropirimine, all of which are already applied or promising for clin. use against viral infections and cancers.  Plasmacytoid dendritic cells express TLR7 and TLR9, and respond to TLR7 and TLR9 ligands by producing a large amt. of interferon (IFN-α).  Thus, TLR3, TLR7, and TLR9 may play an important role in detecting and combating viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfMQi5sN0W37Vg90H21EOLACvtfcHk0lgJFoeklQsjNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVeksw%253D%253D&md5=e9f742c47f1dde6e5a603ea1f192aca6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0165-2478%2802%2900228-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-2478%252802%252900228-6%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DHemmi%26aufirst%3DH.%26atitle%3DRecognition%2520of%2520pathogen-associated%2520molecular%2520patterns%2520by%2520TLR%2520family%26jtitle%3DImmunol.%2520Lett.%26date%3D2003%26volume%3D85%26spage%3D85%26epage%3D95%26doi%3D10.1016%2FS0165-2478%2802%2900228-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Pasare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medzhitov, R.</span><span> </span><span class="NLM_article-title">Toll-like receptors: linking innate and adaptive immunity</span> <span class="citation_source-journal">Microbes Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1016/j.micinf.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.micinf.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=15596124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOntbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1382-1387&author=C.+Pasareauthor=R.+Medzhitov&title=Toll-like+receptors%3A+linking+innate+and+adaptive+immunity&doi=10.1016%2Fj.micinf.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: linking innate and adaptive immunity</span></div><div class="casAuthors">Pasare, Chandrashekhar; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1382-1387</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Detection of and response to microbial infections by the immune system depends largely on a family of pattern-recognition receptors called Toll-like receptors (TLRs).  These receptors recognize conserved mol. products derived from various classes of pathogens, including Gram-pos. and -neg. bacteria, DNA and RNA viruses, fungi, and protozoa.  Recognition of ligands by TLRs leads to a series of signaling events resulting in induction of acute responses necessary to kill the pathogen.  TLRs are also responsible for the induction of dendritic cell maturation, which is responsible and necessary for initiation of adaptive immune responses.  Although TLRs control induction of adaptive immunity, it is not clear at this point how responses are appropriately tailored by individual TLRs to the advantage of the host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVRkv7NpqBLVg90H21EOLACvtfcHk0lgJFoeklQsjNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOntbbP&md5=e2afa44464fe2cd2faaf64f89b23f79d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.micinf.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micinf.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DPasare%26aufirst%3DC.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%253A%2520linking%2520innate%2520and%2520adaptive%2520immunity%26jtitle%3DMicrobes%2520Infect.%26date%3D2004%26volume%3D6%26spage%3D1382%26epage%3D1387%26doi%3D10.1016%2Fj.micinf.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span> </span><span class="NLM_article-title">Toll-like receptors: Critical proteins linking innate and acquired immunity</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1038/90609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2F90609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=11477402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=675-680&author=S.+Akiraauthor=K.+Takedaauthor=T.+Kaisho&title=Toll-like+receptors%3A+Critical+proteins+linking+innate+and+acquired+immunity&doi=10.1038%2F90609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: Critical proteins linking innate and acquired immunity</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi; Kaisho, Tsuneyasu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-680</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review with 84 refs.  Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs).  These receptors recognize conserved mol. patterns (pathogen-assocd. mol. patterns), which are shared by large groups of microorganisms.  Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components.  The TLRs may also recognize endogenous ligands induced during the inflammatory response.  Similar cytoplasmic domains allow TLRs to use the same signaling mols. used by the interleukin 1 receptors (IL-1Rs): these include MyD88, IL-1R-assocd. protein kinase and tumor necrosis factor receptor-activated factor 6.  However, evidence is accumulating that the signaling pathways assocd. with each TLR are not identical and may, therefore, result in different biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8I2sSl7FK7Vg90H21EOLACvtfcHk0liwZPYNppVunA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D&md5=3fd5a975d63e0384c8cffa960159b063</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F90609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F90609%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26atitle%3DToll-like%2520receptors%253A%2520Critical%2520proteins%2520linking%2520innate%2520and%2520acquired%2520immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D675%26epage%3D680%26doi%3D10.1038%2F90609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jurk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heil, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipford, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span> </span><span class="NLM_article-title">Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="refDoi"> DOI: 10.1038/ni0602-499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2Fni0602-499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=12032557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFOmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=499&author=M.+Jurkauthor=F.+Heilauthor=J.+Vollmerauthor=C.+Schetterauthor=A.+Kriegauthor=H.+Wagnerauthor=G.+Lipfordauthor=S.+Bauer&title=Human+TLR7+or+TLR8+independently+confer+responsiveness+to+the+antiviral+compound+R-848&doi=10.1038%2Fni0602-499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848</span></div><div class="casAuthors">Jurk, Marion; Heil, Florian; Vollmer, Joerg; Schetter, Christian; Krieg, Arthur M.; Wagner, Hermann; Lipford, Grayson; Bauer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">In their quest to identify ligands for TLRs, the authors found that the antiviral immunostimulant drug imidazoquinoline resiquimod R-848 induced NF-κB activation in HEK293 cells transfected with human TLR8 in a dose-dependent manner.  The results of the study showed that both human TLR7 and TLR* can independently mediate recognition of the same antiviral compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonRoNyuBI4w7Vg90H21EOLACvtfcHk0liwZPYNppVunA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFOmsLo%253D&md5=f8d7a53ffd849013dba07c33807ccc8f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fni0602-499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni0602-499%26sid%3Dliteratum%253Aachs%26aulast%3DJurk%26aufirst%3DM.%26aulast%3DHeil%26aufirst%3DF.%26aulast%3DVollmer%26aufirst%3DJ.%26aulast%3DSchetter%26aufirst%3DC.%26aulast%3DKrieg%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DH.%26aulast%3DLipford%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DS.%26atitle%3DHuman%2520TLR7%2520or%2520TLR8%2520independently%2520confer%2520responsiveness%2520to%2520the%2520antiviral%2520compound%2520R-848%26jtitle%3DNat.%2520Immunol.%26date%3D2002%26volume%3D3%26spage%3D499%26doi%3D10.1038%2Fni0602-499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hemmi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1038/ni758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2Fni758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=11812998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVygurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=196-200&author=H.+Hemmiauthor=T.+Kaishoauthor=O.+Takeuchiauthor=S.+Satoauthor=H.+Sanjoauthor=K.+Hoshinoauthor=T.+Horiuchiauthor=H.+Tomizawaauthor=K.+Takedaauthor=S.+Akira&title=Small+anti-viral+compounds+activate+immune+cells+via+the+TLR7+MyD88-dependent+signaling+pathway&doi=10.1038%2Fni758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway</span></div><div class="casAuthors">Hemmi, Hiroaki; Kaisho, Tsuneyasu; Takeuchi, Osamu; Sato, Shintaro; Sanjo, Hideki; Hoshino, Katsuaki; Horiuchi, Takao; Tomizawa, Hideyuki; Takeda, Kiyoshi; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-200</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The imidazoquinoline compds. imiquimod and R-848 are low-mol.-wt. immune response modifiers that can induce the synthesis of interferon-α and other cytokines in a variety of cell types.  These compds. have potent anti-viral and anti-tumor properties; however, the mechanisms by which they exert their anti-viral activities remain unclear.  Here the authors show that the imidazoquinolines activate immune cells via the Toll-like receptor 7 (TLR7)-MyD88-dependent signaling pathway.  In response to the imidazoquinolines, neither MyD88- nor TLR7-deficient mice showed any inflammatory cytokine prodn. by macrophages, proliferation of splenocytes or maturation of dendritic cells.  Imidazoquinoline-induced signaling events were also abolished in both MyD88- and TLR7-deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrverWM40gXkrVg90H21EOLACvtfcHk0ljdmgfjCl2lWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVygurc%253D&md5=61c34c1efee9d8931b95c1355fc24d9e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fni758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni758%26sid%3Dliteratum%253Aachs%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DTomizawa%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DSmall%2520anti-viral%2520compounds%2520activate%2520immune%2520cells%2520via%2520the%2520TLR7%2520MyD88-dependent%2520signaling%2520pathway%26jtitle%3DNat.%2520Immunol.%26date%3D2002%26volume%3D3%26spage%3D196%26epage%3D200%26doi%3D10.1038%2Fni758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hanten, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neys, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birmachu, W.</span><span> </span><span class="NLM_article-title">Comparison of human B cell activation by TLR7 and TLR9 agonists</span> <span class="citation_source-journal">BMC Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="refDoi"> DOI: 10.1186/1471-2172-9-39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1186%2F1471-2172-9-39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=18652679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BD1crgsVOlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=39&author=J.+A.+Hantenauthor=J.+P.+Vasilakosauthor=C.+L.+Riterauthor=L.+Neysauthor=K.+E.+Lipsonauthor=S.+S.+Alkanauthor=W.+Birmachu&title=Comparison+of+human+B+cell+activation+by+TLR7+and+TLR9+agonists&doi=10.1186%2F1471-2172-9-39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of human B cell activation by TLR7 and TLR9 agonists</span></div><div class="casAuthors">Hanten John A; Vasilakos John P; Riter Christie L; Neys Lori; Lipson Kenneth E; Alkan Sefik S; Birmachu Woubalem</div><div class="citationInfo"><span class="NLM_cas:title">BMC immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Human B cells and plasmacytoid dendritic cells (pDC) are the only cells known to express both TLR7 and TLR9.  Plasmacytoid dendritic cells are the primary IFN-alpha producing cells in response to TLR7 and TLR9 agonists.  The direct effects of TLR7 stimulation on human B cells is less understood.  The objective of this study was to compare the effects of TLR7 and TLR9 stimulation on human B cell function.  RESULTS:  Gene expression and protein production of cytokines, chemokines, various B cell activation markers, and immunoglobulins were evaluated.  Purified human CD19+ B cells (99.9%, containing both naive and memory populations) from peripheral blood were stimulated with a TLR7-selective agonist (852A), TLR7/8 agonist (3M-003), or TLR9 selective agonist CpG ODN (CpG2006).  TLR7 and TLR9 agonists similarly modulated the expression of cytokine and chemokine genes (IL-6, MIP1 alpha, MIP1 beta, TNF alpha and LTA), co-stimulatory molecules (CD80, CD40 and CD58), Fc receptors (CD23, CD32), anti-apoptotic genes (BCL2L1), certain transcription factors (MYC, TCFL5), and genes critical for B cell proliferation and differentiation (CD72, IL21R).  Both agonists also induced protein expression of the above cytokines and chemokines.  Additionally, TLR7 and TLR9 agonists induced the production of IgM and IgG.  A TLR8-selective agonist was comparatively ineffective at stimulating purified human B cells.  CONCLUSION:  These results demonstrate that despite their molecular differences, the TLR7 and TLR9 agonists induce similar genes and proteins in purified human B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDaPdhWEEavBBrI9DTGjC0fW6udTcc2eYA-Gwfir37nbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crgsVOlug%253D%253D&md5=c5981fbc0a94a0331b3e5846f774a400</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1471-2172-9-39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2172-9-39%26sid%3Dliteratum%253Aachs%26aulast%3DHanten%26aufirst%3DJ.%2BA.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26aulast%3DRiter%26aufirst%3DC.%2BL.%26aulast%3DNeys%26aufirst%3DL.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DAlkan%26aufirst%3DS.%2BS.%26aulast%3DBirmachu%26aufirst%3DW.%26atitle%3DComparison%2520of%2520human%2520B%2520cell%2520activation%2520by%2520TLR7%2520and%2520TLR9%2520agonists%26jtitle%3DBMC%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D39%26doi%3D10.1186%2F1471-2172-9-39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Oord, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andeweg, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterhaus, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pas, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boonstra, A.</span><span> </span><span class="NLM_article-title">Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1002/hep.27805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.27805" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=87-100&author=T.+Vanwolleghemauthor=J.+Houauthor=G.+van+Oordauthor=A.+C.+Andewegauthor=A.+D.+Osterhausauthor=S.+D.+Pasauthor=H.+L.+Janssenauthor=A.+Boonstra&title=Re-evaluation+of+hepatitis+B+virus+clinical+phases+by+systems+biology+identifies+unappreciated+roles+for+the+innate+immune+response+and+B+cells&doi=10.1002%2Fhep.27805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fhep.27805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27805%26sid%3Dliteratum%253Aachs%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3Dvan%2BOord%26aufirst%3DG.%26aulast%3DAndeweg%26aufirst%3DA.%2BC.%26aulast%3DOsterhaus%26aufirst%3DA.%2BD.%26aulast%3DPas%26aufirst%3DS.%2BD.%26aulast%3DJanssen%26aufirst%3DH.%2BL.%26aulast%3DBoonstra%26aufirst%3DA.%26atitle%3DRe-evaluation%2520of%2520hepatitis%2520B%2520virus%2520clinical%2520phases%2520by%2520systems%2520biology%2520identifies%2520unappreciated%2520roles%2520for%2520the%2520innate%2520immune%2520response%2520and%2520B%2520cells%26jtitle%3DHepatology%26date%3D2015%26volume%3D62%26spage%3D87%26epage%3D100%26doi%3D10.1002%2Fhep.27805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bekeredjian-Ding, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span> </span><span class="NLM_article-title">T Cell-Independent, TLR-induced IL-12p70 production in primary human monocytes</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">7438</span><span class="NLM_x">–</span> <span class="NLM_lpage">7446</span><span class="refDoi"> DOI: 10.4049/jimmunol.176.12.7438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.4049%2Fjimmunol.176.12.7438" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=7438-7446&author=I.+Bekeredjian-Dingauthor=S.+I.+Rothauthor=S.+Gillesauthor=T.+Gieseauthor=A.+Ablasserauthor=V.+Hornungauthor=S.+Endresauthor=G.+Hartmann&title=T+Cell-Independent%2C+TLR-induced+IL-12p70+production+in+primary+human+monocytes&doi=10.4049%2Fjimmunol.176.12.7438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.176.12.7438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.176.12.7438%26sid%3Dliteratum%253Aachs%26aulast%3DBekeredjian-Ding%26aufirst%3DI.%26aulast%3DRoth%26aufirst%3DS.%2BI.%26aulast%3DGilles%26aufirst%3DS.%26aulast%3DGiese%26aufirst%3DT.%26aulast%3DAblasser%26aufirst%3DA.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DEndres%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DG.%26atitle%3DT%2520Cell-Independent%252C%2520TLR-induced%2520IL-12p70%2520production%2520in%2520primary%2520human%2520monocytes%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D7438%26epage%3D7446%26doi%3D10.4049%2Fjimmunol.176.12.7438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gorden, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorski, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedl, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieper, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomai, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakos, J. P.</span><span> </span><span class="NLM_article-title">Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span><span class="refDoi"> DOI: 10.4049/jimmunol.174.3.1259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.4049%2Fjimmunol.174.3.1259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=15661881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=1259-1268&author=K.+B.+Gordenauthor=K.+S.+Gorskiauthor=S.+J.+Gibsonauthor=R.+M.+Kedlauthor=W.+C.+Kieperauthor=X.+Qiuauthor=M.+A.+Tomaiauthor=S.+S.+Alkanauthor=J.+P.+Vasilakos&title=Synthetic+TLR+agonists+reveal+functional+differences+between+human+TLR7+and+TLR8&doi=10.4049%2Fjimmunol.174.3.1259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8</span></div><div class="casAuthors">Gorden, Keith B.; Gorski, Kevin S.; Gibson, Sheila J.; Kedl, Ross M.; Kieper, William C.; Qiu, Xiaohong; Tomai, Mark A.; Alkan, Sefik S.; Vasilakos, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1259-1268</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Although TLR7 and TLR8 are phylogenetically and structurally related, their relative functions are largely unknown.  The role of TLR7 has been established using TLR7-deficient mice and small mol. TLR7 agonists.  The absence of TLR8-selective agonists has hampered the authors' understanding of the role of TLR8.  In this study TLR agonists selective for TLR7 or TLR8 were used to det. the repertoire of human innate immune cells that are activated through these TLRs.  The authors found that TLR7 agonists directly activated purified plasmacytoid dendritic cells and, to a lesser extent, monocytes.  Conversely, TLR8 agonists directly activated purified myeloid dendritic cells, monocytes, and monocyte-derived dendritic cells (GM-CSF/IL-4/TGF-β).  Accordingly, TLR7-selective agonists were more effective than TLR8-selective agonists at inducing IFN-α- and IFN-regulated chemokines such as IFN-inducible protein and IFN-inducible T cell α chemoattractant from human PBMC.  In contrast, TLR8 agonists were more effective than TLR7 agonists at inducing proinflammatory cytokines and chemokines, such as TNF-α, IL-12, and MIP-1α.  Thus, this study demonstrated that TLR7 and TLR8 agonists differ in their target cell selectivity and cytokine induction profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxUMK2LBltvrVg90H21EOLACvtfcHk0lhDOnYoIbac-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFyhsQ%253D%253D&md5=1893fde2508086be1f79df76d09e919a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.174.3.1259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.174.3.1259%26sid%3Dliteratum%253Aachs%26aulast%3DGorden%26aufirst%3DK.%2BB.%26aulast%3DGorski%26aufirst%3DK.%2BS.%26aulast%3DGibson%26aufirst%3DS.%2BJ.%26aulast%3DKedl%26aufirst%3DR.%2BM.%26aulast%3DKieper%26aufirst%3DW.%2BC.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DTomai%26aufirst%3DM.%2BA.%26aulast%3DAlkan%26aufirst%3DS.%2BS.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26atitle%3DSynthetic%2520TLR%2520agonists%2520reveal%2520functional%2520differences%2520between%2520human%2520TLR7%2520and%2520TLR8%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D1259%26epage%3D1268%26doi%3D10.4049%2Fjimmunol.174.3.1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Isobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurimoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 9-substituted-8-hydroxyadenine derivatives as potent interferon inducers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2095</span><span class="refDoi"> DOI: 10.1021/jm051089s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051089s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2088-2095&author=Y.+Isobeauthor=A.+Kurimotoauthor=M.+Tobeauthor=K.+Hashimotoauthor=T.+Nakamuraauthor=K.+Norimuraauthor=H.+Ogitaauthor=H.+Takaku&title=Synthesis+and+biological+evaluation+of+novel+9-substituted-8-hydroxyadenine+derivatives+as+potent+interferon+inducers&doi=10.1021%2Fjm051089s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel 9-Substituted-8-Hydroxyadenine Derivatives as Potent Interferon Inducers</span></div><div class="casAuthors">Isobe, Yoshiaki; Kurimoto, Ayumu; Tobe, Masanori; Hashimoto, Kazuki; Nakamura, Tomoaki; Norimura, Kei; Ogita, Haruhisa; Takaku, Haruo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2088-2095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently we reported the adenine derivs. 3a-d as novel interferon (IFN) inducers.  In the present study, we conducted a detailed structure-activity relationship study of analogs of 3a-d with respect to their IFN-inducing activity, mainly focusing on the N(9)-position of the adenine.  From this study, we found that introduction of the 3-pyridylmethyl moiety was effective to increase in vitro activity, and compd. I was identified as being the most potent IFN inducer.  This compd. gave a min. effective concn. (MEC) of 3 nM, which is comparable with that of R-848, a second generation IFN inducer.  Compd. I also demonstrated potent IFN-inducing activity at a dose of 0.1 mg/kg by oral administration in mice.  Furthermore, compd. I induced IFN in monkeys in a dose dependent manner, with a potency superior to that of R-848.  In addn., I did not cause emesis in ferrets even at a dose of 30 mg/kg.  In this study the max. plasma concn. of I was 1019 ng/mL (ca. 3.1 μM), which was approx. 1000-fold higher than the MEC value.  Therefore, with respect to both the efficacy and the safety margin, compd. I (SM-276001) is considered to be a promising compd. as an orally active IFN inducer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkfwkk2DNAOLVg90H21EOLACvtfcHk0lhbhhAd33EoaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOrs70%253D&md5=a5555c918cb910d714d1068e1f6ba4b4</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm051089s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051089s%26sid%3Dliteratum%253Aachs%26aulast%3DIsobe%26aufirst%3DY.%26aulast%3DKurimoto%26aufirst%3DA.%26aulast%3DTobe%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DNorimura%26aufirst%3DK.%26aulast%3DOgita%26aufirst%3DH.%26aulast%3DTakaku%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25209-substituted-8-hydroxyadenine%2520derivatives%2520as%2520potent%2520interferon%2520inducers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2088%26epage%3D2095%26doi%3D10.1021%2Fjm051089s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koga-Yamakawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovedi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leishman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span> </span><span class="NLM_article-title">Intratracheal and Oral Administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1002/ijc.27691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fijc.27691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=22733292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFGiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=580-590&author=E.+Koga-Yamakawaauthor=S.+J.+Dovediauthor=M.+Murataauthor=H.+Matsuiauthor=A.+J.+Leishmanauthor=J.+Bellauthor=D.+Fergusonauthor=S.+P.+Heatonauthor=T.+Okiauthor=H.+Tomizawaauthor=A.+Bahlauthor=H.+Takakuauthor=R.+W.+Wilkinsonauthor=H.+Harada&title=Intratracheal+and+Oral+Administration+of+SM-276001%3A+A+selective+TLR7+agonist%2C+leads+to+antitumor+efficacy+in+primary+and+metastatic+models+of+cancer&doi=10.1002%2Fijc.27691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer</span></div><div class="casAuthors">Koga-Yamakawa, Erina; Dovedi, Simon J.; Murata, Masashi; Matsui, Hiroyuki; Leishman, Andrew J.; Bell, John; Ferguson, Douglas; Heaton, Simon P.; Oki, Toshihiro; Tomizawa, Hideyuki; Bahl, Ash; Takaku, Haruo; Wilkinson, Robert W.; Harada, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">580-590</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Topical TLR7 agonists such as imiquimod are highly effective for the treatment of dermatol. malignancies; however, their efficacy in the treatment of nondermatol. tumors has been less successful.  We report that oral administration of the novel TLR7-selective small mol. agonist; SM-276001, leads to the induction of an inflammatory cytokine and chemokine milieu and to the activation of a diverse population of immune effector cells including T and B lymphocytes, NK and NKT cells.  Oral administration of SM-276001 leads to the induction of IFNα, TNFα and IL-12p40 and a redn. in tumor burden in the Balb/c syngeneic Renca and CT26 models.  Using the OV2944-HM-1 model of ovarian cancer which spontaneously metastasizes to the lungs following s.c. implantation, we evaluated the efficacy of intratracheal and oral administration of SM-276001 in an adjuvant setting following surgical resection of the primary tumor.  We show that both oral and intratracheal TLR7 therapy can reduce the frequency of pulmonary metastasis, and metastasis to the axillary lymph nodes.  These results demonstrate that SM-276001 is a potent selective TLR7 agonist that can induce antitumor immune responses when dosed either intratracheally or orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqioNuAHXa9bLVg90H21EOLACvtfcHk0lhbhhAd33EoaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFGiu7Y%253D&md5=40dc9668f626fcb95440d3f37c132aa7</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1002%2Fijc.27691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27691%26sid%3Dliteratum%253Aachs%26aulast%3DKoga-Yamakawa%26aufirst%3DE.%26aulast%3DDovedi%26aufirst%3DS.%2BJ.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DLeishman%26aufirst%3DA.%2BJ.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOki%26aufirst%3DT.%26aulast%3DTomizawa%26aufirst%3DH.%26aulast%3DBahl%26aufirst%3DA.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DHarada%26aufirst%3DH.%26atitle%3DIntratracheal%2520and%2520Oral%2520Administration%2520of%2520SM-276001%253A%2520A%2520selective%2520TLR7%2520agonist%252C%2520leads%2520to%2520antitumor%2520efficacy%2520in%2520primary%2520and%2520metastatic%2520models%2520of%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D580%26epage%3D590%26doi%3D10.1002%2Fijc.27691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miller, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerster, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomai, M. A.</span><span> </span><span class="NLM_article-title">Imiquimod applied topically: a novel immune response modifier and a new class of drug</span> <span class="citation_source-journal">Int. J. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/S0192-0561(98)00068-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2FS0192-0561%2898%2900068-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10411278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADyaK1MXitFyqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=1-14&author=R.+L.+Millerauthor=J.+F.+Gersterauthor=M.+L.+Owensauthor=H.+B.+Sladeauthor=M.+A.+Tomai&title=Imiquimod+applied+topically%3A+a+novel+immune+response+modifier+and+a+new+class+of+drug&doi=10.1016%2FS0192-0561%2898%2900068-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Imiquimod applied topically: a novel immune response modifier and new class of drug</span></div><div class="casAuthors">Miller, R. L.; Gerster, J. F.; Owens, M. L.; Slade, H. B.; Tomai, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 70 refs.  Imiquimod (S-26308, R-837) (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4 amine), an immune response modifier, demonstrates potent antiviral and antitumor activity in animal models (see structure in Fig. 1).  The drug exhibits no direct antiviral or antiproliferative activity when tested in a no. of cell culture systems.  Imiquimod's activity was discovered while screening for anti-herpes virus activity.  One of the first analogs in the series, S-25059 was tested in the early 1980's and due to slight toxicity, caused slightly reduced herpes cytopathol. in Vero cell cultures.  Follow-up testing in herpes infected guinea pigs showed complete protection toward lesion development.  Activity of these drugs results primarily from interferon alpha (IFN-α) induction and other cytokine induction.  At least part of the cytokine induction is mediated through NF-κB activation.  These cytokines stimulate several other aspects of the innate immune response.  In addn., imiquimod stimulates acquired immunity, in particular the cellular arm which is important for control of viral infections and various tumors.  This effect is mediated by drug induced IFN-α and Interleukin-12 (IL-12) and IFN-γ induced by these cytokines.  Imiquimod is expected to be effective where exogenous IFN-α has shown utility and where enhancement of cell-mediated immunity is needed.  The following is a brief review of the preclin. pharmacol. of imiquimod and the clin. results of genital wart trials.  The mechanism of action of topically applied imiquimod will likely lead to benefits in several other chronic virus infections and tumors of the skin.  Two other reviews on imiquimod that focus mainly on the clin. results have been published (Beutner & Geisse, 1997; Slade, Owens, Tomai & Miller, 1998).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSom1Nk4ulLrVg90H21EOLACvtfcHk0ljxPPiBpz39Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFyqtLk%253D&md5=b4b47faaa21fb4eb2e530ca2bcd6d442</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1016%2FS0192-0561%2898%2900068-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0192-0561%252898%252900068-X%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DR.%2BL.%26aulast%3DGerster%26aufirst%3DJ.%2BF.%26aulast%3DOwens%26aufirst%3DM.%2BL.%26aulast%3DSlade%26aufirst%3DH.%2BB.%26aulast%3DTomai%26aufirst%3DM.%2BA.%26atitle%3DImiquimod%2520applied%2520topically%253A%2520a%2520novel%2520immune%2520response%2520modifier%2520and%2520a%2520new%2520class%2520of%2520drug%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1999%26volume%3D21%26spage%3D1%26epage%3D14%26doi%3D10.1016%2FS0192-0561%2898%2900068-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gerster, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomai, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birmachu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bomersine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbertson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafla, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maye, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaides, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oneyemi, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhurst, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecore, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scribner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testerman, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andre, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupu, M.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of 1<i>H</i>-imidazo[4, 5-<i>c</i>]quinolines that induce interferon production</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3481</span><span class="NLM_x">–</span> <span class="NLM_lpage">3491</span><span class="refDoi"> DOI: 10.1021/jm049211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3481-3491&author=J.+F.+Gersterauthor=K.+J.+Lindstromauthor=R.+L.+Millerauthor=M.+A.+Tomaiauthor=W.+Birmachuauthor=S.+N.+Bomersineauthor=S.+J.+Gibsonauthor=L.+M.+Imbertsonauthor=J.+R.+Jacobsonauthor=R.+T.+Knaflaauthor=P.+V.+Mayeauthor=N.+Nikolaidesauthor=F.+Y.+Oneyemiauthor=G.+J.+Parkhurstauthor=S.+E.+Pecoreauthor=M.+J.+Reiterauthor=L.+S.+Scribnerauthor=T.+L.+Testermanauthor=N.+J.+Thompsonauthor=T.+L.+Wagnerauthor=C.+E.+Weeksauthor=J.+D.+Andreauthor=D.+Lagainauthor=Y.+Bastardauthor=M.+Lupu&title=Synthesis+and+structure-activity+relationships+of+1H-imidazo%5B4%2C+5-c%5Dquinolines+that+induce+interferon+production&doi=10.1021%2Fjm049211v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm049211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049211v%26sid%3Dliteratum%253Aachs%26aulast%3DGerster%26aufirst%3DJ.%2BF.%26aulast%3DLindstrom%26aufirst%3DK.%2BJ.%26aulast%3DMiller%26aufirst%3DR.%2BL.%26aulast%3DTomai%26aufirst%3DM.%2BA.%26aulast%3DBirmachu%26aufirst%3DW.%26aulast%3DBomersine%26aufirst%3DS.%2BN.%26aulast%3DGibson%26aufirst%3DS.%2BJ.%26aulast%3DImbertson%26aufirst%3DL.%2BM.%26aulast%3DJacobson%26aufirst%3DJ.%2BR.%26aulast%3DKnafla%26aufirst%3DR.%2BT.%26aulast%3DMaye%26aufirst%3DP.%2BV.%26aulast%3DNikolaides%26aufirst%3DN.%26aulast%3DOneyemi%26aufirst%3DF.%2BY.%26aulast%3DParkhurst%26aufirst%3DG.%2BJ.%26aulast%3DPecore%26aufirst%3DS.%2BE.%26aulast%3DReiter%26aufirst%3DM.%2BJ.%26aulast%3DScribner%26aufirst%3DL.%2BS.%26aulast%3DTesterman%26aufirst%3DT.%2BL.%26aulast%3DThompson%26aufirst%3DN.%2BJ.%26aulast%3DWagner%26aufirst%3DT.%2BL.%26aulast%3DWeeks%26aufirst%3DC.%2BE.%26aulast%3DAndre%26aufirst%3DJ.%2BD.%26aulast%3DLagain%26aufirst%3DD.%26aulast%3DBastard%26aufirst%3DY.%26aulast%3DLupu%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%25201H-imidazo%255B4%252C%25205-c%255Dquinolines%2520that%2520induce%2520interferon%2520production%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3481%26epage%3D3491%26doi%3D10.1021%2Fjm049211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fosdick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflanz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfgang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic properties of GS-9620, a novel toll-like receptor 7 agonist, demonstrate interferon-stimulated gene induction without detectable serum interferon at low oral doses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1124/jpet.113.207878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1124%2Fjpet.113.207878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=24133297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=96-105&author=A.+Fosdickauthor=J.+Zhengauthor=S.+Pflanzauthor=C.+R.+Freyauthor=J.+Hesselgesserauthor=R.+L.+Halcombauthor=G.+Wolfgangauthor=D.+B.+Tumas&title=Pharmacokinetic+and+pharmacodynamic+properties+of+GS-9620%2C+a+novel+toll-like+receptor+7+agonist%2C+demonstrate+interferon-stimulated+gene+induction+without+detectable+serum+interferon+at+low+oral+doses&doi=10.1124%2Fjpet.113.207878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic properties of GS-9620, a novel toll-like receptor 7 agonist, demonstrate interferon-stimulated gene induction without detectable serum interferon at low oral doses</span></div><div class="casAuthors">Fosdick, Abigail; Zheng, Jim; Pflanz, Stefan; Frey, Christian R.; Hesselgesser, Joseph; Halcomb, Randall L.; Wolfgang, Grushenka; Tumas, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-105, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">GS-9620 [8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5H)-one] is a potent, orally bioavailable small-mol. agonist of Toll-like receptor 7 (TLR7) developed for finite treatment of chronic hepatitis B viral (HBV) infection, with the goal of inducing a liver-targeted antiviral effect without inducing the adverse effects assocd. with current systemic interferon-a (IFN-α) therapies.  We characterized the pharmacodynamic response of GS-9620 in CD-1 mice and cynomolgus monkeys following i.v. or oral administration and showed that GS-9620 induces the prodn. of select chemokines and cytokines, including IFN-α and interferon-stimulated genes (ISGs).  It is noteworthy that we also demonstrated that, in animals and healthy human volunteers, oral administration of GS-9620 can induce a type I interferon-dependent antiviral innate immune response, as measured by whole-blood mRNA of the ISGs 2'5'-oligoadenylate synthetase 1 (OAS1) and myxovirus resistance 1 (MX1), without the induction of detectable systemic IFN-α, i.e., a presystemic response.  Addnl., presystemic induction of hepatic OAS1 and MX1 mRNA was obsd. in CD-1 mice in the absence of detectable systemic IFN-α.  We propose that the mechanism of this presystemic response is likely its high intestinal absorption, which facilitates localized activation of TLR7, probably in plasmacytoid dendritic cells at the level of gut-assocd. lymphoid tissue and/or the liver.  This localized response is further supported by data that indicate only minimal contributions of systemic immune stimulation to the overall pharmacodynamic response to orally administered GS-9620.  These data demonstrate that GS-9620 can induce an antiviral innate immune response without inducing a systemic IFN-α response and thus suggest the therapeutic potential of this approach in the treatment of chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGLt0m-dYGx7Vg90H21EOLACvtfcHk0lgMyHJvgHPDcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKjurw%253D&md5=002591f8338f6bfacaaa13be4297cf87</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.207878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.207878%26sid%3Dliteratum%253Aachs%26aulast%3DFosdick%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DPflanz%26aufirst%3DS.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DHalcomb%26aufirst%3DR.%2BL.%26aulast%3DWolfgang%26aufirst%3DG.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520properties%2520of%2520GS-9620%252C%2520a%2520novel%2520toll-like%2520receptor%25207%2520agonist%252C%2520demonstrate%2520interferon-stimulated%2520gene%2520induction%2520without%2520detectable%2520serum%2520interferon%2520at%2520low%2520oral%2520doses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D96%26epage%3D105%26doi%3D10.1124%2Fjpet.113.207878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tumas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duatschek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosdick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wofgang, G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of GS-9620, a potent and selective oral TLR7 agonist</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">S446</span><span class="NLM_x">–</span> <span class="NLM_lpage">S447</span><span class="refDoi"> DOI: 10.1016/S0168-8278(11)61131-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2FS0168-8278%2811%2961131-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=S446-S447&author=D.+Tumasauthor=X.+Zhengauthor=G.+Rhodesauthor=P.+Duatschekauthor=J.+Hesselgesserauthor=C.+Freyauthor=I.+Henneauthor=A.+Fosdickauthor=R.+Halcombauthor=G.+Wofgang&title=Preclinical+characterization+of+GS-9620%2C+a+potent+and+selective+oral+TLR7+agonist&doi=10.1016%2FS0168-8278%2811%2961131-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0168-8278%2811%2961131-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-8278%252811%252961131-8%26sid%3Dliteratum%253Aachs%26aulast%3DTumas%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DRhodes%26aufirst%3DG.%26aulast%3DDuatschek%26aufirst%3DP.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DFrey%26aufirst%3DC.%26aulast%3DHenne%26aufirst%3DI.%26aulast%3DFosdick%26aufirst%3DA.%26aulast%3DHalcomb%26aufirst%3DR.%26aulast%3DWofgang%26aufirst%3DG.%26atitle%3DPreclinical%2520characterization%2520of%2520GS-9620%252C%2520a%2520potent%2520and%2520selective%2520oral%2520TLR7%2520agonist%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D54%26spage%3DS446%26epage%3DS447%26doi%3D10.1016%2FS0168-8278%2811%2961131-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Last, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoné, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Schoubroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pooter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostmans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khamlichi, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrechts, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhuyvetter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyej, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnoult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span> </span><span class="NLM_article-title">Novel pyrimidine toll-like receptor 7 and 8 dual agonists to treat hepatitis B virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7936</span><span class="NLM_x">–</span> <span class="NLM_lpage">7949</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7936-7949&author=D.+C.+McGowanauthor=F.+Herschkeauthor=F.+Pauwelsauthor=B.+Stoopsauthor=S.+Lastauthor=S.+Pietersauthor=A.+Scholliersauthor=T.+Thon%C3%A9author=B.+Van+Schoubroeckauthor=D.+De+Pooterauthor=W.+Mostmansauthor=M.+D.+Khamlichiauthor=W.+Embrechtsauthor=D.+Dhuyvetterauthor=I.+Smyejauthor=E.+Arnoultauthor=S.+Deminauthor=H.+Borghysauthor=F.+Fanningauthor=J.+Vlachauthor=P.+Raboisson&title=Novel+pyrimidine+toll-like+receptor+7+and+8+dual+agonists+to+treat+hepatitis+B+virus&doi=10.1021%2Facs.jmedchem.6b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus</span></div><div class="casAuthors">McGowan, David; Herschke, Florence; Pauwels, Frederik; Stoops, Bart; Last, Stefaan; Pieters, Serge; Scholliers, Annick; Thone, Tine; Van Schoubroeck, Bertrand; De Pooter, Dorien; Mostmans, Wendy; Khamlichi, Mourad Daoubi; Embrechts, Werner; Dhuyvetter, Deborah; Smyej, Ilham; Arnoult, Eric; Demin, Samuel; Borghys, Herman; Fanning, Gregory; Vlach, Jaromir; Raboisson, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7936-7949</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR) 7 and 8 agonists can potentially be used in the treatment of viral infections and are particularly promising for chronic hepatitis B virus (HBV) infection.  An internal screening effort identified a pyrimidine Toll-like receptor 7 and 8 dual agonist.  This provided a novel alternative over the previously reported adenine and pteridone type of agonists.  Structure-activity relationship, lead optimization, in silico docking, pharmacokinetics, and demonstration of ex vivo and in vivo cytokine prodn. of the lead compd. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-fRW7IJ3nZ7Vg90H21EOLACvtfcHk0ljCF8dgH7KO_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7vF&md5=f98f5bf04418de548b34463b3ebf2c2e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DHerschke%26aufirst%3DF.%26aulast%3DPauwels%26aufirst%3DF.%26aulast%3DStoops%26aufirst%3DB.%26aulast%3DLast%26aufirst%3DS.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DThon%25C3%25A9%26aufirst%3DT.%26aulast%3DVan%2BSchoubroeck%26aufirst%3DB.%26aulast%3DDe%2BPooter%26aufirst%3DD.%26aulast%3DMostmans%26aufirst%3DW.%26aulast%3DKhamlichi%26aufirst%3DM.%2BD.%26aulast%3DEmbrechts%26aufirst%3DW.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DSmyej%26aufirst%3DI.%26aulast%3DArnoult%26aufirst%3DE.%26aulast%3DDemin%26aufirst%3DS.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DFanning%26aufirst%3DF.%26aulast%3DVlach%26aufirst%3DJ.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DNovel%2520pyrimidine%2520toll-like%2520receptor%25207%2520and%25208%2520dual%2520agonists%2520to%2520treat%2520hepatitis%2520B%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7936%26epage%3D7949%26doi%3D10.1021%2Facs.jmedchem.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bennett, N. J.; McInally, T.; Mochel, T.; Thom, S.; Tidén, A.-K.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives for the treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis</span>. WO2009067081,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=N.+J.+Bennett&author=T.+McInally&author=T.+Mochel&author=S.+Thom&author=A.-K.+Tid%C3%A9n&title=Pyrimidine+derivatives+for+the+treatment+of+asthma%2C+COPD%2C+allergic+rhinitis%2C+allergic+conjunctivitis%2C+atopic+dermatitis%2C+cancer%2C+hepatitis+B%2C+hepatitis+C%2C+HIV%2C+HPV%2C+bacterial+infections+and+dermatosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DN.%2BJ.%26atitle%3DPyrimidine%2520derivatives%2520for%2520the%2520treatment%2520of%2520asthma%252C%2520COPD%252C%2520allergic%2520rhinitis%252C%2520allergic%2520conjunctivitis%252C%2520atopic%2520dermatitis%252C%2520cancer%252C%2520hepatitis%2520B%252C%2520hepatitis%2520C%252C%2520HIV%252C%2520HPV%252C%2520bacterial%2520infections%2520and%2520dermatosis%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tosaki, S.; Hori, S.</span><span> </span><span class="NLM_article-title">Cyclic amide compounds and their use in the treatment of disease</span>. WO2012067268,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Tosaki&author=S.+Hori&title=Cyclic+amide+compounds+and+their+use+in+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTosaki%26aufirst%3DS.%26atitle%3DCyclic%2520amide%2520compounds%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520disease%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lanford, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavedoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodara, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasky, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosdick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfgang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span> </span><span class="NLM_article-title">GS-9620, an oral agonist of toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span><span class="refDoi"> DOI: 10.1053/j.gastro.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1053%2Fj.gastro.2013.02.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2013&pages=1508-1517&author=R.+E.+Lanfordauthor=B.+Guerraauthor=D.+Chavezauthor=L.+Giavedoniauthor=V.+L.+Hodaraauthor=K.+M.+Braskyauthor=A.+Fosdickauthor=C.+R.+Freyauthor=J.+Zhengauthor=G.+Wolfgangauthor=R.+L.+Halcombauthor=D.+B.+Tumas&title=GS-9620%2C+an+oral+agonist+of+toll-like+receptor-7%2C+induces+prolonged+suppression+of+hepatitis+B+virus+in+chronically+infected+chimpanzees&doi=10.1053%2Fj.gastro.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DLanford%26aufirst%3DR.%2BE.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DChavez%26aufirst%3DD.%26aulast%3DGiavedoni%26aufirst%3DL.%26aulast%3DHodara%26aufirst%3DV.%2BL.%26aulast%3DBrasky%26aufirst%3DK.%2BM.%26aulast%3DFosdick%26aufirst%3DA.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DWolfgang%26aufirst%3DG.%26aulast%3DHalcomb%26aufirst%3DR.%2BL.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26atitle%3DGS-9620%252C%2520an%2520oral%2520agonist%2520of%2520toll-like%2520receptor-7%252C%2520induces%2520prolonged%2520suppression%2520of%2520hepatitis%2520B%2520virus%2520in%2520chronically%2520infected%2520chimpanzees%26jtitle%3DGastroenterology%26date%3D2013%26volume%3D144%26spage%3D1508%26epage%3D1517%26doi%3D10.1053%2Fj.gastro.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Borovik, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shkurko, O. P.</span><span> </span><span class="NLM_article-title">Synthesis of functional 2-substituted 4-phenyl-9<i>H</i>-pyrimido[4,5-<i>b</i>]indoles</span> <span class="citation_source-journal">Russ. Chem. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2129</span><span class="NLM_x">–</span> <span class="NLM_lpage">2133</span><span class="refDoi"> DOI: 10.1023/A:1021688616234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1023%2FA%3A1021688616234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFOlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=2129-2133&author=V.+P.+Borovikauthor=O.+P.+Shkurko&title=Synthesis+of+functional+2-substituted+4-phenyl-9H-pyrimido%5B4%2C5-b%5Dindoles&doi=10.1023%2FA%3A1021688616234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of functional 2-substituted 4-phenyl-9H-pyrimido[4,5-b]indoles</span></div><div class="casAuthors">Borovik, V. P.; Shkurko, O. P.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya Khimicheskaya)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2129-2133</span>CODEN:
                <span class="NLM_cas:coden">RCBUEY</span>;
        ISSN:<span class="NLM_cas:issn">1066-5285</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">A method was developed for the synthesis of 2-oxo-4-phenyl-2,3-dihydro-9H-pyrimido[4,5-b]indole as well as of 2-chloro- and 2-nitramino-4-phenylpyrimido[4,5-b]indoles.  The replacement of the chlorine atom in 2-chloropyrimidoindole gave rise to a no. of its functional derivs. (morpholino, azido, and cyano).  The reaction of 2-chloro-substituted pyrimidoindole with hydrazine hydrate and catalytic hydrogenation of 2-nitraminopyrimidoindole were studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2bRJ6Su3DJrVg90H21EOLACvtfcHk0lhZmyibjOKhGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFOlsbo%253D&md5=b0bb7828bb765d3af131a2c24e540fda</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1023%2FA%3A1021688616234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1021688616234%26sid%3Dliteratum%253Aachs%26aulast%3DBorovik%26aufirst%3DV.%2BP.%26aulast%3DShkurko%26aufirst%3DO.%2BP.%26atitle%3DSynthesis%2520of%2520functional%25202-substituted%25204-phenyl-9H-pyrimido%255B4%252C5-b%255Dindoles%26jtitle%3DRuss.%2520Chem.%2520Bull.%26date%3D2002%26volume%3D51%26spage%3D2129%26epage%3D2133%26doi%3D10.1023%2FA%3A1021688616234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bräse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knepper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, V.</span><span> </span><span class="NLM_article-title">Organic Azides: An exploding diversity of a unique class of compounds</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5240</span><span class="refDoi"> DOI: 10.1002/anie.200400657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fanie.200400657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVKnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5188-5240&author=S.+Br%C3%A4seauthor=C.+Gilauthor=K.+Knepperauthor=V.+Zimmermann&title=Organic+Azides%3A+An+exploding+diversity+of+a+unique+class+of+compounds&doi=10.1002%2Fanie.200400657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Organic azides. An exploding diversity of a unique class of compounds</span></div><div class="casAuthors">Brase, Stefan; Gil, Carmen; Knepper, Kerstin; Zimmermann, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5188-5240</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Since the discovery of org. azides by Peter Griess more than 140 years ago, numerous syntheses of these energy-rich mols. were developed.  In more recent times in particular, completely new perspectives were developed for their use in peptide chem., combinatorial chem., and heterocyclic synthesis.  Org. azides have assumed an important position at the interface between chem., biol., medicine, and materials science.  In this Review, the fundamental characteristics of azide chem. and current developments are presented.  The focus will be placed on cycloaddns. (Huisgen reaction), aza ylide chem., and the synthesis of heterocycles.  Further reactions such as the aza-Wittig reaction, the Sundberg rearrangement, the Staudinger ligation, the Boyer and Boyer-Aube rearrangements, the Curtius rearrangement, the Schmidt rearrangement, and the Hemetsberger rearrangement bear witness to the versatility of modern azide chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrig_NsoaX0r7Vg90H21EOLACvtfcHk0liNZs4U627y-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVKnu70%253D&md5=e8306c705526b23b0769e9a14cc73a29</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200400657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200400657%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DKnepper%26aufirst%3DK.%26aulast%3DZimmermann%26aufirst%3DV.%26atitle%3DOrganic%2520Azides%253A%2520An%2520exploding%2520diversity%2520of%2520a%2520unique%2520class%2520of%2520compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5188%26epage%3D5240%26doi%3D10.1002%2Fanie.200400657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Click chemistry: Diverse chemical function from a few good reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2021</span><span class="refDoi"> DOI: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=11433435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=2004-2021&author=H.+C.+Kolbauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry%3A+Diverse+chemical+function+from+a+few+good+reactions&doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry: diverse chemical function from a few good reactions</span></div><div class="casAuthors">Kolb, Hartmuth C.; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2004-2021</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Review with > 88 refs.  Examn. of nature's favorite mols. reveals a striking preference for making carbon-heteroatom bonds over carbon-carbon bonds - surely no surprise given that carbon dioxide is nature's starting material and that most reactions are performed in water.  Nucleic acids, proteins, and polysaccharides are condensation polymers of small subunits stitched together by carbon-heteroatom bonds.  Even the 35 or so building blocks from which these crucial mols. are made each contain, at most, six contiguous C-C bonds, except for the three arom. amino acids.  Taking a cue from nature's approach, the development of a set of powerful, highly reliable, and selective reactions for the rapid synthesis of useful new compds. and combinatorial libraries through heteroatom links (C-X-C), an approach called "click chem." is addressed.  Click chem. is at once defined, enabled, and constrained by a handful of nearly perfect "spring-loaded" reactions.  The stringent criteria for a process to earn click chem. status are described along with examples of the mol. frameworks that are easily made using this spartan, but powerful, synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptrjo9nxXNRrVg90H21EOLACvtfcHk0liNZs4U627y-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D&md5=61c28b416c42c87821bc8a5bc2fdec36</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010601%252940%253A11%253C2004%253A%253AAID-ANIE2004%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%253A%2520Diverse%2520chemical%2520function%2520from%2520a%2520few%2520good%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D2004%26epage%3D2021%26doi%3D10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Elliott, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. A.</span><span> </span><span class="NLM_article-title">A short, facile synthesis of 2-amino-1,5-dihydro-4<i>H</i>-pyrrolo[3,2-<i>d</i>]-pyrimidin-4-one (9-deazaguanine)</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4340</span><span class="refDoi"> DOI: 10.1016/0040-4039(96)00840-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2F0040-4039%2896%2900840-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=4339-4340&author=A.+J.+Elliottauthor=J.+A.+Montgomeryauthor=D.+A.+Walsh&title=A+short%2C+facile+synthesis+of+2-amino-1%2C5-dihydro-4H-pyrrolo%5B3%2C2-d%5D-pyrimidin-4-one+%289-deazaguanine%29&doi=10.1016%2F0040-4039%2896%2900840-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2896%2900840-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252896%252900840-4%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DA.%2BJ.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3DA%2520short%252C%2520facile%2520synthesis%2520of%25202-amino-1%252C5-dihydro-4H-pyrrolo%255B3%252C2-d%255D-pyrimidin-4-one%2520%25289-deazaguanine%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D4339%26epage%3D4340%26doi%3D10.1016%2F0040-4039%2896%2900840-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Elliott, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petty, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. H.</span><span> </span><span class="NLM_article-title">An improved synthesis of 7-substituted pyrrolo[3,2-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">8071</span><span class="NLM_x">–</span> <span class="NLM_lpage">8075</span><span class="refDoi"> DOI: 10.1021/jo971062j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971062j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=8071-8075&author=A.+J.+Elliottauthor=P.+E.+Morrisauthor=S.+L.+Pettyauthor=C.+H.+Williams&title=An+improved+synthesis+of+7-substituted+pyrrolo%5B3%2C2-d%5Dpyrimidines&doi=10.1021%2Fjo971062j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Fjo971062j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971062j%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DA.%2BJ.%26aulast%3DMorris%26aufirst%3DP.%2BE.%26aulast%3DPetty%26aufirst%3DS.%2BL.%26aulast%3DWilliams%26aufirst%3DC.%2BH.%26atitle%3DAn%2520improved%2520synthesis%2520of%25207-substituted%2520pyrrolo%255B3%252C2-d%255Dpyrimidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D8071%26epage%3D8075%26doi%3D10.1021%2Fjo971062j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Theoclitou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriotta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Code, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deegan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezhuthachan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadella, M. V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. J.</span><span> </span><span class="NLM_article-title">Discovery of (+)-<i>N</i>-(3-aminopropyl)-<i>N</i>-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-<i>d</i>]-pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6734</span><span class="NLM_x">–</span> <span class="NLM_lpage">6750</span><span class="refDoi"> DOI: 10.1021/jm200629m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200629m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6734-6750&author=M.+Theoclitouauthor=B.+Aquilaauthor=M.+H.+Blockauthor=P.+J.+Brassilauthor=L.+Castriottaauthor=E.+Codeauthor=M.+P.+Collinsauthor=A.+M.+Daviesauthor=T.+Deeganauthor=J.+Ezhuthachanauthor=S.+Fillaauthor=E.+Freedauthor=H.+Huauthor=D.+Huszarauthor=M.+Jayaramanauthor=D.+Lawsonauthor=P.+M.+Lewisauthor=M.+V.+P.+Nadellaauthor=V.+Ozaauthor=M.+Padmanilayamauthor=T.+Pontzauthor=L.+Roncoauthor=D.+Russellauthor=D.+Whitstonauthor=X.+J.+Zheng&title=Discovery+of+%28%2B%29-N-%283-aminopropyl%29-N-%5B1-%285-benzyl-3-methyl-4-oxo-%5B1%2C2%5Dthiazolo%5B5%2C4-d%5D-pyrimidin-6-yl%29-2-methylpropyl%5D-4-methylbenzamide+%28AZD4877%29%2C+a+kinesin+spindle+protein+inhibitor+and+potential+anticancer+agent&doi=10.1021%2Fjm200629m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1021%2Fjm200629m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200629m%26sid%3Dliteratum%253Aachs%26aulast%3DTheoclitou%26aufirst%3DM.%26aulast%3DAquila%26aufirst%3DB.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DBrassil%26aufirst%3DP.%2BJ.%26aulast%3DCastriotta%26aufirst%3DL.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DM.%2BP.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DDeegan%26aufirst%3DT.%26aulast%3DEzhuthachan%26aufirst%3DJ.%26aulast%3DFilla%26aufirst%3DS.%26aulast%3DFreed%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DJayaraman%26aufirst%3DM.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DLewis%26aufirst%3DP.%2BM.%26aulast%3DNadella%26aufirst%3DM.%2BV.%2BP.%26aulast%3DOza%26aufirst%3DV.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DRonco%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DWhitston%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DX.%2BJ.%26atitle%3DDiscovery%2520of%2520%2528%252B%2529-N-%25283-aminopropyl%2529-N-%255B1-%25285-benzyl-3-methyl-4-oxo-%255B1%252C2%255Dthiazolo%255B5%252C4-d%255D-pyrimidin-6-yl%2529-2-methylpropyl%255D-4-methylbenzamide%2520%2528AZD4877%2529%252C%2520a%2520kinesin%2520spindle%2520protein%2520inhibitor%2520and%2520potential%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6734%26epage%3D6750%26doi%3D10.1021%2Fjm200629m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoerter, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menhaji-Klotz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasota, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumberledge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathisen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhambra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3399</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.bmcl.2011.03.117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3399-3403&author=D.+G.+Brownauthor=D.+L.+Maierauthor=M.+A.+Sylvesterauthor=T.+N.+Hoerterauthor=E.+Menhaji-Klotzauthor=C.+C.+Lasotaauthor=L.+T.+Hirataauthor=D.+E.+Wilkinsauthor=C.+W.+Scottauthor=S.+Trivediauthor=T.+Chenauthor=D.+J.+McCarthyauthor=C.+M.+Maciagauthor=E.+J.+Suttonauthor=J.+Cumberledgeauthor=D.+Mathisenauthor=J.+Robertsauthor=A.+Guptaauthor=F.+Liuauthor=C.+S.+Elmoreauthor=C.+Alhambraauthor=J.+R.+Krumrineauthor=X.+Wangauthor=P.+J.+Ciaccioauthor=M.+W.+Woodauthor=J.+B.+Campbellauthor=M.+J.+Johanssonauthor=J.+Xiaauthor=X.+Wenauthor=J.+Jiangauthor=X.+Wangauthor=Z.+Pengauthor=T.+Huauthor=J.+Wang&title=2%2C6-Disubstituted+pyrazines+and+related+analogs+as+NR2B+site+antagonists+of+the+NMDA+receptor+with+anti-depressant+activity&doi=10.1016%2Fj.bmcl.2011.03.117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.117%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DMaier%26aufirst%3DD.%2BL.%26aulast%3DSylvester%26aufirst%3DM.%2BA.%26aulast%3DHoerter%26aufirst%3DT.%2BN.%26aulast%3DMenhaji-Klotz%26aufirst%3DE.%26aulast%3DLasota%26aufirst%3DC.%2BC.%26aulast%3DHirata%26aufirst%3DL.%2BT.%26aulast%3DWilkins%26aufirst%3DD.%2BE.%26aulast%3DScott%26aufirst%3DC.%2BW.%26aulast%3DTrivedi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DMaciag%26aufirst%3DC.%2BM.%26aulast%3DSutton%26aufirst%3DE.%2BJ.%26aulast%3DCumberledge%26aufirst%3DJ.%26aulast%3DMathisen%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DElmore%26aufirst%3DC.%2BS.%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DKrumrine%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26aulast%3DWood%26aufirst%3DM.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DJohansson%26aufirst%3DM.%2BJ.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3D2%252C6-Disubstituted%2520pyrazines%2520and%2520related%2520analogs%2520as%2520NR2B%2520site%2520antagonists%2520of%2520the%2520NMDA%2520receptor%2520with%2520anti-depressant%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3399%26epage%3D3403%26doi%3D10.1016%2Fj.bmcl.2011.03.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Carvalho, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louvel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doornbos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaasse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A.</span><span> </span><span class="NLM_article-title">Strategies to reduce hERG K+ channel blockade. Exploring heteroaromaticity and rigidity in novel analogues of Dofetilide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2840</span><span class="refDoi"> DOI: 10.1021/jm301564f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301564f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2828-2840&author=J.+F.+Carvalhoauthor=J.+Louvelauthor=M.+L.+Doornbosauthor=E.+Klaasseauthor=Z.+Yuauthor=J.+Brusseeauthor=A.+Ijzerman&title=Strategies+to+reduce+hERG+K%2B+channel+blockade.+Exploring+heteroaromaticity+and+rigidity+in+novel+analogues+of+Dofetilide&doi=10.1021%2Fjm301564f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm301564f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301564f%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DJ.%2BF.%26aulast%3DLouvel%26aufirst%3DJ.%26aulast%3DDoornbos%26aufirst%3DM.%2BL.%26aulast%3DKlaasse%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520reduce%2520hERG%2520K%252B%2520channel%2520blockade.%2520Exploring%2520heteroaromaticity%2520and%2520rigidity%2520in%2520novel%2520analogues%2520of%2520Dofetilide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2828%26epage%3D2840%26doi%3D10.1021%2Fjm301564f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">4046</span><span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-4046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+Highlights+and+hang-ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0ljcakRTaZqxHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520Highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D4046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohto, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krayukhina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isobe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span> </span><span class="NLM_article-title">Structural analysis reveals that Toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1016/j.immuni.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.immuni.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=27742543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=737-748&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=E.+Krayukhinaauthor=M.+Taokaauthor=Y.+Yamauchiauthor=H.+Tanjiauthor=T.+Isobeauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+analysis+reveals+that+Toll-like+receptor+7+is+a+dual+receptor+for+guanosine+and+single-stranded+RNA&doi=10.1016%2Fj.immuni.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Krayukhina, Elena; Taoka, Masato; Yamauchi, Yoshio; Tanji, Hiromi; Isobe, Toshiaki; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chem. ligands, such as imidazoquinoline compds.  However, TLR7 activation mechanism by these ligands remain largely unknown.  Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites.  The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation.  The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands.  The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA.  Our structural, biochem., and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-contg. ssRNA.  Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQskd1L0XeX7Vg90H21EOLACvtfcHk0lgAJv2k21e4xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI&md5=194f87d5ea0e88009fd682c00e020f38</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520analysis%2520reveals%2520that%2520Toll-like%2520receptor%25207%2520is%2520a%2520dual%2520receptor%2520for%2520guanosine%2520and%2520single-stranded%2520RNA%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D737%26epage%3D748%26doi%3D10.1016%2Fj.immuni.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Mathes, C.</span><span> </span><span class="NLM_article-title">QPatch: the past, present and future of automated patch clamp</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1517/14728222.10.2.319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1517%2F14728222.10.2.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=16548779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=319-327&author=C.+Mathes&title=QPatch%3A+the+past%2C+present+and+future+of+automated+patch+clamp&doi=10.1517%2F14728222.10.2.319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">QPatch: the past, present and future of automated patch clamp</span></div><div class="casAuthors">Mathes, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-327</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The QPatch 16 significantly increases throughput for gigaseal patch clamp expts., making direct measurements in ion channel drug discovery and safety testing feasible.  Released to the market in the Autumn of 2004 by Sophion Bioscience, the QPatch originated from work done at NeuroSearch (Denmark) in the early days of automated patch clamp.  Today, the QPatch provides many unique features.  For example, only the QPatch includes an automated cell prepn. station making several hours of unattended operation possible.  The 16-channel electrode array, called the QPlate, includes glass-coated microfluidic channels for less compd. absorption and, hence, more accurate IC50 values.  The microfluidic pathways also allow for very small amts. of compd. used for each expt. (∼ 5 μl per addn.).  Only the QPatch has four independent pipetting heads for more efficient liq. handling (esp. for ligand-gated ion channel expts.).  Patch clamp recordings with the QPatch match the high quality of conventional patch clamp and in some cases the results are even better.  For example, only the QPatch includes 100% series resistance compensation for the elimination of false positives due to voltage errors.  Finally, the modular QPatch 16 was designed with more channels in mind.  The upgrade pathway to 48-channels (the QPatch HT) will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywPZMP8PNwrVg90H21EOLACvtfcHk0lgAJv2k21e4xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D&md5=7dcd02a69652955e261f6928fbb76b81</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.2.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.2.319%26sid%3Dliteratum%253Aachs%26aulast%3DMathes%26aufirst%3DC.%26atitle%3DQPatch%253A%2520the%2520past%252C%2520present%2520and%2520future%2520of%2520automated%2520patch%2520clamp%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D319%26epage%3D327%26doi%3D10.1517%2F14728222.10.2.319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Huang, L.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.-S.</span><span> </span><span class="NLM_article-title">An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17862</span><span class="NLM_x">–</span> <span class="NLM_lpage">17867</span><span class="refDoi"> DOI: 10.1073/pnas.0608578103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1073%2Fpnas.0608578103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17862-17867&author=L.-R.+Huangauthor=H.-L.+Wuauthor=P.-J.+Chenauthor=D.-S.+Chen&title=An+immunocompetent+mouse+model+for+the+tolerance+of+human+chronic+hepatitis+B+virus+infection&doi=10.1073%2Fpnas.0608578103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0608578103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0608578103%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.-R.%26aulast%3DWu%26aufirst%3DH.-L.%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DChen%26aufirst%3DD.-S.%26atitle%3DAn%2520immunocompetent%2520mouse%2520model%2520for%2520the%2520tolerance%2520of%2520human%2520chronic%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D17862%26epage%3D17867%26doi%3D10.1073%2Fpnas.0608578103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ketloy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engering, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srichairatanakul, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limsalakpetch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yongvanitchit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichyangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruxrungtham, K.</span><span> </span><span class="NLM_article-title">Expression and function of toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates</span> <span class="citation_source-journal">Vet. Immunol. Immunopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.vetimm.2008.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.vetimm.2008.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=18571243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWitrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2008&pages=18-30&author=C.+Ketloyauthor=A.+Engeringauthor=U.+Srichairatanakulauthor=A.+Limsalakpetchauthor=K.+Yongvanitchitauthor=S.+Pichyangkulauthor=K.+Ruxrungtham&title=Expression+and+function+of+toll-like+receptors+on+dendritic+cells+and+other+antigen+presenting+cells+from+non-human+primates&doi=10.1016%2Fj.vetimm.2008.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates</span></div><div class="casAuthors">Ketloy, Chutitorn; Engering, Anneke; Srichairatanakul, Utaiwan; Limsalakpetch, Amporn; Yongvanitchit, Kosol; Pichyangkul, Sathit; Ruxrungtham, Kiat</div><div class="citationInfo"><span class="NLM_cas:title">Veterinary Immunology and Immunopathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">18-30</span>CODEN:
                <span class="NLM_cas:coden">VIIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0165-2427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Antigen presenting cells (APCs), esp. dendritic cells (DCs), play a crucial role in immune responses against infections by sensing microbial invasion through Toll-like receptors (TLRs).  In this regard, TLR ligands are attractive candidates for use in humans and animal models as vaccine adjuvants.  So far, no studies have been performed on TLR expression in non-human primates such as rhesus macaques.  Therefore, we studied the TLR expression patterns in different subsets of APC in rhesus macaques and compared them to similar APC subsets in human.  Also, expression was compared with corresponding DC subsets from different organs from mice.  Here we show by semi-quant. RT-PCR, that blood DC subsets of rhesus macaque expressed the same sets of TLRs as those of human but substantially differed from mouse DC subsets.  Macaque myeloid DCs (MDCs) expressed TLR3, 4, 7 and 8 whereas macaque plasmacytoid DCs (PDCs) expressed only TLR7 and 9.  Addnl., TLR expression patterns in macaque monocyte-derived dendritic cells (mo-DCs) (i.e., TLR3, 4, 8 and 9), monocytes (i.e., TLR4, 7, and 8) and B cells (i.e., TLR4, 7, 8, and 9) were also similar to their human counterparts.  However, the responsiveness of macaque APCs to certain TLR ligands partially differed from that of human in terms of phenotype differentiation and cytokine prodn.  Strikingly, in contrast to human mo-DCs, no IL-12p70 prodn. was obsd. when macaque mo-DCs were stimulated with TLR ligands.  In addn., CD40 and CD86 phenotypic responses to TLR8 ligand (poly U) in mo-DCs of macaque were higher than that of human.  Despite these functional differences, our results provide important information for a rational design of animal models in evaluating TLR ligands as adjuvant in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1XrRF7tZBrVg90H21EOLACvtfcHk0lgu-w3qCM_ezA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWitrvE&md5=974ee47d1b6f9e3717adc886ae9514bb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.vetimm.2008.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vetimm.2008.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DKetloy%26aufirst%3DC.%26aulast%3DEngering%26aufirst%3DA.%26aulast%3DSrichairatanakul%26aufirst%3DU.%26aulast%3DLimsalakpetch%26aufirst%3DA.%26aulast%3DYongvanitchit%26aufirst%3DK.%26aulast%3DPichyangkul%26aufirst%3DS.%26aulast%3DRuxrungtham%26aufirst%3DK.%26atitle%3DExpression%2520and%2520function%2520of%2520toll-like%2520receptors%2520on%2520dendritic%2520cells%2520and%2520other%2520antigen%2520presenting%2520cells%2520from%2520non-human%2520primates%26jtitle%3DVet.%2520Immunol.%2520Immunopathol.%26date%3D2008%26volume%3D125%26spage%3D18%26epage%3D30%26doi%3D10.1016%2Fj.vetimm.2008.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Starkhammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georén, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlén, S.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardell, L.-O.</span><span> </span><span class="NLM_article-title">Toll-like receptor ligands LPS and Poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e104114</span><span class="refDoi"> DOI: 10.1371/journal.pone.0104114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1371%2Fjournal.pone.0104114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e104114&author=M.+Starkhammarauthor=O.+Larssonauthor=S.+K.+Geor%C3%A9nauthor=M.+Leinoauthor=S.-E.+Dahl%C3%A9nauthor=M.+Adnerauthor=L.-O.+Cardell&title=Toll-like+receptor+ligands+LPS+and+Poly+%28I%3AC%29+exacerbate+airway+hyperresponsiveness+in+a+model+of+airway+allergy+in+mice%2C+independently+of+inflammation&doi=10.1371%2Fjournal.pone.0104114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0104114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0104114%26sid%3Dliteratum%253Aachs%26aulast%3DStarkhammar%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DGeor%25C3%25A9n%26aufirst%3DS.%2BK.%26aulast%3DLeino%26aufirst%3DM.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.-E.%26aulast%3DAdner%26aufirst%3DM.%26aulast%3DCardell%26aufirst%3DL.-O.%26atitle%3DToll-like%2520receptor%2520ligands%2520LPS%2520and%2520Poly%2520%2528I%253AC%2529%2520exacerbate%2520airway%2520hyperresponsiveness%2520in%2520a%2520model%2520of%2520airway%2520allergy%2520in%2520mice%252C%2520independently%2520of%2520inflammation%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De104114%26doi%3D10.1371%2Fjournal.pone.0104114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Ronit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plovsing, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaardbo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartling, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, Å.B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Møller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. D.</span><span> </span><span class="NLM_article-title">Inflammation-induced changes in circulating T-cell subsets and cytokine production during human endotoxemia</span> <span class="citation_source-journal">J. Intensive Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1177/0885066615606673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1177%2F0885066615606673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=26392625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BC283ksF2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=77-85&author=A.+Ronitauthor=R.+R.+Plovsingauthor=J.+C.+Gaardboauthor=R.+M.+Bergauthor=H.+J.+Hartlingauthor=H.+Ullumauthor=%C3%85.B.+Andersenauthor=H.+O.+Madsenauthor=K.+M%C3%B8llerauthor=S.+D.+Nielsen&title=Inflammation-induced+changes+in+circulating+T-cell+subsets+and+cytokine+production+during+human+endotoxemia&doi=10.1177%2F0885066615606673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-Induced Changes in Circulating T-Cell Subsets and Cytokine Production During Human Endotoxemia</span></div><div class="casAuthors">Ronit Andreas; Gaardbo Julie C; Hartling Hans J; Andersen ¡ÑÜAse B; Nielsen Susanne D; Ronit Andreas; Gaardbo Julie C; Hartling Hans J; Ullum Henrik; Plovsing Ronni R; Berg Ronan M G; Plovsing Ronni R; Berg Ronan M G; Moller Kirsten; Madsen Hans O; Moller Kirsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of intensive care medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Observational clinical studies suggest the initial phase of sepsis may involve impaired cellular immunity.  In the present study, we investigated temporal changes in T-cell subsets and T-cell cytokine production during human endotoxemia.  Endotoxin (Escherichia coli lipopolysaccharide 4 ng/kg) was administered intravenously in 15 healthy volunteers.  Peripheral blood and bronchoalveolar lavage fluid (BALF) were collected at baseline and after 2, 4, 6, 8, and 24 hours for flow cytometry.  CD4(+)CD25(+)CD127lowFoxp3(+) regulatory T cells (Tregs), CD4(+)CD161(+) cells, and activated Human leukocyte antigen, HLA-DR(+)CD38(+) T cells were determined.  Ex vivo whole-blood cytokine production and Toll-like receptor (TLR)-4 expression on Tregs were measured.  Absolute number of CD3(+)CD4(+) (P = .026), CD3(+)CD8(+) (P = .046), Tregs (P = .023), and CD4(+)CD161(+) cells (P = .042) decreased after endotoxin administration.  The frequency of anti-inflammatory Tregs increased (P = .033), whereas the frequency of proinflammatory CD4(+)CD161(+) cells decreased (P = .034).  Endotoxemia was associated with impaired whole-blood production of tumor necrosis factor-α, interleukin-10, IL-6, IL-17, IL-2, and interferon-γ in response to phytohaemagglutinin but did not affect TLR4 expression on Tregs.  No changes in the absolute count or frequency of BALF T cells were observed.  Systemic inflammation is associated with lymphopenia, a relative increase in the frequency of anti-inflammatory Tregs, and a functional impairment of T-cell cytokine production.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXdAJXsBpl3v9pSBfyDvp7fW6udTcc2eYItNIVIymRPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ksF2gtg%253D%253D&md5=f7dbfd460c5a4a95218bdea42de8c2da</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F0885066615606673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0885066615606673%26sid%3Dliteratum%253Aachs%26aulast%3DRonit%26aufirst%3DA.%26aulast%3DPlovsing%26aufirst%3DR.%2BR.%26aulast%3DGaardbo%26aufirst%3DJ.%2BC.%26aulast%3DBerg%26aufirst%3DR.%2BM.%26aulast%3DHartling%26aufirst%3DH.%2BJ.%26aulast%3DUllum%26aufirst%3DH.%26aulast%3DAndersen%26aufirst%3D%25C3%2585.B.%26aulast%3DMadsen%26aufirst%3DH.%2BO.%26aulast%3DM%25C3%25B8ller%26aufirst%3DK.%26aulast%3DNielsen%26aufirst%3DS.%2BD.%26atitle%3DInflammation-induced%2520changes%2520in%2520circulating%2520T-cell%2520subsets%2520and%2520cytokine%2520production%2520during%2520human%2520endotoxemia%26jtitle%3DJ.%2520Intensive%2520Care%2520Med.%26date%3D2017%26volume%3D32%26spage%3D77%26epage%3D85%26doi%3D10.1177%2F0885066615606673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Baenziger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikenwalder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diemand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundig, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, R. F.</span><span> </span><span class="NLM_article-title">Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1182/blood-2008-04-151712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1182%2Fblood-2008-04-151712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=377-388&author=S.+Baenzigerauthor=M.+Heikenwalderauthor=P.+Johansenauthor=E.+Schlaepferauthor=U.+Hoferauthor=R.+C.+Millerauthor=S.+Diemandauthor=K.+Hondaauthor=T.+M.+Kundigauthor=A.+Aguzziauthor=R.+F.+Speck&title=Triggering+TLR7+in+mice+induces+immune+activation+and+lymphoid+system+disruption%2C+resembling+HIV-mediated+pathology&doi=10.1182%2Fblood-2008-04-151712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-04-151712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-04-151712%26sid%3Dliteratum%253Aachs%26aulast%3DBaenziger%26aufirst%3DS.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DP.%26aulast%3DSchlaepfer%26aufirst%3DE.%26aulast%3DHofer%26aufirst%3DU.%26aulast%3DMiller%26aufirst%3DR.%2BC.%26aulast%3DDiemand%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DK.%26aulast%3DKundig%26aufirst%3DT.%2BM.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DSpeck%26aufirst%3DR.%2BF.%26atitle%3DTriggering%2520TLR7%2520in%2520mice%2520induces%2520immune%2520activation%2520and%2520lymphoid%2520system%2520disruption%252C%2520resembling%2520HIV-mediated%2520pathology%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D377%26epage%3D388%26doi%3D10.1182%2Fblood-2008-04-151712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30a','cit30b','cit30c'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Arindam Talukdar, Dipyaman Ganguly, Swarnali Roy, Nirmal Das, <span class="NLM_string-name hlFld-ContribAuthor">Dipika Sarkar</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8010-8041. <a href="https://doi.org/10.1021/acs.jmedchem.1c00300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00300%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BEvolution%252Band%252BTranslational%252BPotential%252Bfor%252BAgonists%252Band%252BAntagonists%252Bof%252BEndosomal%252BToll-like%252BReceptors%26aulast%3DTalukdar%26aufirst%3DArindam%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8010%26epage%3D8041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stefano Federico, Luca Pozzetti, Alessandro Papa, Gabriele Carullo, Sandra Gemma, Stefania Butini, Giuseppe Campiani, <span class="NLM_string-name hlFld-ContribAuthor">Nicola Relitti</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13466-13513. <a href="https://doi.org/10.1021/acs.jmedchem.0c01049" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulation%252Bof%252Bthe%252BInnate%252BImmune%252BResponse%252Bby%252BTargeting%252BToll-like%252BReceptors%25253A%252BA%252BPerspective%252Bon%252BTheir%252BAgonists%252Band%252BAntagonists%26aulast%3DFederico%26aufirst%3DStefano%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18062020%26date%3D16092020%26date%3D26082020%26volume%3D63%26issue%3D22%26spage%3D13466%26epage%3D13513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nour Bou Karroum, Georges Moarbess, Jean-François Guichou, Pierre-Antoine Bonnet, Cindy Patinote, Hasnaa Bouharoun-Tayoun, Soulaima Chamat, Pierre Cuq, Mona Diab-Assaf, Issam Kassab, <span class="NLM_string-name hlFld-ContribAuthor">Carine Deleuze-Masquefa</span>. </span><span class="cited-content_cbyCitation_article-title">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 7015-7031. <a href="https://doi.org/10.1021/acs.jmedchem.9b00411" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00411</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00411%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Band%252BSelective%252BTLR7%252BAntagonists%252Bamong%252Bthe%252BImidazo%25255B1%25252C2-a%25255Dpyrazines%25252C%252BImidazo%25255B1%25252C5-a%25255Dquinoxalines%25252C%252Band%252BPyrazolo%25255B1%25252C5-a%25255Dquinoxalines%252BSeries%26aulast%3DBou%2BKarroum%26aufirst%3DNour%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08032019%26date%3D19072019%26date%3D08072019%26volume%3D62%26issue%3D15%26spage%3D7015%26epage%3D7031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepender  Kaushik</span>, <span class="hlFld-ContribAuthor ">Arshpreet  Kaur</span>, <span class="hlFld-ContribAuthor ">Nikolai  Petrovsky</span>, <span class="hlFld-ContribAuthor ">Deepak B.  Salunke</span>. </span><span class="cited-content_cbyCitation_article-title">Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1065-1120. <a href="https://doi.org/10.1039/D1MD00031D" title="DOI URL">https://doi.org/10.1039/D1MD00031D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00031D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00031D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Bevolution%252Bof%252Btoll-like%252Breceptor%252B7%25252F8%252Bagonists%252Bfrom%252Bimidazoquinolines%252Bto%252Bimidazoles%26aulast%3DKaushik%26aufirst%3DDeepender%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D1065%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>, <span class="hlFld-ContribAuthor ">Weijie  Gu</span>, <span class="hlFld-ContribAuthor ">Erik  Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Anti‐DNA Virus Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-41. <a href="https://doi.org/10.1002/0471266949.bmc237.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc237.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc237.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc237.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAnti%2525E2%252580%252590DNA%252BVirus%252BAgents%26aulast%3DHerdewijn%26aufirst%3DPiet%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D41%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C.  McGowan</span>. </span><span class="cited-content_cbyCitation_article-title">Latest Advances in Small Molecule TLR 7/8 Agonist Drug Research. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (24)
                                     , 2228-2238. <a href="https://doi.org/10.2174/1568026619666191009165418" title="DOI URL">https://doi.org/10.2174/1568026619666191009165418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191009165418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191009165418%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DLatest%252BAdvances%252Bin%252BSmall%252BMolecule%252BTLR%252B7%25252F8%252BAgonist%252BDrug%252BResearch%26aulast%3DMcGowan%26aufirst%3DDavid%2BC.%26date%3D2019%26volume%3D19%26issue%3D24%26spage%3D2228%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhikuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Umeharu  Ohto</span>, <span class="hlFld-ContribAuthor ">Takuma  Shibata</span>, <span class="hlFld-ContribAuthor ">Masato  Taoka</span>, <span class="hlFld-ContribAuthor ">Yoshio  Yamauchi</span>, <span class="hlFld-ContribAuthor ">Ryota  Sato</span>, <span class="hlFld-ContribAuthor ">Nikunj M.  Shukla</span>, <span class="hlFld-ContribAuthor ">Sunil A.  David</span>, <span class="hlFld-ContribAuthor ">Toshiaki  Isobe</span>, <span class="hlFld-ContribAuthor ">Kensuke  Miyake</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Shimizu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>25 </em>
                                    (12)
                                     , 3371-3381.e5. <a href="https://doi.org/10.1016/j.celrep.2018.11.081" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.11.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.11.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.11.081%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DStructural%252BAnalyses%252Bof%252BToll-like%252BReceptor%252B7%252BReveal%252BDetailed%252BRNA%252BSequence%252BSpecificity%252Band%252BRecognition%252BMechanism%252Bof%252BAgonistic%252BLigands%26aulast%3DZhang%26aufirst%3DZhikuan%26date%3D2018%26volume%3D25%26issue%3D12%26spage%3D3371%26epage%3D3381.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Pieters</span>, <span class="hlFld-ContribAuthor ">David  McGowan</span>, <span class="hlFld-ContribAuthor ">Florence  Herschke</span>, <span class="hlFld-ContribAuthor ">Frederik  Pauwels</span>, <span class="hlFld-ContribAuthor ">Bart  Stoops</span>, <span class="hlFld-ContribAuthor ">Stefaan  Last</span>, <span class="hlFld-ContribAuthor ">Werner  Embrechts</span>, <span class="hlFld-ContribAuthor ">Annick  Scholliers</span>, <span class="hlFld-ContribAuthor ">Wendy  Mostmans</span>, <span class="hlFld-ContribAuthor ">Kris  Van Dijck</span>, <span class="hlFld-ContribAuthor ">Bertrand  Van Schoubroeck</span>, <span class="hlFld-ContribAuthor ">Tine  Thoné</span>, <span class="hlFld-ContribAuthor ">Dorien  De Pooter</span>, <span class="hlFld-ContribAuthor ">Gregory  Fanning</span>, <span class="hlFld-ContribAuthor ">Mari Luz  Rosauro</span>, <span class="hlFld-ContribAuthor ">Mourad Daoubi  Khamlichi</span>, <span class="hlFld-ContribAuthor ">Ioannis  Houpis</span>, <span class="hlFld-ContribAuthor ">Eric  Arnoult</span>, <span class="hlFld-ContribAuthor ">Tim H.M.  Jonckers</span>, <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective 2,4-diaminoquinazoline toll-like receptor 7 (TLR 7) agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (4)
                                     , 711-719. <a href="https://doi.org/10.1016/j.bmcl.2018.01.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.01.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.01.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bselective%252B2%25252C4-diaminoquinazoline%252Btoll-like%252Breceptor%252B7%252B%252528TLR%252B7%252529%252Bagonists%26aulast%3DPieters%26aufirst%3DSerge%26date%3D2018%26volume%3D28%26issue%3D4%26spage%3D711%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Described TLR 7 agonists and novel pyrrolo[3,2-<i>d</i>]pyrimidine (<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Representative Synthetic Route of Pyrrolo[3,2-<i>d</i>]pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 50% isolated yield; (b) <i>n</i>-butylamine, 1,4-dioxane, 100 °C, 67% yield; (c) HOAc, aq HCl, 100 °C, 24 h, 40%; (d) NaN<sub>3</sub>, NMP/H<sub>2</sub>O 9/1, microwave 170 °C, 5 h, 86%; (e) PPh<sub>3</sub>, 1,4-dioxane:H<sub>2</sub>O 9:1, 120 °C, 16 h, 76%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Alternative Synthesis of Pyrrolo[3,2-<i>d</i>]pyrimidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,3-bis(methoxycarbonyl)-2-methyl-2-thiopseudourea, HOAc, NaOCH<sub>3</sub>, CH<sub>3</sub>OH, rt, 16 h, 87%; (b) POCl<sub>3</sub>, DIPEA, ACN, 70 °C, 1 h, 46%; (c) 2-pyridylmethanol, PPh<sub>3</sub>, DIAD, THF, rt, 30 min, 65%; (d) NaOH, 1,4-dioxane, 60 °C, 5 h, 75%; (e) 5-methyl-2-oxazolemethanamine, DMSO, 110 °C, 16 h, 15%; (f) (5-methyloxazol-2-yl)methanol), NaH, THF, 0–50 °C, 30 min, 22%. See patent applications WO2014056953 and WO2014207082.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Left: Electrostatic potential comparison, based on AM1-BCC charges, between isoxazole (<b>54</b>), oxazole (<b>55</b>), thiazole (<b>56</b>), and oxadiazole (<b>57</b>). Right: Predicted binding mode by docking (Glide XP) for compound <b>54</b> in a monkeyTLR7 structure (one TLR7 monomer in cyan and the other in green). See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/medium/jm-2017-00365k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Efficacy of <b>54</b> in the HDI-HBV mouse model. Left: Serum HBV viral load over time (mean ± SD). Right: Liver HBV viral load at end of dosing (qPCR, mean ± SD). Seven groups of eight male C57Bl/6 mice, 4–6 weeks old, were administered 20 μg of pAAV2-HBV1.3mer genotype D plasmid by hydrodynamic injection. One day later, groups 1–7 received compound <b>54</b> orally at 0, 0.3, 1, 2.5, and 5 mg/kg q.d., respectively, for 5 days. HPbCD20% at acidic pH was used as vehicle. At different time points, blood was sampled to measure serum HBV viral load by qPCR. One day after the last dose, mice were euthanized to measure liver HBV viral load by qPCR. LLOQ indicates lower limit of quantification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00365/20170721/images/large/jm-2017-00365k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00365&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Dienstag, J. L.</span><span> </span><span class="NLM_article-title">Hepatitis B virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1486</span><span class="NLM_x">–</span> <span class="NLM_lpage">1500</span><span class="refDoi"> DOI: 10.1056/NEJMra0801644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1056%2FNEJMra0801644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=18832247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2008&pages=1486-1500&author=J.+L.+Dienstag&title=Hepatitis+B+virus+infection&doi=10.1056%2FNEJMra0801644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis B virus infection</span></div><div class="casAuthors">Dienstag, Jules L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1486-1500</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with refs. on drug therapy of chronic hepatitis B, its co-infection with HIV viral infection, mono- and combination therapy and overcoming antiviral resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5ybm-V9V7urVg90H21EOLACvtfcHk0liqd3W5eDG4rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7bL&md5=e4ca2dbdb0fa268fa483eb7b77cf4643</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0801644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0801644%26sid%3Dliteratum%253Aachs%26aulast%3DDienstag%26aufirst%3DJ.%2BL.%26atitle%3DHepatitis%2520B%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D359%26spage%3D1486%26epage%3D1500%26doi%3D10.1056%2FNEJMra0801644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span> <span class="citation_source-book">Guidelines for the Prevention, Care, and Treatment of Persons with Chronic Hepatitis B Infection</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Guidelines+for+the+Prevention%2C+Care%2C+and+Treatment+of+Persons+with+Chronic+Hepatitis+B+Infection%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGuidelines%2520for%2520the%2520Prevention%252C%2520Care%252C%2520and%2520Treatment%2520of%2520Persons%2520with%2520Chronic%2520Hepatitis%2520B%2520Infection%26pub%3DWorld%2520Health%2520Organization%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Chang, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Man, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeHertogh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apelian, D.</span><span> </span><span class="NLM_article-title">A Comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1056/NEJMoa051285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1056%2FNEJMoa051285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=16525137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFWms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=1001-1010&author=T.-T.+Changauthor=R.+G.+Gishauthor=R.+de+Manauthor=A.+Gadanoauthor=J.+Sollanoauthor=Y.-C.+Chaoauthor=A.+Lokauthor=K.-H.+Hanauthor=Z.+Goodmanauthor=J.+Zhuauthor=A.+Crossauthor=D.+DeHertoghauthor=R.+Wilberauthor=R.+Colonnoauthor=D.+Apelian&title=A+Comparison+of+entecavir+and+lamivudine+for+HBeAg-positive+chronic+hepatitis+B&doi=10.1056%2FNEJMoa051285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B</span></div><div class="casAuthors">Chang, Ting-Tsung; Gish, Robert G.; de Man, Robert; Gadano, Adrian; Sollano, Jose; Chao, You-Chen; Lok, Anna S.; Han, Kwang-Hyub; Goodman, Zachary; Zhu, Jin; Cross, Anne; DeHertogh, Deborah; Wilber, Richard; Colonno, Richard; Apelian, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1001-1010</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Entecavir is a potent and selective guanosine analog with significant activity against hepatitis B virus (HBV).  METHODS: In this phase 3, double-blind trial, we randomly assigned 715 patients with hepatitis B e antigen (HBeAg)-pos. chronic hepatitis B who had not previously received a nucleoside analog to receive either 0.5 mg of entecavir or 100 mg of lamivudine once daily for a min. of 52 wk.  The primary efficacy end point was histol. improvement (a decrease by at least two points in the Knodell necroinflammatory score, without worsening of fibrosis) at week 48.  Secondary end points included a redn. in the serum HBV DNA level, HBeAg loss and seroconversion, and normalization of the alanine aminotransferase level.  RESULTS: Histol. improvement after 48 wk occurred in 226 of 314 patients in the entecavir group (72 %) and 195 of 314 patients in the lamivudine group (62 %, P = 0.009).  More patients in the entecavir group than in the lamivudine group had undetectable serum HBV DNA levels according to a polymerase-chain-reaction assay (67 % vs. 36 %, P < 0.001) and normalization of alanine amino-transferase levels (68 % vs. 60 %, P = 0.02).  The mean redn. in serum HBV DNA from baseline to week 48 was greater with entecavir than with lamivudine (6.9 vs. 5.4 log [on a base-10 scale] copies per mL, P < 0.001).  HBeAg seroconversion occurred in 21 % of entecavir-treated patients and 18 % of those treated with lamivudine (P = 0.33).  No viral resistance to entecavir was detected.  Safety was similar in the two groups.  CONCLUSIONS: Among patients with HBeAg-pos. chronic hepatitis B, the rates of histol., virol., and biochem. improvement are significantly higher with entecavir than with lamivudine.  The safety profile of the two agents is similar, and there is no evidence of viral resistance to entecavir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0BpM3kEiocbVg90H21EOLACvtfcHk0lincbxgWtWgDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFWms7Y%253D&md5=4294c677544040ede9823bfdf8d53f8f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051285%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DT.-T.%26aulast%3DGish%26aufirst%3DR.%2BG.%26aulast%3Dde%2BMan%26aufirst%3DR.%26aulast%3DGadano%26aufirst%3DA.%26aulast%3DSollano%26aufirst%3DJ.%26aulast%3DChao%26aufirst%3DY.-C.%26aulast%3DLok%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DK.-H.%26aulast%3DGoodman%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DCross%26aufirst%3DA.%26aulast%3DDeHertogh%26aufirst%3DD.%26aulast%3DWilber%26aufirst%3DR.%26aulast%3DColonno%26aufirst%3DR.%26aulast%3DApelian%26aufirst%3DD.%26atitle%3DA%2520Comparison%2520of%2520entecavir%2520and%2520lamivudine%2520for%2520HBeAg-positive%2520chronic%2520hepatitis%2520B%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D1001%26epage%3D1010%26doi%3D10.1056%2FNEJMoa051285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Perrillo, R.</span><span> </span><span class="NLM_article-title">Benefits and risks of interferon therapy for hepatitis B</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">S103</span><span class="NLM_x">–</span> <span class="NLM_lpage">S111</span><span class="refDoi"> DOI: 10.1002/hep.22956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.22956" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=S103-S111&author=R.+Perrillo&title=Benefits+and+risks+of+interferon+therapy+for+hepatitis+B&doi=10.1002%2Fhep.22956"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fhep.22956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22956%26sid%3Dliteratum%253Aachs%26aulast%3DPerrillo%26aufirst%3DR.%26atitle%3DBenefits%2520and%2520risks%2520of%2520interferon%2520therapy%2520for%2520hepatitis%2520B%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3DS103%26epage%3DS111%26doi%3D10.1002%2Fhep.22956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Terrault, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonas, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murad, M. H.</span><span> </span><span class="NLM_article-title">AASLD guidelines for treatment of chronic hepatitis B</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1002/hep.28156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.28156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=26566064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BC28vhslGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=261-283&author=N.+A.+Terraultauthor=N.+H.+Bzowejauthor=K.-M.+Changauthor=J.+P.+Hwangauthor=M.+M.+Jonasauthor=M.+H.+Murad&title=AASLD+guidelines+for+treatment+of+chronic+hepatitis+B&doi=10.1002%2Fhep.28156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AASLD guidelines for treatment of chronic hepatitis B</span></div><div class="casAuthors">Terrault Norah A; Bzowej Natalie H; Chang Kyong-Mi; Hwang Jessica P; Jonas Maureen M; Murad M Hassan</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Baltimore, Md.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">261-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo5dAGIpJclHthwrmtH4OBfW6udTcc2eZMlcBnW8zL1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vhslGjsQ%253D%253D&md5=5790f93ea0f12638fc24a20608b7d11a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fhep.28156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.28156%26sid%3Dliteratum%253Aachs%26aulast%3DTerrault%26aufirst%3DN.%2BA.%26aulast%3DBzowej%26aufirst%3DN.%2BH.%26aulast%3DChang%26aufirst%3DK.-M.%26aulast%3DHwang%26aufirst%3DJ.%2BP.%26aulast%3DJonas%26aufirst%3DM.%2BM.%26aulast%3DMurad%26aufirst%3DM.%2BH.%26atitle%3DAASLD%2520guidelines%2520for%2520treatment%2520of%2520chronic%2520hepatitis%2520B%26jtitle%3DHepatology%26date%3D2016%26volume%3D63%26spage%3D261%26epage%3D283%26doi%3D10.1002%2Fhep.28156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Protzer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, P. A.</span><span> </span><span class="NLM_article-title">Living in the liver: hepatic infections</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/nri3169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2Fnri3169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=22362353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC38XislynsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=201-213&author=U.+Protzerauthor=M.+K.+Mainiauthor=P.+A.+Knolle&title=Living+in+the+liver%3A+hepatic+infections&doi=10.1038%2Fnri3169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Living in the liver: hepatic infections</span></div><div class="casAuthors">Protzer, Ulrike; Maini, Mala K.; Knolle, Percy A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-213</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The liver has vital metabolic and clearance functions that involve the uptake of nutrients, waste products and pathogens from the blood.  In addn., its unique immunoregulatory functions mediated by local expression of co-inhibitory receptors and immunosuppressive mediators help to prevent inadvertent organ damage.  However, these tolerogenic properties render the liver an attractive target site for pathogens.  Although most pathogens that reach the liver via the blood are eliminated or controlled by local innate and adaptive immune responses, some pathogens (such as hepatitis viruses) can escape immune control and persist in hepatocytes, causing substantial morbidity and mortality worldwide.  Here, we review our current knowledge of the mechanisms of liver targeting by pathogens and describe the interplay between pathogens and host factors that promote pathogen elimination and maintain organ integrity or that allow pathogen persistence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYKgwrpjMpx7Vg90H21EOLACvtfcHk0lhrTaGLGKdYAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XislynsL0%253D&md5=d4a033645cb461f84550ea4c292aaaaa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnri3169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3169%26sid%3Dliteratum%253Aachs%26aulast%3DProtzer%26aufirst%3DU.%26aulast%3DMaini%26aufirst%3DM.%2BK.%26aulast%3DKnolle%26aufirst%3DP.%2BA.%26atitle%3DLiving%2520in%2520the%2520liver%253A%2520hepatic%2520infections%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2012%26volume%3D12%26spage%3D201%26epage%3D213%26doi%3D10.1038%2Fnri3169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chan, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinot-Peignoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piratvisuth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillmann, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locarnini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span> </span><span class="NLM_article-title">Hepatitis B surface antigen quantification: why and how to use it in 2011 - A core group report</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span><span class="refDoi"> DOI: 10.1016/j.jhep.2011.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.jhep.2011.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=21718667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BC3MbitFShsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=1121-1131&author=H.+L.+Chanauthor=A.+Thompsonauthor=M.+Martinot-Peignouxauthor=T.+Piratvisuthauthor=M.+Cornbergauthor=M.+R.+Brunettoauthor=H.+L.+Tillmannauthor=J.+H.+Kaoauthor=J.+D.+Jiaauthor=H.+Wedemeyerauthor=S.+Locarniniauthor=H.+L.+Janssenauthor=P.+Marcellin&title=Hepatitis+B+surface+antigen+quantification%3A+why+and+how+to+use+it+in+2011+-+A+core+group+report&doi=10.1016%2Fj.jhep.2011.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report</span></div><div class="casAuthors">Chan Henry Lik-Yuen; Thompson Alex; Martinot-Peignoux Michelle; Piratvisuth Teerha; Cornberg Markus; Brunetto Maurizia Rossana; Tillmann Hans L; Kao Jia-Horng; Jia Ji-Dong; Wedemeyer Heiner; Locarnini Stephen; Janssen Harry L A; Marcellin Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1121-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Quantitative HBsAg had been suggested to be helpful in management of HBV, but assays were cumbersome.  The recent availability of commercial quantitative assays has restarted the interest in quantitative serum hepatitis B surface antigen (HBsAg) as a biomarker for prognosis and treatment response in chronic hepatitis B.  HBsAg level reflects the transcriptional activity of cccDNA rather than the absolute amount of cccDNA copies.  Serum HBsAg level tends to be higher in hepatitis B e antigen (HBeAg)-positive than HBeAg-negative patients.  Among patients with a low HBV DNA (<2000IU/ml), HBsAg <1000IU/ml in genotype D HBV infection and HBsAg <100IU/ml in genotype B/C HBV infection is associated with inactive carrier state in HBeAg-negative patients.  The HBsAg reduction by nucleos(t)ide analogues (NA) is not as pronounced as by interferon treatment.  On peginterferon treatment, sustained responders tend to show greater HBsAg decline than the non-responders.  The optimal on-treatment HBsAg cutoff to predict response needs further evaluation in HBeAg-positive patients, but an absence of HBsAg decline together with a <2 log reduction in HBV DNA at week 12 can serve as stopping rule in HBeAg-negative patients with genotype D HBV infection.  A rapid serum HBsAg decline during NA therapy may identify patients who will clear HBsAg in the long-term.  There are early reports among Asian patients that an HBsAg level of <100IU/ml might predict lower risk of relapse after stopping NA treatment.  In clinical practice, serum HBsAg level should be used together with, but not as a substitute for, HBV DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4Ym-TR-Q2esRAV4D_Ins_fW6udTcc2eY2WREGgT250rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbitFShsg%253D%253D&md5=025b70ddfc809716d6d24c534ae3b334</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2011.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DH.%2BL.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DMartinot-Peignoux%26aufirst%3DM.%26aulast%3DPiratvisuth%26aufirst%3DT.%26aulast%3DCornberg%26aufirst%3DM.%26aulast%3DBrunetto%26aufirst%3DM.%2BR.%26aulast%3DTillmann%26aufirst%3DH.%2BL.%26aulast%3DKao%26aufirst%3DJ.%2BH.%26aulast%3DJia%26aufirst%3DJ.%2BD.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DLocarnini%26aufirst%3DS.%26aulast%3DJanssen%26aufirst%3DH.%2BL.%26aulast%3DMarcellin%26aufirst%3DP.%26atitle%3DHepatitis%2520B%2520surface%2520antigen%2520quantification%253A%2520why%2520and%2520how%2520to%2520use%2520it%2520in%25202011%2520-%2520A%2520core%2520group%2520report%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D55%26spage%3D1121%26epage%3D1131%26doi%3D10.1016%2Fj.jhep.2011.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Schoggins, J. W.</span><span> </span><span class="NLM_article-title">Interferon-stimulated genes: roles in viral pathogenesis</span> <span class="citation_source-journal">Curr. Opin. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/j.coviro.2014.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.coviro.2014.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=24713352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVarsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=40-46&author=J.+W.+Schoggins&title=Interferon-stimulated+genes%3A+roles+in+viral+pathogenesis&doi=10.1016%2Fj.coviro.2014.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-stimulated genes: roles in viral pathogenesis</span></div><div class="casAuthors">Schoggins, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-46</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Interferon-stimulated genes (ISGs) are crit. for controlling virus infections.  As new antiviral ISGs continue to be identified and characterized, their roles in viral pathogenesis are also being explored in more detail.  Our current understanding of how ISGs impact viral pathogenesis comes largely from studies in knockout mice, with isolated examples from human clin. data.  This review outlines recent developments on the contributions of various ISGs to viral disease outcomes in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwZqeFB6vxL7Vg90H21EOLACvtfcHk0lgevf5K3NnC9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVarsLnI&md5=b551c90c2a205ad79260310617a552c8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DSchoggins%26aufirst%3DJ.%2BW.%26atitle%3DInterferon-stimulated%2520genes%253A%2520roles%2520in%2520viral%2520pathogenesis%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2014%26volume%3D6%26spage%3D40%26epage%3D46%26doi%3D10.1016%2Fj.coviro.2014.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Yokosuka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imazeki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, J.</span><span> </span><span class="NLM_article-title">Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span><span class="refDoi"> DOI: 10.1002/hep.1840050505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.1840050505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1985&pages=728-734&author=O.+Yokosukaauthor=M.+Omataauthor=F.+Imazekiauthor=K.+Okudaauthor=J.+Summers&title=Changes+of+hepatitis+B+virus+DNA+in+liver+and+serum+caused+by+recombinant+leukocyte+interferon+treatment%3A+analysis+of+intrahepatic+replicative+hepatitis+B+virus+DNA&doi=10.1002%2Fhep.1840050505"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fhep.1840050505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.1840050505%26sid%3Dliteratum%253Aachs%26aulast%3DYokosuka%26aufirst%3DO.%26aulast%3DOmata%26aufirst%3DM.%26aulast%3DImazeki%26aufirst%3DF.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DSummers%26aufirst%3DJ.%26atitle%3DChanges%2520of%2520hepatitis%2520B%2520virus%2520DNA%2520in%2520liver%2520and%2520serum%2520caused%2520by%2520recombinant%2520leukocyte%2520interferon%2520treatment%253A%2520analysis%2520of%2520intrahepatic%2520replicative%2520hepatitis%2520B%2520virus%2520DNA%26jtitle%3DHepatology%26date%3D1985%26volume%3D5%26spage%3D728%26epage%3D734%26doi%3D10.1002%2Fhep.1840050505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Santini, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapenta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pucchio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardelli, F.</span><span> </span><span class="NLM_article-title">Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">1777</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span><span class="refDoi"> DOI: 10.1084/jem.191.10.1777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1084%2Fjem.191.10.1777" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=1777-1788&author=S.+M.+Santiniauthor=C.+Lapentaauthor=M.+Logozziauthor=S.+Parlatoauthor=M.+Spadaauthor=T.+Di+Pucchioauthor=F.+Belardelli&title=Type+I+interferon+as+a+powerful+adjuvant+for+monocyte-derived+dendritic+cell+development+and+activity+in+vitro+and+in+Hu-PBL-SCID+mice&doi=10.1084%2Fjem.191.10.1777"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1084%2Fjem.191.10.1777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.191.10.1777%26sid%3Dliteratum%253Aachs%26aulast%3DSantini%26aufirst%3DS.%2BM.%26aulast%3DLapenta%26aufirst%3DC.%26aulast%3DLogozzi%26aufirst%3DM.%26aulast%3DParlato%26aufirst%3DS.%26aulast%3DSpada%26aufirst%3DM.%26aulast%3DDi%2BPucchio%26aufirst%3DT.%26aulast%3DBelardelli%26aufirst%3DF.%26atitle%3DType%2520I%2520interferon%2520as%2520a%2520powerful%2520adjuvant%2520for%2520monocyte-derived%2520dendritic%2520cell%2520development%2520and%2520activity%2520in%2520vitro%2520and%2520in%2520Hu-PBL-SCID%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D1777%26epage%3D1788%26doi%3D10.1084%2Fjem.191.10.1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Roethle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadden, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrvatin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graupe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duatschek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R. L.</span><span> </span><span class="NLM_article-title">Identification and optimization of pteridinone toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7324</span><span class="NLM_x">–</span> <span class="NLM_lpage">7333</span><span class="refDoi"> DOI: 10.1021/jm400815m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400815m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7324-7333&author=P.+A.+Roethleauthor=R.+M.+McFaddenauthor=H.+Yangauthor=P.+Hrvatinauthor=H.+Huiauthor=M.+Graupeauthor=B.+Gallagherauthor=J.+Chaoauthor=J.+Hesselgesserauthor=P.+Duatschekauthor=J.+Zhengauthor=B.+Luauthor=D.+B.+Tumasauthor=J.+Perryauthor=R.+L.+Halcomb&title=Identification+and+optimization+of+pteridinone+toll-like+receptor+7+%28TLR7%29+agonists+for+the+oral+treatment+of+viral+hepatitis&doi=10.1021%2Fjm400815m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis</span></div><div class="casAuthors">Roethle, Paul A.; McFadden, Ryan M.; Yang, Hong; Hrvatin, Paul; Hui, Hon; Graupe, Michael; Gallagher, Brian; Chao, Jessica; Hesselgesser, Joseph; Duatschek, Paul; Zheng, Jim; Lu, Bing; Tumas, Daniel B.; Perry, Jason; Halcomb, Randall L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7324-7333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pteridinone-based Toll-like receptor 7 (TLR7) agonists were identified as potent and selective alternatives to the previously reported adenine-based agonists, leading to the discovery of GS-9620 (I).  Analogs were optimized for the immunomodulatory activity and selectivity vs. other TLRs, based on differential induction of key cytokines including interferon α (IFN-α) and tumor necrosis factor α (TNF-α).  In addn., physicochem. properties were adjusted to achieve desirable in vivo pharmacokinetic and pharmacodynamic properties.  GS-9620 is currently in clin. evaluation for the treatment of chronic hepatitis B (HBV) infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2wrWq68pK7Vg90H21EOLACvtfcHk0lj_2kOst2J51A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjtbfL&md5=753aa20b0d0f9b16eb3a1d205fbe0a30</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm400815m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400815m%26sid%3Dliteratum%253Aachs%26aulast%3DRoethle%26aufirst%3DP.%2BA.%26aulast%3DMcFadden%26aufirst%3DR.%2BM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHrvatin%26aufirst%3DP.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DGallagher%26aufirst%3DB.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DDuatschek%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DHalcomb%26aufirst%3DR.%2BL.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520pteridinone%2520toll-like%2520receptor%25207%2520%2528TLR7%2529%2520agonists%2520for%2520the%2520oral%2520treatment%2520of%2520viral%2520hepatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7324%26epage%3D7333%26doi%3D10.1021%2Fjm400815m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmi, H.</span><span> </span><span class="NLM_article-title">Recognition of pathogen-associated molecular patterns by TLR family</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/S0165-2478(02)00228-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2FS0165-2478%2802%2900228-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=12527213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2003&pages=85-95&author=S.+Akiraauthor=H.+Hemmi&title=Recognition+of+pathogen-associated+molecular+patterns+by+TLR+family&doi=10.1016%2FS0165-2478%2802%2900228-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recognition of pathogen-associated molecular patterns by TLR family</span></div><div class="casAuthors">Akira, Shizuo; Hemmi, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are type I transmembrane proteins involved in innate immunity by recognizing microbial conserved structures.  Recent studies have shown that TLR3 recognizes dsRNA, a viral product, whereas TLR9 recognizes unmethylated CpG motifs frequently found in the genome of bacteria and viruses, but not vertebrates.  TLR7 recognizes small synthetic immune modifiers including imiquimod, R-848, loxoribine, and bropirimine, all of which are already applied or promising for clin. use against viral infections and cancers.  Plasmacytoid dendritic cells express TLR7 and TLR9, and respond to TLR7 and TLR9 ligands by producing a large amt. of interferon (IFN-α).  Thus, TLR3, TLR7, and TLR9 may play an important role in detecting and combating viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfMQi5sN0W37Vg90H21EOLACvtfcHk0lj_2kOst2J51A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVeksw%253D%253D&md5=e9f742c47f1dde6e5a603ea1f192aca6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0165-2478%2802%2900228-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-2478%252802%252900228-6%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DHemmi%26aufirst%3DH.%26atitle%3DRecognition%2520of%2520pathogen-associated%2520molecular%2520patterns%2520by%2520TLR%2520family%26jtitle%3DImmunol.%2520Lett.%26date%3D2003%26volume%3D85%26spage%3D85%26epage%3D95%26doi%3D10.1016%2FS0165-2478%2802%2900228-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Pasare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medzhitov, R.</span><span> </span><span class="NLM_article-title">Toll-like receptors: linking innate and adaptive immunity</span> <span class="citation_source-journal">Microbes Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1382</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1016/j.micinf.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.micinf.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=15596124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOntbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1382-1387&author=C.+Pasareauthor=R.+Medzhitov&title=Toll-like+receptors%3A+linking+innate+and+adaptive+immunity&doi=10.1016%2Fj.micinf.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: linking innate and adaptive immunity</span></div><div class="casAuthors">Pasare, Chandrashekhar; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1382-1387</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Detection of and response to microbial infections by the immune system depends largely on a family of pattern-recognition receptors called Toll-like receptors (TLRs).  These receptors recognize conserved mol. products derived from various classes of pathogens, including Gram-pos. and -neg. bacteria, DNA and RNA viruses, fungi, and protozoa.  Recognition of ligands by TLRs leads to a series of signaling events resulting in induction of acute responses necessary to kill the pathogen.  TLRs are also responsible for the induction of dendritic cell maturation, which is responsible and necessary for initiation of adaptive immune responses.  Although TLRs control induction of adaptive immunity, it is not clear at this point how responses are appropriately tailored by individual TLRs to the advantage of the host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVRkv7NpqBLVg90H21EOLACvtfcHk0lhzEPaJdFwa5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOntbbP&md5=e2afa44464fe2cd2faaf64f89b23f79d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.micinf.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micinf.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DPasare%26aufirst%3DC.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%253A%2520linking%2520innate%2520and%2520adaptive%2520immunity%26jtitle%3DMicrobes%2520Infect.%26date%3D2004%26volume%3D6%26spage%3D1382%26epage%3D1387%26doi%3D10.1016%2Fj.micinf.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span> </span><span class="NLM_article-title">Toll-like receptors: Critical proteins linking innate and acquired immunity</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1038/90609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2F90609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=11477402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=675-680&author=S.+Akiraauthor=K.+Takedaauthor=T.+Kaisho&title=Toll-like+receptors%3A+Critical+proteins+linking+innate+and+acquired+immunity&doi=10.1038%2F90609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: Critical proteins linking innate and acquired immunity</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi; Kaisho, Tsuneyasu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-680</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review with 84 refs.  Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs).  These receptors recognize conserved mol. patterns (pathogen-assocd. mol. patterns), which are shared by large groups of microorganisms.  Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components.  The TLRs may also recognize endogenous ligands induced during the inflammatory response.  Similar cytoplasmic domains allow TLRs to use the same signaling mols. used by the interleukin 1 receptors (IL-1Rs): these include MyD88, IL-1R-assocd. protein kinase and tumor necrosis factor receptor-activated factor 6.  However, evidence is accumulating that the signaling pathways assocd. with each TLR are not identical and may, therefore, result in different biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8I2sSl7FK7Vg90H21EOLACvtfcHk0lhzEPaJdFwa5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D&md5=3fd5a975d63e0384c8cffa960159b063</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F90609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F90609%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26atitle%3DToll-like%2520receptors%253A%2520Critical%2520proteins%2520linking%2520innate%2520and%2520acquired%2520immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D675%26epage%3D680%26doi%3D10.1038%2F90609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jurk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heil, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipford, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span> </span><span class="NLM_article-title">Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="refDoi"> DOI: 10.1038/ni0602-499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2Fni0602-499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=12032557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFOmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=499&author=M.+Jurkauthor=F.+Heilauthor=J.+Vollmerauthor=C.+Schetterauthor=A.+Kriegauthor=H.+Wagnerauthor=G.+Lipfordauthor=S.+Bauer&title=Human+TLR7+or+TLR8+independently+confer+responsiveness+to+the+antiviral+compound+R-848&doi=10.1038%2Fni0602-499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848</span></div><div class="casAuthors">Jurk, Marion; Heil, Florian; Vollmer, Joerg; Schetter, Christian; Krieg, Arthur M.; Wagner, Hermann; Lipford, Grayson; Bauer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">In their quest to identify ligands for TLRs, the authors found that the antiviral immunostimulant drug imidazoquinoline resiquimod R-848 induced NF-κB activation in HEK293 cells transfected with human TLR8 in a dose-dependent manner.  The results of the study showed that both human TLR7 and TLR* can independently mediate recognition of the same antiviral compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonRoNyuBI4w7Vg90H21EOLACvtfcHk0lhzEPaJdFwa5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFOmsLo%253D&md5=f8d7a53ffd849013dba07c33807ccc8f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fni0602-499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni0602-499%26sid%3Dliteratum%253Aachs%26aulast%3DJurk%26aufirst%3DM.%26aulast%3DHeil%26aufirst%3DF.%26aulast%3DVollmer%26aufirst%3DJ.%26aulast%3DSchetter%26aufirst%3DC.%26aulast%3DKrieg%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DH.%26aulast%3DLipford%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DS.%26atitle%3DHuman%2520TLR7%2520or%2520TLR8%2520independently%2520confer%2520responsiveness%2520to%2520the%2520antiviral%2520compound%2520R-848%26jtitle%3DNat.%2520Immunol.%26date%3D2002%26volume%3D3%26spage%3D499%26doi%3D10.1038%2Fni0602-499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hemmi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaisho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1038/ni758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1038%2Fni758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=11812998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVygurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=196-200&author=H.+Hemmiauthor=T.+Kaishoauthor=O.+Takeuchiauthor=S.+Satoauthor=H.+Sanjoauthor=K.+Hoshinoauthor=T.+Horiuchiauthor=H.+Tomizawaauthor=K.+Takedaauthor=S.+Akira&title=Small+anti-viral+compounds+activate+immune+cells+via+the+TLR7+MyD88-dependent+signaling+pathway&doi=10.1038%2Fni758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway</span></div><div class="casAuthors">Hemmi, Hiroaki; Kaisho, Tsuneyasu; Takeuchi, Osamu; Sato, Shintaro; Sanjo, Hideki; Hoshino, Katsuaki; Horiuchi, Takao; Tomizawa, Hideyuki; Takeda, Kiyoshi; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-200</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The imidazoquinoline compds. imiquimod and R-848 are low-mol.-wt. immune response modifiers that can induce the synthesis of interferon-α and other cytokines in a variety of cell types.  These compds. have potent anti-viral and anti-tumor properties; however, the mechanisms by which they exert their anti-viral activities remain unclear.  Here the authors show that the imidazoquinolines activate immune cells via the Toll-like receptor 7 (TLR7)-MyD88-dependent signaling pathway.  In response to the imidazoquinolines, neither MyD88- nor TLR7-deficient mice showed any inflammatory cytokine prodn. by macrophages, proliferation of splenocytes or maturation of dendritic cells.  Imidazoquinoline-induced signaling events were also abolished in both MyD88- and TLR7-deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrverWM40gXkrVg90H21EOLACvtfcHk0lhzEPaJdFwa5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVygurc%253D&md5=61c34c1efee9d8931b95c1355fc24d9e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fni758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni758%26sid%3Dliteratum%253Aachs%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DTomizawa%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DSmall%2520anti-viral%2520compounds%2520activate%2520immune%2520cells%2520via%2520the%2520TLR7%2520MyD88-dependent%2520signaling%2520pathway%26jtitle%3DNat.%2520Immunol.%26date%3D2002%26volume%3D3%26spage%3D196%26epage%3D200%26doi%3D10.1038%2Fni758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hanten, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neys, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birmachu, W.</span><span> </span><span class="NLM_article-title">Comparison of human B cell activation by TLR7 and TLR9 agonists</span> <span class="citation_source-journal">BMC Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="refDoi"> DOI: 10.1186/1471-2172-9-39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1186%2F1471-2172-9-39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=18652679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BD1crgsVOlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=39&author=J.+A.+Hantenauthor=J.+P.+Vasilakosauthor=C.+L.+Riterauthor=L.+Neysauthor=K.+E.+Lipsonauthor=S.+S.+Alkanauthor=W.+Birmachu&title=Comparison+of+human+B+cell+activation+by+TLR7+and+TLR9+agonists&doi=10.1186%2F1471-2172-9-39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of human B cell activation by TLR7 and TLR9 agonists</span></div><div class="casAuthors">Hanten John A; Vasilakos John P; Riter Christie L; Neys Lori; Lipson Kenneth E; Alkan Sefik S; Birmachu Woubalem</div><div class="citationInfo"><span class="NLM_cas:title">BMC immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Human B cells and plasmacytoid dendritic cells (pDC) are the only cells known to express both TLR7 and TLR9.  Plasmacytoid dendritic cells are the primary IFN-alpha producing cells in response to TLR7 and TLR9 agonists.  The direct effects of TLR7 stimulation on human B cells is less understood.  The objective of this study was to compare the effects of TLR7 and TLR9 stimulation on human B cell function.  RESULTS:  Gene expression and protein production of cytokines, chemokines, various B cell activation markers, and immunoglobulins were evaluated.  Purified human CD19+ B cells (99.9%, containing both naive and memory populations) from peripheral blood were stimulated with a TLR7-selective agonist (852A), TLR7/8 agonist (3M-003), or TLR9 selective agonist CpG ODN (CpG2006).  TLR7 and TLR9 agonists similarly modulated the expression of cytokine and chemokine genes (IL-6, MIP1 alpha, MIP1 beta, TNF alpha and LTA), co-stimulatory molecules (CD80, CD40 and CD58), Fc receptors (CD23, CD32), anti-apoptotic genes (BCL2L1), certain transcription factors (MYC, TCFL5), and genes critical for B cell proliferation and differentiation (CD72, IL21R).  Both agonists also induced protein expression of the above cytokines and chemokines.  Additionally, TLR7 and TLR9 agonists induced the production of IgM and IgG.  A TLR8-selective agonist was comparatively ineffective at stimulating purified human B cells.  CONCLUSION:  These results demonstrate that despite their molecular differences, the TLR7 and TLR9 agonists induce similar genes and proteins in purified human B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDaPdhWEEavBBrI9DTGjC0fW6udTcc2eaH74BUDR4mubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crgsVOlug%253D%253D&md5=c5981fbc0a94a0331b3e5846f774a400</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1471-2172-9-39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2172-9-39%26sid%3Dliteratum%253Aachs%26aulast%3DHanten%26aufirst%3DJ.%2BA.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26aulast%3DRiter%26aufirst%3DC.%2BL.%26aulast%3DNeys%26aufirst%3DL.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DAlkan%26aufirst%3DS.%2BS.%26aulast%3DBirmachu%26aufirst%3DW.%26atitle%3DComparison%2520of%2520human%2520B%2520cell%2520activation%2520by%2520TLR7%2520and%2520TLR9%2520agonists%26jtitle%3DBMC%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D39%26doi%3D10.1186%2F1471-2172-9-39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Oord, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andeweg, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterhaus, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pas, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boonstra, A.</span><span> </span><span class="NLM_article-title">Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1002/hep.27805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fhep.27805" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=87-100&author=T.+Vanwolleghemauthor=J.+Houauthor=G.+van+Oordauthor=A.+C.+Andewegauthor=A.+D.+Osterhausauthor=S.+D.+Pasauthor=H.+L.+Janssenauthor=A.+Boonstra&title=Re-evaluation+of+hepatitis+B+virus+clinical+phases+by+systems+biology+identifies+unappreciated+roles+for+the+innate+immune+response+and+B+cells&doi=10.1002%2Fhep.27805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fhep.27805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27805%26sid%3Dliteratum%253Aachs%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3Dvan%2BOord%26aufirst%3DG.%26aulast%3DAndeweg%26aufirst%3DA.%2BC.%26aulast%3DOsterhaus%26aufirst%3DA.%2BD.%26aulast%3DPas%26aufirst%3DS.%2BD.%26aulast%3DJanssen%26aufirst%3DH.%2BL.%26aulast%3DBoonstra%26aufirst%3DA.%26atitle%3DRe-evaluation%2520of%2520hepatitis%2520B%2520virus%2520clinical%2520phases%2520by%2520systems%2520biology%2520identifies%2520unappreciated%2520roles%2520for%2520the%2520innate%2520immune%2520response%2520and%2520B%2520cells%26jtitle%3DHepatology%26date%3D2015%26volume%3D62%26spage%3D87%26epage%3D100%26doi%3D10.1002%2Fhep.27805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bekeredjian-Ding, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ablasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span> </span><span class="NLM_article-title">T Cell-Independent, TLR-induced IL-12p70 production in primary human monocytes</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">7438</span><span class="NLM_x">–</span> <span class="NLM_lpage">7446</span><span class="refDoi"> DOI: 10.4049/jimmunol.176.12.7438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.4049%2Fjimmunol.176.12.7438" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=7438-7446&author=I.+Bekeredjian-Dingauthor=S.+I.+Rothauthor=S.+Gillesauthor=T.+Gieseauthor=A.+Ablasserauthor=V.+Hornungauthor=S.+Endresauthor=G.+Hartmann&title=T+Cell-Independent%2C+TLR-induced+IL-12p70+production+in+primary+human+monocytes&doi=10.4049%2Fjimmunol.176.12.7438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.176.12.7438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.176.12.7438%26sid%3Dliteratum%253Aachs%26aulast%3DBekeredjian-Ding%26aufirst%3DI.%26aulast%3DRoth%26aufirst%3DS.%2BI.%26aulast%3DGilles%26aufirst%3DS.%26aulast%3DGiese%26aufirst%3DT.%26aulast%3DAblasser%26aufirst%3DA.%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DEndres%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DG.%26atitle%3DT%2520Cell-Independent%252C%2520TLR-induced%2520IL-12p70%2520production%2520in%2520primary%2520human%2520monocytes%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D7438%26epage%3D7446%26doi%3D10.4049%2Fjimmunol.176.12.7438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gorden, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorski, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedl, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieper, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomai, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakos, J. P.</span><span> </span><span class="NLM_article-title">Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span><span class="refDoi"> DOI: 10.4049/jimmunol.174.3.1259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.4049%2Fjimmunol.174.3.1259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=15661881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=1259-1268&author=K.+B.+Gordenauthor=K.+S.+Gorskiauthor=S.+J.+Gibsonauthor=R.+M.+Kedlauthor=W.+C.+Kieperauthor=X.+Qiuauthor=M.+A.+Tomaiauthor=S.+S.+Alkanauthor=J.+P.+Vasilakos&title=Synthetic+TLR+agonists+reveal+functional+differences+between+human+TLR7+and+TLR8&doi=10.4049%2Fjimmunol.174.3.1259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8</span></div><div class="casAuthors">Gorden, Keith B.; Gorski, Kevin S.; Gibson, Sheila J.; Kedl, Ross M.; Kieper, William C.; Qiu, Xiaohong; Tomai, Mark A.; Alkan, Sefik S.; Vasilakos, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1259-1268</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Although TLR7 and TLR8 are phylogenetically and structurally related, their relative functions are largely unknown.  The role of TLR7 has been established using TLR7-deficient mice and small mol. TLR7 agonists.  The absence of TLR8-selective agonists has hampered the authors' understanding of the role of TLR8.  In this study TLR agonists selective for TLR7 or TLR8 were used to det. the repertoire of human innate immune cells that are activated through these TLRs.  The authors found that TLR7 agonists directly activated purified plasmacytoid dendritic cells and, to a lesser extent, monocytes.  Conversely, TLR8 agonists directly activated purified myeloid dendritic cells, monocytes, and monocyte-derived dendritic cells (GM-CSF/IL-4/TGF-β).  Accordingly, TLR7-selective agonists were more effective than TLR8-selective agonists at inducing IFN-α- and IFN-regulated chemokines such as IFN-inducible protein and IFN-inducible T cell α chemoattractant from human PBMC.  In contrast, TLR8 agonists were more effective than TLR7 agonists at inducing proinflammatory cytokines and chemokines, such as TNF-α, IL-12, and MIP-1α.  Thus, this study demonstrated that TLR7 and TLR8 agonists differ in their target cell selectivity and cytokine induction profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxUMK2LBltvrVg90H21EOLACvtfcHk0liGCSHudZx2YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFyhsQ%253D%253D&md5=1893fde2508086be1f79df76d09e919a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.174.3.1259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.174.3.1259%26sid%3Dliteratum%253Aachs%26aulast%3DGorden%26aufirst%3DK.%2BB.%26aulast%3DGorski%26aufirst%3DK.%2BS.%26aulast%3DGibson%26aufirst%3DS.%2BJ.%26aulast%3DKedl%26aufirst%3DR.%2BM.%26aulast%3DKieper%26aufirst%3DW.%2BC.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DTomai%26aufirst%3DM.%2BA.%26aulast%3DAlkan%26aufirst%3DS.%2BS.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26atitle%3DSynthetic%2520TLR%2520agonists%2520reveal%2520functional%2520differences%2520between%2520human%2520TLR7%2520and%2520TLR8%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D1259%26epage%3D1268%26doi%3D10.4049%2Fjimmunol.174.3.1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Isobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurimoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 9-substituted-8-hydroxyadenine derivatives as potent interferon inducers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2095</span><span class="refDoi"> DOI: 10.1021/jm051089s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051089s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2088-2095&author=Y.+Isobeauthor=A.+Kurimotoauthor=M.+Tobeauthor=K.+Hashimotoauthor=T.+Nakamuraauthor=K.+Norimuraauthor=H.+Ogitaauthor=H.+Takaku&title=Synthesis+and+biological+evaluation+of+novel+9-substituted-8-hydroxyadenine+derivatives+as+potent+interferon+inducers&doi=10.1021%2Fjm051089s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel 9-Substituted-8-Hydroxyadenine Derivatives as Potent Interferon Inducers</span></div><div class="casAuthors">Isobe, Yoshiaki; Kurimoto, Ayumu; Tobe, Masanori; Hashimoto, Kazuki; Nakamura, Tomoaki; Norimura, Kei; Ogita, Haruhisa; Takaku, Haruo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2088-2095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently we reported the adenine derivs. 3a-d as novel interferon (IFN) inducers.  In the present study, we conducted a detailed structure-activity relationship study of analogs of 3a-d with respect to their IFN-inducing activity, mainly focusing on the N(9)-position of the adenine.  From this study, we found that introduction of the 3-pyridylmethyl moiety was effective to increase in vitro activity, and compd. I was identified as being the most potent IFN inducer.  This compd. gave a min. effective concn. (MEC) of 3 nM, which is comparable with that of R-848, a second generation IFN inducer.  Compd. I also demonstrated potent IFN-inducing activity at a dose of 0.1 mg/kg by oral administration in mice.  Furthermore, compd. I induced IFN in monkeys in a dose dependent manner, with a potency superior to that of R-848.  In addn., I did not cause emesis in ferrets even at a dose of 30 mg/kg.  In this study the max. plasma concn. of I was 1019 ng/mL (ca. 3.1 μM), which was approx. 1000-fold higher than the MEC value.  Therefore, with respect to both the efficacy and the safety margin, compd. I (SM-276001) is considered to be a promising compd. as an orally active IFN inducer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkfwkk2DNAOLVg90H21EOLACvtfcHk0liGCSHudZx2YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOrs70%253D&md5=a5555c918cb910d714d1068e1f6ba4b4</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm051089s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051089s%26sid%3Dliteratum%253Aachs%26aulast%3DIsobe%26aufirst%3DY.%26aulast%3DKurimoto%26aufirst%3DA.%26aulast%3DTobe%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DNorimura%26aufirst%3DK.%26aulast%3DOgita%26aufirst%3DH.%26aulast%3DTakaku%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25209-substituted-8-hydroxyadenine%2520derivatives%2520as%2520potent%2520interferon%2520inducers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2088%26epage%3D2095%26doi%3D10.1021%2Fjm051089s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koga-Yamakawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovedi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leishman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span> </span><span class="NLM_article-title">Intratracheal and Oral Administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1002/ijc.27691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fijc.27691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=22733292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFGiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=580-590&author=E.+Koga-Yamakawaauthor=S.+J.+Dovediauthor=M.+Murataauthor=H.+Matsuiauthor=A.+J.+Leishmanauthor=J.+Bellauthor=D.+Fergusonauthor=S.+P.+Heatonauthor=T.+Okiauthor=H.+Tomizawaauthor=A.+Bahlauthor=H.+Takakuauthor=R.+W.+Wilkinsonauthor=H.+Harada&title=Intratracheal+and+Oral+Administration+of+SM-276001%3A+A+selective+TLR7+agonist%2C+leads+to+antitumor+efficacy+in+primary+and+metastatic+models+of+cancer&doi=10.1002%2Fijc.27691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer</span></div><div class="casAuthors">Koga-Yamakawa, Erina; Dovedi, Simon J.; Murata, Masashi; Matsui, Hiroyuki; Leishman, Andrew J.; Bell, John; Ferguson, Douglas; Heaton, Simon P.; Oki, Toshihiro; Tomizawa, Hideyuki; Bahl, Ash; Takaku, Haruo; Wilkinson, Robert W.; Harada, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">580-590</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Topical TLR7 agonists such as imiquimod are highly effective for the treatment of dermatol. malignancies; however, their efficacy in the treatment of nondermatol. tumors has been less successful.  We report that oral administration of the novel TLR7-selective small mol. agonist; SM-276001, leads to the induction of an inflammatory cytokine and chemokine milieu and to the activation of a diverse population of immune effector cells including T and B lymphocytes, NK and NKT cells.  Oral administration of SM-276001 leads to the induction of IFNα, TNFα and IL-12p40 and a redn. in tumor burden in the Balb/c syngeneic Renca and CT26 models.  Using the OV2944-HM-1 model of ovarian cancer which spontaneously metastasizes to the lungs following s.c. implantation, we evaluated the efficacy of intratracheal and oral administration of SM-276001 in an adjuvant setting following surgical resection of the primary tumor.  We show that both oral and intratracheal TLR7 therapy can reduce the frequency of pulmonary metastasis, and metastasis to the axillary lymph nodes.  These results demonstrate that SM-276001 is a potent selective TLR7 agonist that can induce antitumor immune responses when dosed either intratracheally or orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqioNuAHXa9bLVg90H21EOLACvtfcHk0liGCSHudZx2YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFGiu7Y%253D&md5=40dc9668f626fcb95440d3f37c132aa7</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1002%2Fijc.27691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27691%26sid%3Dliteratum%253Aachs%26aulast%3DKoga-Yamakawa%26aufirst%3DE.%26aulast%3DDovedi%26aufirst%3DS.%2BJ.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DLeishman%26aufirst%3DA.%2BJ.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOki%26aufirst%3DT.%26aulast%3DTomizawa%26aufirst%3DH.%26aulast%3DBahl%26aufirst%3DA.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DHarada%26aufirst%3DH.%26atitle%3DIntratracheal%2520and%2520Oral%2520Administration%2520of%2520SM-276001%253A%2520A%2520selective%2520TLR7%2520agonist%252C%2520leads%2520to%2520antitumor%2520efficacy%2520in%2520primary%2520and%2520metastatic%2520models%2520of%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D580%26epage%3D590%26doi%3D10.1002%2Fijc.27691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miller, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerster, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomai, M. A.</span><span> </span><span class="NLM_article-title">Imiquimod applied topically: a novel immune response modifier and a new class of drug</span> <span class="citation_source-journal">Int. J. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/S0192-0561(98)00068-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2FS0192-0561%2898%2900068-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10411278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADyaK1MXitFyqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=1-14&author=R.+L.+Millerauthor=J.+F.+Gersterauthor=M.+L.+Owensauthor=H.+B.+Sladeauthor=M.+A.+Tomai&title=Imiquimod+applied+topically%3A+a+novel+immune+response+modifier+and+a+new+class+of+drug&doi=10.1016%2FS0192-0561%2898%2900068-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Imiquimod applied topically: a novel immune response modifier and new class of drug</span></div><div class="casAuthors">Miller, R. L.; Gerster, J. F.; Owens, M. L.; Slade, H. B.; Tomai, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 70 refs.  Imiquimod (S-26308, R-837) (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4 amine), an immune response modifier, demonstrates potent antiviral and antitumor activity in animal models (see structure in Fig. 1).  The drug exhibits no direct antiviral or antiproliferative activity when tested in a no. of cell culture systems.  Imiquimod's activity was discovered while screening for anti-herpes virus activity.  One of the first analogs in the series, S-25059 was tested in the early 1980's and due to slight toxicity, caused slightly reduced herpes cytopathol. in Vero cell cultures.  Follow-up testing in herpes infected guinea pigs showed complete protection toward lesion development.  Activity of these drugs results primarily from interferon alpha (IFN-α) induction and other cytokine induction.  At least part of the cytokine induction is mediated through NF-κB activation.  These cytokines stimulate several other aspects of the innate immune response.  In addn., imiquimod stimulates acquired immunity, in particular the cellular arm which is important for control of viral infections and various tumors.  This effect is mediated by drug induced IFN-α and Interleukin-12 (IL-12) and IFN-γ induced by these cytokines.  Imiquimod is expected to be effective where exogenous IFN-α has shown utility and where enhancement of cell-mediated immunity is needed.  The following is a brief review of the preclin. pharmacol. of imiquimod and the clin. results of genital wart trials.  The mechanism of action of topically applied imiquimod will likely lead to benefits in several other chronic virus infections and tumors of the skin.  Two other reviews on imiquimod that focus mainly on the clin. results have been published (Beutner & Geisse, 1997; Slade, Owens, Tomai & Miller, 1998).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSom1Nk4ulLrVg90H21EOLACvtfcHk0lilU5JU1KKPpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFyqtLk%253D&md5=b4b47faaa21fb4eb2e530ca2bcd6d442</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1016%2FS0192-0561%2898%2900068-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0192-0561%252898%252900068-X%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DR.%2BL.%26aulast%3DGerster%26aufirst%3DJ.%2BF.%26aulast%3DOwens%26aufirst%3DM.%2BL.%26aulast%3DSlade%26aufirst%3DH.%2BB.%26aulast%3DTomai%26aufirst%3DM.%2BA.%26atitle%3DImiquimod%2520applied%2520topically%253A%2520a%2520novel%2520immune%2520response%2520modifier%2520and%2520a%2520new%2520class%2520of%2520drug%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1999%26volume%3D21%26spage%3D1%26epage%3D14%26doi%3D10.1016%2FS0192-0561%2898%2900068-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gerster, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomai, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birmachu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bomersine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbertson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafla, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maye, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaides, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oneyemi, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhurst, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecore, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scribner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testerman, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andre, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupu, M.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of 1<i>H</i>-imidazo[4, 5-<i>c</i>]quinolines that induce interferon production</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3481</span><span class="NLM_x">–</span> <span class="NLM_lpage">3491</span><span class="refDoi"> DOI: 10.1021/jm049211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3481-3491&author=J.+F.+Gersterauthor=K.+J.+Lindstromauthor=R.+L.+Millerauthor=M.+A.+Tomaiauthor=W.+Birmachuauthor=S.+N.+Bomersineauthor=S.+J.+Gibsonauthor=L.+M.+Imbertsonauthor=J.+R.+Jacobsonauthor=R.+T.+Knaflaauthor=P.+V.+Mayeauthor=N.+Nikolaidesauthor=F.+Y.+Oneyemiauthor=G.+J.+Parkhurstauthor=S.+E.+Pecoreauthor=M.+J.+Reiterauthor=L.+S.+Scribnerauthor=T.+L.+Testermanauthor=N.+J.+Thompsonauthor=T.+L.+Wagnerauthor=C.+E.+Weeksauthor=J.+D.+Andreauthor=D.+Lagainauthor=Y.+Bastardauthor=M.+Lupu&title=Synthesis+and+structure-activity+relationships+of+1H-imidazo%5B4%2C+5-c%5Dquinolines+that+induce+interferon+production&doi=10.1021%2Fjm049211v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm049211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049211v%26sid%3Dliteratum%253Aachs%26aulast%3DGerster%26aufirst%3DJ.%2BF.%26aulast%3DLindstrom%26aufirst%3DK.%2BJ.%26aulast%3DMiller%26aufirst%3DR.%2BL.%26aulast%3DTomai%26aufirst%3DM.%2BA.%26aulast%3DBirmachu%26aufirst%3DW.%26aulast%3DBomersine%26aufirst%3DS.%2BN.%26aulast%3DGibson%26aufirst%3DS.%2BJ.%26aulast%3DImbertson%26aufirst%3DL.%2BM.%26aulast%3DJacobson%26aufirst%3DJ.%2BR.%26aulast%3DKnafla%26aufirst%3DR.%2BT.%26aulast%3DMaye%26aufirst%3DP.%2BV.%26aulast%3DNikolaides%26aufirst%3DN.%26aulast%3DOneyemi%26aufirst%3DF.%2BY.%26aulast%3DParkhurst%26aufirst%3DG.%2BJ.%26aulast%3DPecore%26aufirst%3DS.%2BE.%26aulast%3DReiter%26aufirst%3DM.%2BJ.%26aulast%3DScribner%26aufirst%3DL.%2BS.%26aulast%3DTesterman%26aufirst%3DT.%2BL.%26aulast%3DThompson%26aufirst%3DN.%2BJ.%26aulast%3DWagner%26aufirst%3DT.%2BL.%26aulast%3DWeeks%26aufirst%3DC.%2BE.%26aulast%3DAndre%26aufirst%3DJ.%2BD.%26aulast%3DLagain%26aufirst%3DD.%26aulast%3DBastard%26aufirst%3DY.%26aulast%3DLupu%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%25201H-imidazo%255B4%252C%25205-c%255Dquinolines%2520that%2520induce%2520interferon%2520production%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3481%26epage%3D3491%26doi%3D10.1021%2Fjm049211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fosdick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflanz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfgang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic properties of GS-9620, a novel toll-like receptor 7 agonist, demonstrate interferon-stimulated gene induction without detectable serum interferon at low oral doses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1124/jpet.113.207878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1124%2Fjpet.113.207878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=24133297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=96-105&author=A.+Fosdickauthor=J.+Zhengauthor=S.+Pflanzauthor=C.+R.+Freyauthor=J.+Hesselgesserauthor=R.+L.+Halcombauthor=G.+Wolfgangauthor=D.+B.+Tumas&title=Pharmacokinetic+and+pharmacodynamic+properties+of+GS-9620%2C+a+novel+toll-like+receptor+7+agonist%2C+demonstrate+interferon-stimulated+gene+induction+without+detectable+serum+interferon+at+low+oral+doses&doi=10.1124%2Fjpet.113.207878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic properties of GS-9620, a novel toll-like receptor 7 agonist, demonstrate interferon-stimulated gene induction without detectable serum interferon at low oral doses</span></div><div class="casAuthors">Fosdick, Abigail; Zheng, Jim; Pflanz, Stefan; Frey, Christian R.; Hesselgesser, Joseph; Halcomb, Randall L.; Wolfgang, Grushenka; Tumas, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-105, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">GS-9620 [8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5H)-one] is a potent, orally bioavailable small-mol. agonist of Toll-like receptor 7 (TLR7) developed for finite treatment of chronic hepatitis B viral (HBV) infection, with the goal of inducing a liver-targeted antiviral effect without inducing the adverse effects assocd. with current systemic interferon-a (IFN-α) therapies.  We characterized the pharmacodynamic response of GS-9620 in CD-1 mice and cynomolgus monkeys following i.v. or oral administration and showed that GS-9620 induces the prodn. of select chemokines and cytokines, including IFN-α and interferon-stimulated genes (ISGs).  It is noteworthy that we also demonstrated that, in animals and healthy human volunteers, oral administration of GS-9620 can induce a type I interferon-dependent antiviral innate immune response, as measured by whole-blood mRNA of the ISGs 2'5'-oligoadenylate synthetase 1 (OAS1) and myxovirus resistance 1 (MX1), without the induction of detectable systemic IFN-α, i.e., a presystemic response.  Addnl., presystemic induction of hepatic OAS1 and MX1 mRNA was obsd. in CD-1 mice in the absence of detectable systemic IFN-α.  We propose that the mechanism of this presystemic response is likely its high intestinal absorption, which facilitates localized activation of TLR7, probably in plasmacytoid dendritic cells at the level of gut-assocd. lymphoid tissue and/or the liver.  This localized response is further supported by data that indicate only minimal contributions of systemic immune stimulation to the overall pharmacodynamic response to orally administered GS-9620.  These data demonstrate that GS-9620 can induce an antiviral innate immune response without inducing a systemic IFN-α response and thus suggest the therapeutic potential of this approach in the treatment of chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGLt0m-dYGx7Vg90H21EOLACvtfcHk0lgITW2jyQ8bwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKjurw%253D&md5=002591f8338f6bfacaaa13be4297cf87</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.207878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.207878%26sid%3Dliteratum%253Aachs%26aulast%3DFosdick%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DPflanz%26aufirst%3DS.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DHalcomb%26aufirst%3DR.%2BL.%26aulast%3DWolfgang%26aufirst%3DG.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520properties%2520of%2520GS-9620%252C%2520a%2520novel%2520toll-like%2520receptor%25207%2520agonist%252C%2520demonstrate%2520interferon-stimulated%2520gene%2520induction%2520without%2520detectable%2520serum%2520interferon%2520at%2520low%2520oral%2520doses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D96%26epage%3D105%26doi%3D10.1124%2Fjpet.113.207878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tumas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duatschek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosdick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wofgang, G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of GS-9620, a potent and selective oral TLR7 agonist</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">S446</span><span class="NLM_x">–</span> <span class="NLM_lpage">S447</span><span class="refDoi"> DOI: 10.1016/S0168-8278(11)61131-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2FS0168-8278%2811%2961131-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=S446-S447&author=D.+Tumasauthor=X.+Zhengauthor=G.+Rhodesauthor=P.+Duatschekauthor=J.+Hesselgesserauthor=C.+Freyauthor=I.+Henneauthor=A.+Fosdickauthor=R.+Halcombauthor=G.+Wofgang&title=Preclinical+characterization+of+GS-9620%2C+a+potent+and+selective+oral+TLR7+agonist&doi=10.1016%2FS0168-8278%2811%2961131-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0168-8278%2811%2961131-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-8278%252811%252961131-8%26sid%3Dliteratum%253Aachs%26aulast%3DTumas%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DRhodes%26aufirst%3DG.%26aulast%3DDuatschek%26aufirst%3DP.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DFrey%26aufirst%3DC.%26aulast%3DHenne%26aufirst%3DI.%26aulast%3DFosdick%26aufirst%3DA.%26aulast%3DHalcomb%26aufirst%3DR.%26aulast%3DWofgang%26aufirst%3DG.%26atitle%3DPreclinical%2520characterization%2520of%2520GS-9620%252C%2520a%2520potent%2520and%2520selective%2520oral%2520TLR7%2520agonist%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D54%26spage%3DS446%26epage%3DS447%26doi%3D10.1016%2FS0168-8278%2811%2961131-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Last, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoné, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Schoubroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pooter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostmans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khamlichi, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrechts, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhuyvetter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyej, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnoult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span> </span><span class="NLM_article-title">Novel pyrimidine toll-like receptor 7 and 8 dual agonists to treat hepatitis B virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7936</span><span class="NLM_x">–</span> <span class="NLM_lpage">7949</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7936-7949&author=D.+C.+McGowanauthor=F.+Herschkeauthor=F.+Pauwelsauthor=B.+Stoopsauthor=S.+Lastauthor=S.+Pietersauthor=A.+Scholliersauthor=T.+Thon%C3%A9author=B.+Van+Schoubroeckauthor=D.+De+Pooterauthor=W.+Mostmansauthor=M.+D.+Khamlichiauthor=W.+Embrechtsauthor=D.+Dhuyvetterauthor=I.+Smyejauthor=E.+Arnoultauthor=S.+Deminauthor=H.+Borghysauthor=F.+Fanningauthor=J.+Vlachauthor=P.+Raboisson&title=Novel+pyrimidine+toll-like+receptor+7+and+8+dual+agonists+to+treat+hepatitis+B+virus&doi=10.1021%2Facs.jmedchem.6b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus</span></div><div class="casAuthors">McGowan, David; Herschke, Florence; Pauwels, Frederik; Stoops, Bart; Last, Stefaan; Pieters, Serge; Scholliers, Annick; Thone, Tine; Van Schoubroeck, Bertrand; De Pooter, Dorien; Mostmans, Wendy; Khamlichi, Mourad Daoubi; Embrechts, Werner; Dhuyvetter, Deborah; Smyej, Ilham; Arnoult, Eric; Demin, Samuel; Borghys, Herman; Fanning, Gregory; Vlach, Jaromir; Raboisson, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7936-7949</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR) 7 and 8 agonists can potentially be used in the treatment of viral infections and are particularly promising for chronic hepatitis B virus (HBV) infection.  An internal screening effort identified a pyrimidine Toll-like receptor 7 and 8 dual agonist.  This provided a novel alternative over the previously reported adenine and pteridone type of agonists.  Structure-activity relationship, lead optimization, in silico docking, pharmacokinetics, and demonstration of ex vivo and in vivo cytokine prodn. of the lead compd. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-fRW7IJ3nZ7Vg90H21EOLACvtfcHk0lgITW2jyQ8bwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7vF&md5=f98f5bf04418de548b34463b3ebf2c2e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DHerschke%26aufirst%3DF.%26aulast%3DPauwels%26aufirst%3DF.%26aulast%3DStoops%26aufirst%3DB.%26aulast%3DLast%26aufirst%3DS.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DThon%25C3%25A9%26aufirst%3DT.%26aulast%3DVan%2BSchoubroeck%26aufirst%3DB.%26aulast%3DDe%2BPooter%26aufirst%3DD.%26aulast%3DMostmans%26aufirst%3DW.%26aulast%3DKhamlichi%26aufirst%3DM.%2BD.%26aulast%3DEmbrechts%26aufirst%3DW.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DSmyej%26aufirst%3DI.%26aulast%3DArnoult%26aufirst%3DE.%26aulast%3DDemin%26aufirst%3DS.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DFanning%26aufirst%3DF.%26aulast%3DVlach%26aufirst%3DJ.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DNovel%2520pyrimidine%2520toll-like%2520receptor%25207%2520and%25208%2520dual%2520agonists%2520to%2520treat%2520hepatitis%2520B%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7936%26epage%3D7949%26doi%3D10.1021%2Facs.jmedchem.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bennett, N. J.; McInally, T.; Mochel, T.; Thom, S.; Tidén, A.-K.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives for the treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis</span>. WO2009067081,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=N.+J.+Bennett&author=T.+McInally&author=T.+Mochel&author=S.+Thom&author=A.-K.+Tid%C3%A9n&title=Pyrimidine+derivatives+for+the+treatment+of+asthma%2C+COPD%2C+allergic+rhinitis%2C+allergic+conjunctivitis%2C+atopic+dermatitis%2C+cancer%2C+hepatitis+B%2C+hepatitis+C%2C+HIV%2C+HPV%2C+bacterial+infections+and+dermatosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DN.%2BJ.%26atitle%3DPyrimidine%2520derivatives%2520for%2520the%2520treatment%2520of%2520asthma%252C%2520COPD%252C%2520allergic%2520rhinitis%252C%2520allergic%2520conjunctivitis%252C%2520atopic%2520dermatitis%252C%2520cancer%252C%2520hepatitis%2520B%252C%2520hepatitis%2520C%252C%2520HIV%252C%2520HPV%252C%2520bacterial%2520infections%2520and%2520dermatosis%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tosaki, S.; Hori, S.</span><span> </span><span class="NLM_article-title">Cyclic amide compounds and their use in the treatment of disease</span>. WO2012067268,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Tosaki&author=S.+Hori&title=Cyclic+amide+compounds+and+their+use+in+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTosaki%26aufirst%3DS.%26atitle%3DCyclic%2520amide%2520compounds%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520disease%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lanford, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giavedoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodara, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasky, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosdick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfgang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halcomb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span> </span><span class="NLM_article-title">GS-9620, an oral agonist of toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span><span class="refDoi"> DOI: 10.1053/j.gastro.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1053%2Fj.gastro.2013.02.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2013&pages=1508-1517&author=R.+E.+Lanfordauthor=B.+Guerraauthor=D.+Chavezauthor=L.+Giavedoniauthor=V.+L.+Hodaraauthor=K.+M.+Braskyauthor=A.+Fosdickauthor=C.+R.+Freyauthor=J.+Zhengauthor=G.+Wolfgangauthor=R.+L.+Halcombauthor=D.+B.+Tumas&title=GS-9620%2C+an+oral+agonist+of+toll-like+receptor-7%2C+induces+prolonged+suppression+of+hepatitis+B+virus+in+chronically+infected+chimpanzees&doi=10.1053%2Fj.gastro.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DLanford%26aufirst%3DR.%2BE.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DChavez%26aufirst%3DD.%26aulast%3DGiavedoni%26aufirst%3DL.%26aulast%3DHodara%26aufirst%3DV.%2BL.%26aulast%3DBrasky%26aufirst%3DK.%2BM.%26aulast%3DFosdick%26aufirst%3DA.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DWolfgang%26aufirst%3DG.%26aulast%3DHalcomb%26aufirst%3DR.%2BL.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26atitle%3DGS-9620%252C%2520an%2520oral%2520agonist%2520of%2520toll-like%2520receptor-7%252C%2520induces%2520prolonged%2520suppression%2520of%2520hepatitis%2520B%2520virus%2520in%2520chronically%2520infected%2520chimpanzees%26jtitle%3DGastroenterology%26date%3D2013%26volume%3D144%26spage%3D1508%26epage%3D1517%26doi%3D10.1053%2Fj.gastro.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Borovik, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shkurko, O. P.</span><span> </span><span class="NLM_article-title">Synthesis of functional 2-substituted 4-phenyl-9<i>H</i>-pyrimido[4,5-<i>b</i>]indoles</span> <span class="citation_source-journal">Russ. Chem. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2129</span><span class="NLM_x">–</span> <span class="NLM_lpage">2133</span><span class="refDoi"> DOI: 10.1023/A:1021688616234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1023%2FA%3A1021688616234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFOlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=2129-2133&author=V.+P.+Borovikauthor=O.+P.+Shkurko&title=Synthesis+of+functional+2-substituted+4-phenyl-9H-pyrimido%5B4%2C5-b%5Dindoles&doi=10.1023%2FA%3A1021688616234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of functional 2-substituted 4-phenyl-9H-pyrimido[4,5-b]indoles</span></div><div class="casAuthors">Borovik, V. P.; Shkurko, O. P.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya Khimicheskaya)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2129-2133</span>CODEN:
                <span class="NLM_cas:coden">RCBUEY</span>;
        ISSN:<span class="NLM_cas:issn">1066-5285</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">A method was developed for the synthesis of 2-oxo-4-phenyl-2,3-dihydro-9H-pyrimido[4,5-b]indole as well as of 2-chloro- and 2-nitramino-4-phenylpyrimido[4,5-b]indoles.  The replacement of the chlorine atom in 2-chloropyrimidoindole gave rise to a no. of its functional derivs. (morpholino, azido, and cyano).  The reaction of 2-chloro-substituted pyrimidoindole with hydrazine hydrate and catalytic hydrogenation of 2-nitraminopyrimidoindole were studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2bRJ6Su3DJrVg90H21EOLACvtfcHk0lgM2SoUqywZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFOlsbo%253D&md5=b0bb7828bb765d3af131a2c24e540fda</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1023%2FA%3A1021688616234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1021688616234%26sid%3Dliteratum%253Aachs%26aulast%3DBorovik%26aufirst%3DV.%2BP.%26aulast%3DShkurko%26aufirst%3DO.%2BP.%26atitle%3DSynthesis%2520of%2520functional%25202-substituted%25204-phenyl-9H-pyrimido%255B4%252C5-b%255Dindoles%26jtitle%3DRuss.%2520Chem.%2520Bull.%26date%3D2002%26volume%3D51%26spage%3D2129%26epage%3D2133%26doi%3D10.1023%2FA%3A1021688616234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bräse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knepper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, V.</span><span> </span><span class="NLM_article-title">Organic Azides: An exploding diversity of a unique class of compounds</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5240</span><span class="refDoi"> DOI: 10.1002/anie.200400657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2Fanie.200400657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVKnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5188-5240&author=S.+Br%C3%A4seauthor=C.+Gilauthor=K.+Knepperauthor=V.+Zimmermann&title=Organic+Azides%3A+An+exploding+diversity+of+a+unique+class+of+compounds&doi=10.1002%2Fanie.200400657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Organic azides. An exploding diversity of a unique class of compounds</span></div><div class="casAuthors">Brase, Stefan; Gil, Carmen; Knepper, Kerstin; Zimmermann, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5188-5240</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Since the discovery of org. azides by Peter Griess more than 140 years ago, numerous syntheses of these energy-rich mols. were developed.  In more recent times in particular, completely new perspectives were developed for their use in peptide chem., combinatorial chem., and heterocyclic synthesis.  Org. azides have assumed an important position at the interface between chem., biol., medicine, and materials science.  In this Review, the fundamental characteristics of azide chem. and current developments are presented.  The focus will be placed on cycloaddns. (Huisgen reaction), aza ylide chem., and the synthesis of heterocycles.  Further reactions such as the aza-Wittig reaction, the Sundberg rearrangement, the Staudinger ligation, the Boyer and Boyer-Aube rearrangements, the Curtius rearrangement, the Schmidt rearrangement, and the Hemetsberger rearrangement bear witness to the versatility of modern azide chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrig_NsoaX0r7Vg90H21EOLACvtfcHk0lgd2z_ZxFIgWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVKnu70%253D&md5=e8306c705526b23b0769e9a14cc73a29</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200400657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200400657%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DKnepper%26aufirst%3DK.%26aulast%3DZimmermann%26aufirst%3DV.%26atitle%3DOrganic%2520Azides%253A%2520An%2520exploding%2520diversity%2520of%2520a%2520unique%2520class%2520of%2520compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5188%26epage%3D5240%26doi%3D10.1002%2Fanie.200400657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Click chemistry: Diverse chemical function from a few good reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2021</span><span class="refDoi"> DOI: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=11433435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=2004-2021&author=H.+C.+Kolbauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry%3A+Diverse+chemical+function+from+a+few+good+reactions&doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry: diverse chemical function from a few good reactions</span></div><div class="casAuthors">Kolb, Hartmuth C.; Finn, M. G.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2004-2021</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Review with > 88 refs.  Examn. of nature's favorite mols. reveals a striking preference for making carbon-heteroatom bonds over carbon-carbon bonds - surely no surprise given that carbon dioxide is nature's starting material and that most reactions are performed in water.  Nucleic acids, proteins, and polysaccharides are condensation polymers of small subunits stitched together by carbon-heteroatom bonds.  Even the 35 or so building blocks from which these crucial mols. are made each contain, at most, six contiguous C-C bonds, except for the three arom. amino acids.  Taking a cue from nature's approach, the development of a set of powerful, highly reliable, and selective reactions for the rapid synthesis of useful new compds. and combinatorial libraries through heteroatom links (C-X-C), an approach called "click chem." is addressed.  Click chem. is at once defined, enabled, and constrained by a handful of nearly perfect "spring-loaded" reactions.  The stringent criteria for a process to earn click chem. status are described along with examples of the mol. frameworks that are easily made using this spartan, but powerful, synthetic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptrjo9nxXNRrVg90H21EOLACvtfcHk0lj8n63VcLTpnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOis78%253D&md5=61c28b416c42c87821bc8a5bc2fdec36</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010601%252940%253A11%253C2004%253A%253AAID-ANIE2004%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%253A%2520Diverse%2520chemical%2520function%2520from%2520a%2520few%2520good%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D2004%26epage%3D2021%26doi%3D10.1002%2F1521-3773%2820010601%2940%3A11%3C2004%3A%3AAID-ANIE2004%3E3.0.CO%3B2-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Elliott, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. A.</span><span> </span><span class="NLM_article-title">A short, facile synthesis of 2-amino-1,5-dihydro-4<i>H</i>-pyrrolo[3,2-<i>d</i>]-pyrimidin-4-one (9-deazaguanine)</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4340</span><span class="refDoi"> DOI: 10.1016/0040-4039(96)00840-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2F0040-4039%2896%2900840-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=4339-4340&author=A.+J.+Elliottauthor=J.+A.+Montgomeryauthor=D.+A.+Walsh&title=A+short%2C+facile+synthesis+of+2-amino-1%2C5-dihydro-4H-pyrrolo%5B3%2C2-d%5D-pyrimidin-4-one+%289-deazaguanine%29&doi=10.1016%2F0040-4039%2896%2900840-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2896%2900840-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252896%252900840-4%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DA.%2BJ.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3DA%2520short%252C%2520facile%2520synthesis%2520of%25202-amino-1%252C5-dihydro-4H-pyrrolo%255B3%252C2-d%255D-pyrimidin-4-one%2520%25289-deazaguanine%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D4339%26epage%3D4340%26doi%3D10.1016%2F0040-4039%2896%2900840-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Elliott, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petty, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. H.</span><span> </span><span class="NLM_article-title">An improved synthesis of 7-substituted pyrrolo[3,2-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">8071</span><span class="NLM_x">–</span> <span class="NLM_lpage">8075</span><span class="refDoi"> DOI: 10.1021/jo971062j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971062j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=8071-8075&author=A.+J.+Elliottauthor=P.+E.+Morrisauthor=S.+L.+Pettyauthor=C.+H.+Williams&title=An+improved+synthesis+of+7-substituted+pyrrolo%5B3%2C2-d%5Dpyrimidines&doi=10.1021%2Fjo971062j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1021%2Fjo971062j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971062j%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DA.%2BJ.%26aulast%3DMorris%26aufirst%3DP.%2BE.%26aulast%3DPetty%26aufirst%3DS.%2BL.%26aulast%3DWilliams%26aufirst%3DC.%2BH.%26atitle%3DAn%2520improved%2520synthesis%2520of%25207-substituted%2520pyrrolo%255B3%252C2-d%255Dpyrimidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D8071%26epage%3D8075%26doi%3D10.1021%2Fjo971062j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Theoclitou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriotta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Code, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deegan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezhuthachan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadella, M. V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanilayam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. J.</span><span> </span><span class="NLM_article-title">Discovery of (+)-<i>N</i>-(3-aminopropyl)-<i>N</i>-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-<i>d</i>]-pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6734</span><span class="NLM_x">–</span> <span class="NLM_lpage">6750</span><span class="refDoi"> DOI: 10.1021/jm200629m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200629m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6734-6750&author=M.+Theoclitouauthor=B.+Aquilaauthor=M.+H.+Blockauthor=P.+J.+Brassilauthor=L.+Castriottaauthor=E.+Codeauthor=M.+P.+Collinsauthor=A.+M.+Daviesauthor=T.+Deeganauthor=J.+Ezhuthachanauthor=S.+Fillaauthor=E.+Freedauthor=H.+Huauthor=D.+Huszarauthor=M.+Jayaramanauthor=D.+Lawsonauthor=P.+M.+Lewisauthor=M.+V.+P.+Nadellaauthor=V.+Ozaauthor=M.+Padmanilayamauthor=T.+Pontzauthor=L.+Roncoauthor=D.+Russellauthor=D.+Whitstonauthor=X.+J.+Zheng&title=Discovery+of+%28%2B%29-N-%283-aminopropyl%29-N-%5B1-%285-benzyl-3-methyl-4-oxo-%5B1%2C2%5Dthiazolo%5B5%2C4-d%5D-pyrimidin-6-yl%29-2-methylpropyl%5D-4-methylbenzamide+%28AZD4877%29%2C+a+kinesin+spindle+protein+inhibitor+and+potential+anticancer+agent&doi=10.1021%2Fjm200629m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1021%2Fjm200629m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200629m%26sid%3Dliteratum%253Aachs%26aulast%3DTheoclitou%26aufirst%3DM.%26aulast%3DAquila%26aufirst%3DB.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DBrassil%26aufirst%3DP.%2BJ.%26aulast%3DCastriotta%26aufirst%3DL.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DM.%2BP.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DDeegan%26aufirst%3DT.%26aulast%3DEzhuthachan%26aufirst%3DJ.%26aulast%3DFilla%26aufirst%3DS.%26aulast%3DFreed%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DJayaraman%26aufirst%3DM.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DLewis%26aufirst%3DP.%2BM.%26aulast%3DNadella%26aufirst%3DM.%2BV.%2BP.%26aulast%3DOza%26aufirst%3DV.%26aulast%3DPadmanilayam%26aufirst%3DM.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DRonco%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DWhitston%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DX.%2BJ.%26atitle%3DDiscovery%2520of%2520%2528%252B%2529-N-%25283-aminopropyl%2529-N-%255B1-%25285-benzyl-3-methyl-4-oxo-%255B1%252C2%255Dthiazolo%255B5%252C4-d%255D-pyrimidin-6-yl%2529-2-methylpropyl%255D-4-methylbenzamide%2520%2528AZD4877%2529%252C%2520a%2520kinesin%2520spindle%2520protein%2520inhibitor%2520and%2520potential%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6734%26epage%3D6750%26doi%3D10.1021%2Fjm200629m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoerter, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menhaji-Klotz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasota, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumberledge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathisen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhambra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3399</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.bmcl.2011.03.117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3399-3403&author=D.+G.+Brownauthor=D.+L.+Maierauthor=M.+A.+Sylvesterauthor=T.+N.+Hoerterauthor=E.+Menhaji-Klotzauthor=C.+C.+Lasotaauthor=L.+T.+Hirataauthor=D.+E.+Wilkinsauthor=C.+W.+Scottauthor=S.+Trivediauthor=T.+Chenauthor=D.+J.+McCarthyauthor=C.+M.+Maciagauthor=E.+J.+Suttonauthor=J.+Cumberledgeauthor=D.+Mathisenauthor=J.+Robertsauthor=A.+Guptaauthor=F.+Liuauthor=C.+S.+Elmoreauthor=C.+Alhambraauthor=J.+R.+Krumrineauthor=X.+Wangauthor=P.+J.+Ciaccioauthor=M.+W.+Woodauthor=J.+B.+Campbellauthor=M.+J.+Johanssonauthor=J.+Xiaauthor=X.+Wenauthor=J.+Jiangauthor=X.+Wangauthor=Z.+Pengauthor=T.+Huauthor=J.+Wang&title=2%2C6-Disubstituted+pyrazines+and+related+analogs+as+NR2B+site+antagonists+of+the+NMDA+receptor+with+anti-depressant+activity&doi=10.1016%2Fj.bmcl.2011.03.117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.117%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DMaier%26aufirst%3DD.%2BL.%26aulast%3DSylvester%26aufirst%3DM.%2BA.%26aulast%3DHoerter%26aufirst%3DT.%2BN.%26aulast%3DMenhaji-Klotz%26aufirst%3DE.%26aulast%3DLasota%26aufirst%3DC.%2BC.%26aulast%3DHirata%26aufirst%3DL.%2BT.%26aulast%3DWilkins%26aufirst%3DD.%2BE.%26aulast%3DScott%26aufirst%3DC.%2BW.%26aulast%3DTrivedi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DMcCarthy%26aufirst%3DD.%2BJ.%26aulast%3DMaciag%26aufirst%3DC.%2BM.%26aulast%3DSutton%26aufirst%3DE.%2BJ.%26aulast%3DCumberledge%26aufirst%3DJ.%26aulast%3DMathisen%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DElmore%26aufirst%3DC.%2BS.%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DKrumrine%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26aulast%3DWood%26aufirst%3DM.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DJohansson%26aufirst%3DM.%2BJ.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3D2%252C6-Disubstituted%2520pyrazines%2520and%2520related%2520analogs%2520as%2520NR2B%2520site%2520antagonists%2520of%2520the%2520NMDA%2520receptor%2520with%2520anti-depressant%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3399%26epage%3D3403%26doi%3D10.1016%2Fj.bmcl.2011.03.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Carvalho, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louvel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doornbos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaasse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A.</span><span> </span><span class="NLM_article-title">Strategies to reduce hERG K+ channel blockade. Exploring heteroaromaticity and rigidity in novel analogues of Dofetilide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2840</span><span class="refDoi"> DOI: 10.1021/jm301564f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301564f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2828-2840&author=J.+F.+Carvalhoauthor=J.+Louvelauthor=M.+L.+Doornbosauthor=E.+Klaasseauthor=Z.+Yuauthor=J.+Brusseeauthor=A.+Ijzerman&title=Strategies+to+reduce+hERG+K%2B+channel+blockade.+Exploring+heteroaromaticity+and+rigidity+in+novel+analogues+of+Dofetilide&doi=10.1021%2Fjm301564f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm301564f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301564f%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DJ.%2BF.%26aulast%3DLouvel%26aufirst%3DJ.%26aulast%3DDoornbos%26aufirst%3DM.%2BL.%26aulast%3DKlaasse%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520reduce%2520hERG%2520K%252B%2520channel%2520blockade.%2520Exploring%2520heteroaromaticity%2520and%2520rigidity%2520in%2520novel%2520analogues%2520of%2520Dofetilide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2828%26epage%3D2840%26doi%3D10.1021%2Fjm301564f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">4046</span><span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-4046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+Highlights+and+hang-ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lgOOjuz0_XzFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520Highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D4046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohto, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krayukhina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isobe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span> </span><span class="NLM_article-title">Structural analysis reveals that Toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1016/j.immuni.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.immuni.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=27742543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=737-748&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=E.+Krayukhinaauthor=M.+Taokaauthor=Y.+Yamauchiauthor=H.+Tanjiauthor=T.+Isobeauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+analysis+reveals+that+Toll-like+receptor+7+is+a+dual+receptor+for+guanosine+and+single-stranded+RNA&doi=10.1016%2Fj.immuni.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Krayukhina, Elena; Taoka, Masato; Yamauchi, Yoshio; Tanji, Hiromi; Isobe, Toshiaki; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chem. ligands, such as imidazoquinoline compds.  However, TLR7 activation mechanism by these ligands remain largely unknown.  Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites.  The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation.  The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands.  The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA.  Our structural, biochem., and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-contg. ssRNA.  Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQskd1L0XeX7Vg90H21EOLACvtfcHk0lgOOjuz0_XzFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI&md5=194f87d5ea0e88009fd682c00e020f38</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520analysis%2520reveals%2520that%2520Toll-like%2520receptor%25207%2520is%2520a%2520dual%2520receptor%2520for%2520guanosine%2520and%2520single-stranded%2520RNA%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D737%26epage%3D748%26doi%3D10.1016%2Fj.immuni.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Mathes, C.</span><span> </span><span class="NLM_article-title">QPatch: the past, present and future of automated patch clamp</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1517/14728222.10.2.319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1517%2F14728222.10.2.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=16548779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=319-327&author=C.+Mathes&title=QPatch%3A+the+past%2C+present+and+future+of+automated+patch+clamp&doi=10.1517%2F14728222.10.2.319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">QPatch: the past, present and future of automated patch clamp</span></div><div class="casAuthors">Mathes, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-327</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The QPatch 16 significantly increases throughput for gigaseal patch clamp expts., making direct measurements in ion channel drug discovery and safety testing feasible.  Released to the market in the Autumn of 2004 by Sophion Bioscience, the QPatch originated from work done at NeuroSearch (Denmark) in the early days of automated patch clamp.  Today, the QPatch provides many unique features.  For example, only the QPatch includes an automated cell prepn. station making several hours of unattended operation possible.  The 16-channel electrode array, called the QPlate, includes glass-coated microfluidic channels for less compd. absorption and, hence, more accurate IC50 values.  The microfluidic pathways also allow for very small amts. of compd. used for each expt. (∼ 5 μl per addn.).  Only the QPatch has four independent pipetting heads for more efficient liq. handling (esp. for ligand-gated ion channel expts.).  Patch clamp recordings with the QPatch match the high quality of conventional patch clamp and in some cases the results are even better.  For example, only the QPatch includes 100% series resistance compensation for the elimination of false positives due to voltage errors.  Finally, the modular QPatch 16 was designed with more channels in mind.  The upgrade pathway to 48-channels (the QPatch HT) will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywPZMP8PNwrVg90H21EOLACvtfcHk0lgOOjuz0_XzFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D&md5=7dcd02a69652955e261f6928fbb76b81</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.2.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.2.319%26sid%3Dliteratum%253Aachs%26aulast%3DMathes%26aufirst%3DC.%26atitle%3DQPatch%253A%2520the%2520past%252C%2520present%2520and%2520future%2520of%2520automated%2520patch%2520clamp%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D319%26epage%3D327%26doi%3D10.1517%2F14728222.10.2.319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Huang, L.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.-S.</span><span> </span><span class="NLM_article-title">An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17862</span><span class="NLM_x">–</span> <span class="NLM_lpage">17867</span><span class="refDoi"> DOI: 10.1073/pnas.0608578103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1073%2Fpnas.0608578103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17862-17867&author=L.-R.+Huangauthor=H.-L.+Wuauthor=P.-J.+Chenauthor=D.-S.+Chen&title=An+immunocompetent+mouse+model+for+the+tolerance+of+human+chronic+hepatitis+B+virus+infection&doi=10.1073%2Fpnas.0608578103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0608578103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0608578103%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.-R.%26aulast%3DWu%26aufirst%3DH.-L.%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DChen%26aufirst%3DD.-S.%26atitle%3DAn%2520immunocompetent%2520mouse%2520model%2520for%2520the%2520tolerance%2520of%2520human%2520chronic%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D17862%26epage%3D17867%26doi%3D10.1073%2Fpnas.0608578103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ketloy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engering, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srichairatanakul, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limsalakpetch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yongvanitchit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichyangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruxrungtham, K.</span><span> </span><span class="NLM_article-title">Expression and function of toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates</span> <span class="citation_source-journal">Vet. Immunol. Immunopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.vetimm.2008.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1016%2Fj.vetimm.2008.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=18571243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWitrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2008&pages=18-30&author=C.+Ketloyauthor=A.+Engeringauthor=U.+Srichairatanakulauthor=A.+Limsalakpetchauthor=K.+Yongvanitchitauthor=S.+Pichyangkulauthor=K.+Ruxrungtham&title=Expression+and+function+of+toll-like+receptors+on+dendritic+cells+and+other+antigen+presenting+cells+from+non-human+primates&doi=10.1016%2Fj.vetimm.2008.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates</span></div><div class="casAuthors">Ketloy, Chutitorn; Engering, Anneke; Srichairatanakul, Utaiwan; Limsalakpetch, Amporn; Yongvanitchit, Kosol; Pichyangkul, Sathit; Ruxrungtham, Kiat</div><div class="citationInfo"><span class="NLM_cas:title">Veterinary Immunology and Immunopathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">18-30</span>CODEN:
                <span class="NLM_cas:coden">VIIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0165-2427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Antigen presenting cells (APCs), esp. dendritic cells (DCs), play a crucial role in immune responses against infections by sensing microbial invasion through Toll-like receptors (TLRs).  In this regard, TLR ligands are attractive candidates for use in humans and animal models as vaccine adjuvants.  So far, no studies have been performed on TLR expression in non-human primates such as rhesus macaques.  Therefore, we studied the TLR expression patterns in different subsets of APC in rhesus macaques and compared them to similar APC subsets in human.  Also, expression was compared with corresponding DC subsets from different organs from mice.  Here we show by semi-quant. RT-PCR, that blood DC subsets of rhesus macaque expressed the same sets of TLRs as those of human but substantially differed from mouse DC subsets.  Macaque myeloid DCs (MDCs) expressed TLR3, 4, 7 and 8 whereas macaque plasmacytoid DCs (PDCs) expressed only TLR7 and 9.  Addnl., TLR expression patterns in macaque monocyte-derived dendritic cells (mo-DCs) (i.e., TLR3, 4, 8 and 9), monocytes (i.e., TLR4, 7, and 8) and B cells (i.e., TLR4, 7, 8, and 9) were also similar to their human counterparts.  However, the responsiveness of macaque APCs to certain TLR ligands partially differed from that of human in terms of phenotype differentiation and cytokine prodn.  Strikingly, in contrast to human mo-DCs, no IL-12p70 prodn. was obsd. when macaque mo-DCs were stimulated with TLR ligands.  In addn., CD40 and CD86 phenotypic responses to TLR8 ligand (poly U) in mo-DCs of macaque were higher than that of human.  Despite these functional differences, our results provide important information for a rational design of animal models in evaluating TLR ligands as adjuvant in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG1XrRF7tZBrVg90H21EOLACvtfcHk0liJN0od0Z9bPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWitrvE&md5=974ee47d1b6f9e3717adc886ae9514bb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.vetimm.2008.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vetimm.2008.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DKetloy%26aufirst%3DC.%26aulast%3DEngering%26aufirst%3DA.%26aulast%3DSrichairatanakul%26aufirst%3DU.%26aulast%3DLimsalakpetch%26aufirst%3DA.%26aulast%3DYongvanitchit%26aufirst%3DK.%26aulast%3DPichyangkul%26aufirst%3DS.%26aulast%3DRuxrungtham%26aufirst%3DK.%26atitle%3DExpression%2520and%2520function%2520of%2520toll-like%2520receptors%2520on%2520dendritic%2520cells%2520and%2520other%2520antigen%2520presenting%2520cells%2520from%2520non-human%2520primates%26jtitle%3DVet.%2520Immunol.%2520Immunopathol.%26date%3D2008%26volume%3D125%26spage%3D18%26epage%3D30%26doi%3D10.1016%2Fj.vetimm.2008.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Starkhammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georén, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlén, S.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardell, L.-O.</span><span> </span><span class="NLM_article-title">Toll-like receptor ligands LPS and Poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e104114</span><span class="refDoi"> DOI: 10.1371/journal.pone.0104114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1371%2Fjournal.pone.0104114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e104114&author=M.+Starkhammarauthor=O.+Larssonauthor=S.+K.+Geor%C3%A9nauthor=M.+Leinoauthor=S.-E.+Dahl%C3%A9nauthor=M.+Adnerauthor=L.-O.+Cardell&title=Toll-like+receptor+ligands+LPS+and+Poly+%28I%3AC%29+exacerbate+airway+hyperresponsiveness+in+a+model+of+airway+allergy+in+mice%2C+independently+of+inflammation&doi=10.1371%2Fjournal.pone.0104114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0104114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0104114%26sid%3Dliteratum%253Aachs%26aulast%3DStarkhammar%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DGeor%25C3%25A9n%26aufirst%3DS.%2BK.%26aulast%3DLeino%26aufirst%3DM.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.-E.%26aulast%3DAdner%26aufirst%3DM.%26aulast%3DCardell%26aufirst%3DL.-O.%26atitle%3DToll-like%2520receptor%2520ligands%2520LPS%2520and%2520Poly%2520%2528I%253AC%2529%2520exacerbate%2520airway%2520hyperresponsiveness%2520in%2520a%2520model%2520of%2520airway%2520allergy%2520in%2520mice%252C%2520independently%2520of%2520inflammation%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De104114%26doi%3D10.1371%2Fjournal.pone.0104114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Ronit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plovsing, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaardbo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartling, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, Å.B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Møller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. D.</span><span> </span><span class="NLM_article-title">Inflammation-induced changes in circulating T-cell subsets and cytokine production during human endotoxemia</span> <span class="citation_source-journal">J. Intensive Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1177/0885066615606673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1177%2F0885066615606673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=26392625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=1%3ACAS%3A280%3ADC%252BC283ksF2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=77-85&author=A.+Ronitauthor=R.+R.+Plovsingauthor=J.+C.+Gaardboauthor=R.+M.+Bergauthor=H.+J.+Hartlingauthor=H.+Ullumauthor=%C3%85.B.+Andersenauthor=H.+O.+Madsenauthor=K.+M%C3%B8llerauthor=S.+D.+Nielsen&title=Inflammation-induced+changes+in+circulating+T-cell+subsets+and+cytokine+production+during+human+endotoxemia&doi=10.1177%2F0885066615606673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-Induced Changes in Circulating T-Cell Subsets and Cytokine Production During Human Endotoxemia</span></div><div class="casAuthors">Ronit Andreas; Gaardbo Julie C; Hartling Hans J; Andersen ¡ÑÜAse B; Nielsen Susanne D; Ronit Andreas; Gaardbo Julie C; Hartling Hans J; Ullum Henrik; Plovsing Ronni R; Berg Ronan M G; Plovsing Ronni R; Berg Ronan M G; Moller Kirsten; Madsen Hans O; Moller Kirsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of intensive care medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Observational clinical studies suggest the initial phase of sepsis may involve impaired cellular immunity.  In the present study, we investigated temporal changes in T-cell subsets and T-cell cytokine production during human endotoxemia.  Endotoxin (Escherichia coli lipopolysaccharide 4 ng/kg) was administered intravenously in 15 healthy volunteers.  Peripheral blood and bronchoalveolar lavage fluid (BALF) were collected at baseline and after 2, 4, 6, 8, and 24 hours for flow cytometry.  CD4(+)CD25(+)CD127lowFoxp3(+) regulatory T cells (Tregs), CD4(+)CD161(+) cells, and activated Human leukocyte antigen, HLA-DR(+)CD38(+) T cells were determined.  Ex vivo whole-blood cytokine production and Toll-like receptor (TLR)-4 expression on Tregs were measured.  Absolute number of CD3(+)CD4(+) (P = .026), CD3(+)CD8(+) (P = .046), Tregs (P = .023), and CD4(+)CD161(+) cells (P = .042) decreased after endotoxin administration.  The frequency of anti-inflammatory Tregs increased (P = .033), whereas the frequency of proinflammatory CD4(+)CD161(+) cells decreased (P = .034).  Endotoxemia was associated with impaired whole-blood production of tumor necrosis factor-α, interleukin-10, IL-6, IL-17, IL-2, and interferon-γ in response to phytohaemagglutinin but did not affect TLR4 expression on Tregs.  No changes in the absolute count or frequency of BALF T cells were observed.  Systemic inflammation is associated with lymphopenia, a relative increase in the frequency of anti-inflammatory Tregs, and a functional impairment of T-cell cytokine production.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXdAJXsBpl3v9pSBfyDvp7fW6udTcc2eaaK7hpZmkKPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ksF2gtg%253D%253D&md5=f7dbfd460c5a4a95218bdea42de8c2da</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F0885066615606673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0885066615606673%26sid%3Dliteratum%253Aachs%26aulast%3DRonit%26aufirst%3DA.%26aulast%3DPlovsing%26aufirst%3DR.%2BR.%26aulast%3DGaardbo%26aufirst%3DJ.%2BC.%26aulast%3DBerg%26aufirst%3DR.%2BM.%26aulast%3DHartling%26aufirst%3DH.%2BJ.%26aulast%3DUllum%26aufirst%3DH.%26aulast%3DAndersen%26aufirst%3D%25C3%2585.B.%26aulast%3DMadsen%26aufirst%3DH.%2BO.%26aulast%3DM%25C3%25B8ller%26aufirst%3DK.%26aulast%3DNielsen%26aufirst%3DS.%2BD.%26atitle%3DInflammation-induced%2520changes%2520in%2520circulating%2520T-cell%2520subsets%2520and%2520cytokine%2520production%2520during%2520human%2520endotoxemia%26jtitle%3DJ.%2520Intensive%2520Care%2520Med.%26date%3D2017%26volume%3D32%26spage%3D77%26epage%3D85%26doi%3D10.1177%2F0885066615606673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Baenziger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikenwalder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diemand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundig, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, R. F.</span><span> </span><span class="NLM_article-title">Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1182/blood-2008-04-151712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;key=10.1182%2Fblood-2008-04-151712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=377-388&author=S.+Baenzigerauthor=M.+Heikenwalderauthor=P.+Johansenauthor=E.+Schlaepferauthor=U.+Hoferauthor=R.+C.+Millerauthor=S.+Diemandauthor=K.+Hondaauthor=T.+M.+Kundigauthor=A.+Aguzziauthor=R.+F.+Speck&title=Triggering+TLR7+in+mice+induces+immune+activation+and+lymphoid+system+disruption%2C+resembling+HIV-mediated+pathology&doi=10.1182%2Fblood-2008-04-151712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-04-151712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-04-151712%26sid%3Dliteratum%253Aachs%26aulast%3DBaenziger%26aufirst%3DS.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DP.%26aulast%3DSchlaepfer%26aufirst%3DE.%26aulast%3DHofer%26aufirst%3DU.%26aulast%3DMiller%26aufirst%3DR.%2BC.%26aulast%3DDiemand%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DK.%26aulast%3DKundig%26aufirst%3DT.%2BM.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DSpeck%26aufirst%3DR.%2BF.%26atitle%3DTriggering%2520TLR7%2520in%2520mice%2520induces%2520immune%2520activation%2520and%2520lymphoid%2520system%2520disruption%252C%2520resembling%2520HIV-mediated%2520pathology%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D377%26epage%3D388%26doi%3D10.1182%2Fblood-2008-04-151712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00365">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_43045"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00365">10.1021/acs.jmedchem.7b00365</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental details, docking methods, biological assay details, and NMR spectra of <b>54</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_001.csv">jm7b00365_si_001.csv (2.45 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00365/suppl_file/jm7b00365_si_002.pdf">jm7b00365_si_002.pdf (395.07 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00365&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00365%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00365" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a594eb403d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
